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Australia was among the first countries to report the emergence of viral encephalopathy and 
retinopathy (VER), observed as mass mortality of larval fish from marine aquaculture during 
1987-1990. The viral aetiology of the disease was not identified until 1997 by which time 
nervous necrosis virus (NNV) became one of the first aquatic pathogens considered significant 
by the OIE. Unfortunately, the disease emerged during a period when transboundary 
biosecurity controls governing the transport of live aquatic organisms was poor. Today, the 
almost global distribution of the virus, led to its exclusion as a notifiable disease within the 
modern OIE framework in 2003/2004. In Australia, VER remains a notifiable disease of finfish 
and is the major impediment to the expansion and development of grouper aquaculture. Gaps 
in bodies of knowledge that are critical to understanding the disease hinder the management 
of VER in grouper aquaculture in Australia. A review of the literature is discussed in Chapter 1 
and formed the platform for defining the aims of this thesis. This project aimed to improve 
knowledge about NNV in North Queensland and develop strategies to prevent the severe 
economic losses NNV causes grouper aquaculture in Australia.  
At the commencement of this project, there were no complete genome sequences of NNV 
collected from grouper in Australia. The National Centre for Biotechnology Information (NCBI) 
database contained only two complete sequences from VER outbreaks in Australia. Neither 
strain originated from Queensland, which is the region of Australia with sufficient 
infrastructure and environmental parameters to support a grouper aquaculture industry. Only 
one sequence was from a tropical species.  
This project has improved the knowledge of Betanodavirus strains present in Northern 
Queensland. Complete mRNA sequences of NNV were collected from three naturally occurring 
VER outbreaks in marine aquaculture farms of barramundi Lates calcarifer, gold-spotted 
grouper Epinephelus coioides and giant Queensland grouper, Epinephelus lanceolatus (Chapter 
3) herein referred to collectively as the North Queensland Australia (NQAus) NNV strains.  
Phylogenetic comparison of the NQAus NNV genome sequences to reference strains from the 
four recognised Betanodavirus species determined all three strains were members of the 
Redspotted grouper nervous necrosis virus species (RGNNV) (Chapter 3). With this finding, 
RGNNV continues to be the only Betanodavirus species known to be associated with VER in 
Australian fish species. Comparative analysis of the NQAus NNV strains with other strains 
sourced from Australian fish species indicated remarkable conservation of the RGNNV genome 
both temporally and geographically. The RNA 1 and RNA 2 segments of the NQAus NNV strains 
collected in this study retained more than 97% homology to other NNV strains collected from 
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tropical species in Australia and 97-98% homology to the genome of the original RGNNV strain 
isolated from Japan (SGwak97) in 1997. The significant genetic conservation of the RNA 2 
segment across all of the Australian strains of NNV, provided confidence that a vaccine that 
targeted the capsid protein would be applicable across a broad geographic range in Australia. 
The high level of conservation of capsid protein sequence in the RGNNV species also suggested 
that a vaccine effective against any of the three strains studied in this project could have a 
potential global market. The low variance of RNA 2 temporally, indicates there is potentially 
low risk of viral mutation and vaccine escape over time. 
A comprehensive review of the literature discussing the functional motifs of the Betanodavirus 
was conducted (Chapter 4). Positions of the functional motifs to Protein A and the capsid 
protein were mapped on schematic diagrams. Review and identification of the multiple motifs 
across an entire genome have not been reported previously from any strain of Betanodavirus. 
The motifs that have been identified as critical for viral replication and associated with 
virulence were retained by the NQAus NNV strains. Confirmation of the motifs ensured the 
strains used in this study retained the virulence factors reported in the literature and were 
suitable strains for future studies within a context of ensuring that any successful outcomes 
from this study should be translatable to industry.  
Examination of the genome sequences of the NQAus NNV strains collected in this study also 
indicated the RT-qPCRs developed by Hick & Whittington, (2010) would theoretically be 
acceptable to monitor the viral genome copy number throughout this study. PCR amplicons 
produced from RNA 1 and RNA 2 segments of the viral extracts were cloned to produce 
standard control plasmids for the qR1T and qR2T RT-qPCR assays described by Hick & 
Whittington (2010). The RT-qPCR assays of Hick & Whittington (2010) were implemented 
within the laboratory to support the subsequent project activities (Chapter 5).  
Two prophylactics, namely a vaccine and a dsRNA construct were prepared to target and 
prevent disease caused by the NNV strain obtained from a VER outbreak in farmed gold spot 
grouper, Epinephelus coioides (Ec2NQAus) (Chapter 6). The vaccine was based on expressed 
capsid protein produced from the recombinant insertion of the mRNA of RNA 2 of Ec2NQAus 
NNV into a bacterial expression system. The dsRNA targeted nucleotide (nt) region 722 to 738 
of the RNA 2 segment. 
An experimental exposure model for application to test the efficacy of the prophylactic 
measures was tested (Chapter 7). Exposure models that are representative of the natural 
infection route are preferred to test the efficacy of prophylactic measures. In a novel study, 
waterborne challenge via co-circulation with diseased fish along with co-infection with the 
marine leech, Zeylanicobdella arugamensis was tested as an infection model. During a 40-day 
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trial, despite habitation within a shared recirculation system containing ten fish that displayed 
VER following exposure to Ec2NQAus RGNNV via IM challenge, none of the juvenile 
groupers E.lanceolatus exposed by co-circulation succumbed to VER. Furthermore, the viral 
genome was not detected by RT-qPCR from leeches collected from any tank or from tissues 
collected from E.lanceolatus that were exposed by co-circulation. The inability to induce VER 
via waterborne challenge despite the addition of leech infestation, lead to the adoption of 
intramuscular injection of viral extract as a challenge model for subsequent studies. 
The prophylactic measures, including vaccine and dsRNA constructs, were tested for efficacy 
to prevent VER in juvenile E.lanceolatus (~18 g body mass) following IM challenge with 
Ec2NQAus NNV viral extract (Chapter 8). In an initial trial, the dsRNA appeared to have no 
impact in preventing the severity of disease following challenge. The initial trial indicated that 
improvement in survival with vaccination was modest. The vaccinated groups of fish displayed 
between 43-53% cumulative morbidity compared to 88% morbidity in dsRNA exposed groups. 
This modest improvement of 35-45% reduction in morbidity indicated the vaccine formulation 
presented some potential as a preventative measure. Also, the RT-qPCRs qR1T and qR2T were 
applied to trace the viral copy number of RGNNV during the progression of disease following 
experimental challenge (Chapter 8). Both RT-qPCR assays detected viral genome before the 
onset of clinical signs at a cycle threshold value range of 31.8-36.8 (qR1T) and 29.9-45 (qR2T). 
Both RT-qPCR assays detected viral genome with a cycle threshold range of 12.9 to 19.5 (qR1T) 
and 11.1 to 19.0 (qR2T) during the peak period of morbidity. Fish that did not display signs of 
disease were positive for the detection of viral genome indicating the vaccine may improve 
tolerance to the infection rather than preventing infection. However robust conclusions 
regarding fish resistance or tolerance cannot be determined based on RT-qPCR analysis. There 
was relatively few vaccinated fish over 50g that succumbed to VER.  
A mass spawning event with eight potential parents produced the cohort of fish used in the 
experimental challenge trials. Multilocus sequence analysis (MLSA) using microsatellite 
markers was applied to vaccinated fish to investigate the influence of parentage on 
survival/mortality (Chapter 9). Parentage did not coincide with improved survival or increased 
mortality within the studies conducted.  
Assessment of vaccine efficacy on juvenile fish can be flawed if conducted before the 
development of essential components of the fish immune system, therefore E.lanceolatus 
larger than 50g body weight were used to reassess the efficacy of vaccination (Chapter 10). An 
additional vaccine based on heat killed cell culture Ec2NQAus NNV was also evaluated. The 
refined strategy indicated improved protection against VER in the slightly larger fish. Only 20%-
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23% of the E.lanceolatus that were vaccinated displayed signs of VER which was a marked 
improvement compared to the placebo vaccinated groupers (93% morbidity). 
Unfortunately, an investigation into the mechanism of improved protection is beyond the 
scope of this study. RT-qPCR analysis detected NNV genome in all three groups of groupers 
challenged with viral extract. NNV genome was detected in groupers that did and did not 
display signs of VER. Because detection by RT-qPCR does not indicate viability of virus further 
conclusions regarding the protective effect of the vaccines are not proposed.  
 
This work has filled significant gaps in understanding the management of Betanodavirus in 
aquaculture of grouper in Australia, namely:  
 the acquisition of the complete mRNA of three strains of NNV collected from VER 
outbreaks in aquaculture systems in North Queensland;  
 compiling the collection of works that describe the functional motifs of the 
Betanodavirus genome; 
 the preparation of a vaccine that reduced expression of VER to 20%-23% following 
experimental challenge with Ec2NQAus NNV strain; 
 noting there is a mechanism that relates to body weight that affects vaccine efficacy 
and 
 extending the fit for purpose application of two RT-qPCR assays developed by Hick & 
Whittington (2010)to track the pathogenesis of NNV in grouper.  
 
Legacy outcomes from this project are the continued contribution to research into the 
management of disease in tropical aquaculture systems. Specifically, towards FRDC project 
2018:098 which is field trials to test the efficacy of expressed recombinant capsid protein 
vaccine to prevent VNN in the grow-out aquaculture of Epinephelus lanceolatus. In addition, 
the application of the RT-qPCRs of Hick & Whittington (2010) in this project extended the fit 
for purpose of those assays beyond those initially described on tissues from barramundi and 
Australian bass and was applied to support NATA accreditation of a laboratory, JCU AquaPATH, 
to ISO17025 in the field of animal health. The establishment of the AquaPATH laboratory 
ensures that aquaculture industries in Northern Queensland have access to quality assured, 
rapid, high throughput, and quantitative molecular detection assays to help manage the risk 
posed by pathogens of aquaculture species. 
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CHAPTER 1. LITERATURE REVIEW 
Background  
 
Aims of this Chapter  
 
 
 In Cairns, North Queensland, The Company One is one of the most efficient commercial 
grouper hatcheries in the world, with annual production of several million fingerlings.  
 
 Commercial production of grouper in grow-out aquaculture production in Australia is 
restricted by the severe economic losses caused by Viral Encephalopathy and 
Retinopathy (VER) syn., Viral Nervous Necrosis (VNN) disease outbreaks. 
 
 Groupers do not have the restricted period of susceptibility and VER outbreaks have 
been reported in fish up to 3 years old.  
 
 In recent years, as the industry has attempted to expand, the rapid mass mortality of 
grouper in grow-out pond production have occurred with sufficient frequency to 
threaten the economic viability of the industry in Australia.  
 
 Vaccines that protect against virulent strains of viruses are widely adopted as an 
effective strategy to prevent losses due to viral diseases in many fish aquaculture 
systems.  
 
 Despite reported success in experimental systems, there are no commercially available 
vaccines to prevent VER in Australia.  
 Provide current state of knowledge of Betanodavirus  
 Discuss aspects of host biology that have an association with VER 
 Discuss options for the management of Betanodavirus infections in aquaculture 




Grouper, Epinephelus spp., are an important marine fish aquaculture species in many 
countries, particularly Asia (Rimmer and Glamuzia 2017). In 2017 the global aquaculture 
production of grouper was 147 379 tonnes (value 0.7 US$ Billion) (FAO, 2018). The majority of 
the world’s aquaculture production of grouper is from China and Indonesia (Rimmer and 
Glamuzia 2017). However, due to their rapid growth rates and strong market value, grouper 
have potential to be a profitable aquaculture species in Australia (Knuckey, 2015). In Cairns, 
North Queensland, The Company One is one of the most efficient commercial grouper 
hatcheries in the world, with annual production of several million fingerlings. However, the 
majority of the fingerlings produced are exported into Asia for grow out aquaculture 
production (Knuckey pers. comm. 2019).  
 In recent years, as the industry has attempted to expand into grow out production, the rapid 
mass mortality of grouper due to Viral Encephalopathy and Retinopathy (VER) syn., Viral 
Nervous Necrosis (VNN) have occurred with sufficient frequency to threaten the economic 
viability of the industry in Australia. Commercial production of grouper in grow-out 
aquaculture production in Australia is restricted by the severe economic losses caused by VER 
disease outbreaks (Knuckey pers. comm. 2019). Management of VER in grouper hatchery 
systems can be achieved through the implementation of strict biosecurity protocols that 
prevent the entry of Betanodavirus into the culture system. The strategies impose increased 
costs to production but are not practical to prevent VER outbreaks in grouper grow-out 
farming systems such as sea cage or pond cultures. 
Other management strategies must be developed for grouper grow out and pond systems.  
Forty years of research into VER has resulted in the development of cell culture replication 
systems, serological and molecular detection techniques and vaccination and novel anti-VER 
preventatives (Hick et al., 2010; Hick et al., 2011; Tanaka et al., 2001) . However, in Australia, 
there is no commercially available preventative or treatment to manage VER outbreaks. 
Pharmaq™ and HIPRA recently commenced commercial sale of a VNN vaccine in the 
Mediterranean to protect European sea bass against NNV. However, neither vaccines are 
approved for import into Australia and the suitability of the vaccine to prevent VER in grouper 
is untested.  
Vaccines that protect against virulent strains of viruses are widely adopted as an effective 
strategy to prevent losses due to viral diseases in many fish aquaculture systems. However, 
despite the long history of VER in Australia, knowledge of the strains of Betanodavirus that 
cause VER in Northern Australia is limited. The paucity of knowledge of Betanodavirus in 
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Australia along with gaps in the knowledge about critical aspects of grouper biology, including 
antiviral immunity, creates a situation whereby evidence-based management of VER is very 
difficult. This review will discuss the emergence of VER; characteristics of viral taxonomy and 
replication; and host/environmental factors that are believed to associate with VER outbreaks. 
Knowledge of such aspects can be applied to develop evidence-based strategies to manage 
VER in grouper grow out systems in Australia. 
1.2 Emergence of VER in Australia 
Members of the genus Betanodavirus cause the disease Viral Encephalopathy and Retinopathy 
(VER) syn. Viral Nervous Necrosis (VNN) (OIE, 2018). The disease emerged in Australasia, 
Europe and North America during 1985 to 1989 and has been reported from wild and cultured 
freshwater and marine fish in all continents except South America and Antarctica. The National 
Centre for Biotechnology Information (NCBI) database contains 1200+ nucleotide accessions of 
Betanodavirus sourced from over 220 fish species and 30+ countries (Condon et al., 2019). Ten 
gene sequences of Betanodavirus have been published in NCBI from Australian fish 
(www.ncbi.nlm.nih.gov accessed 12.2.2019). In Queensland, VER outbreaks occur in 
commercial larval barramundi, Lates calcarifer (Bloch, 1790) and giant grouper, Epinephelus 
lanceolatus (Bloch, 1790) hatcheries. The World Organisation for Animal Health, Office 
International des Epizooties (OIE) delisted VER in 2004, as notifiable disease, due to the 
worldwide distribution failing to meet one of the defining criteria of a restricted geographical 
host range (OIE, 2004). Despite the de-listing, VER is notifiable in Australia and an impediment 
to successful culture of a number of highly susceptible fish species worldwide. 
1.3 Viral Taxonomy 
The Nodaviridae consists of the genera, Betanodavirus, which infect fish and Alphanodavirus, 
which infect insects. Members of the Nodaviridae also infect crustaceans but taxonomic 
divisions recognising the crustacean-infecting species have not occurred. Four species of 
Betanodavirus are officially recognised by the International Committee for the Taxonomy of 
Viruses (ICTV) namely Striped jack nervous necrosis virus (SJNNV), Barfin flounder nervous 
necrosis virus (BFNNV), Tiger puffer nervous necrosis virus (TPNNV) and Red spotted grouper 
nervous necrosis virus (RGNNV) (ICTV//www.ictvonline.org./virustaxonomy.asp). The species 
names represent the host species of the original viral isolate and are supported by variation in 
the viral genomic sequence. An additional viral strain isolated from Turbot, proposed as a new 
Betanodavirus species, Turbot Nervous Necrosis Virus (TNNV), displays variation in genomic 
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sequence from the four recognised species however formal recognition of TNNV as another 
species has not occurred (Johansen et al., 2004,ICTV//www.ictvonline.org./virustaxonomy.asp)  
The viral species were originally proposed to have strong host specificity. However, excluding 
TPNNV, the different genotypes can infect a variety of fish species (Thiery et al., 2004). The 
viral species were also originally observed to have species-specific temperature dependency 
(Iwamoto et al., 1999) however, variation from the original temperature distributions are 
known to occur and RGNNV exhibits the greatest temperature tolerance (Panzarin et al., 
2016). The taxonomic distribution of the 1400+ sequences published in NCBI nucleotide 
database includes SJNNV (182), RGNNV (389) BFNNV (76), TPNNV (5) and other strains which 
have not been formerly classified into species divisions (www.ncbi.nlm.nih.gov. accessed 
18.8.19).  
1.4 Viral genome characteristics 
Nodaviruses possess a small linear single stranded bi-segmented positive sense RNA (+ss RNA) 
genome contained within an approximate 25 to 35 nm un-enveloped capsid of icosahedral 
symmetry (Venter and Schneemann 2008). Nodaviruses replicate exclusively in the cytoplasm. 
Virions are stable between pH 2 to 9 and resistant to heating at 56 °C for 30 min (Frerichs et 
al., 2000). The Nodaviridae possess one of the smallest animal infecting viral genomes. 
Genomes are approximately 4.5 kb nucleotides (nt) consisting of a Segment 1 (RNA 1) of 3.1kb 
nt and Segment 2 (RNA 2) 1.4kb nt. Both segments possess a 5’ end methylated cap that 
assists in recruiting the eukaryotic translation machinery to translate viral proteins (Mori et al., 
1992). Both segments lack a 3’ poly a tail but the RNAs are protected by an unknown moiety 
(Venter & Schneemann 2008).  
The RNA 1 (3.1kb nt) contains the mRNA for the ~ 1000 amino acid (aa) Protein A encoded by 
nt 79 to 3027( ). A sub-genomic RNA, termed RNA3, not packaged into virions, is synthesised 
from the 3’ end of the RNA 1 segment. RNA 3 consists of ~387 nt and encodes the B1 (111 aa) 
and B2 (72 aa) proteins (Venter & Schneemann 2008; Toffolo et al., 2007). The B1 protein is 
translated in the same reading frame as Protein A and is encoded by the 336nt of the 3’ 
terminus of the RNA 1(nt 2688 to 3027). The B2 protein requires a +1-reading frame shift for 
translation compared to B1 and is encoded by 227 nt on the RNA 1 (nt 2753 to 2980) 
(Biacchesi 2011; Venter & Schneemann 2008). RNA 3 also acts as a transactivator in the 
replication of RNA 2. Paradoxically, the replication of RNA 2 results is the cessation of 
replication of RNA 3 (Venter & Schneemann 2008). RNA 2 (1.4kb nt) contains the mRNA for the 
capsid protein. In the Alphaviruses the capsid protein is ~ 430 aa compared to 338 aa of the 
Betanodaviruses (Venter & Schneemann 2008). How the nodavirus Viral RNA interacts to 
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infect and cause disease in vertebrates is not completely understood. Knowledge of viral 
replication processes will aid in developing novel anti-viral therapies to limit disease. 
1.5 Phylogenetic comparison of Betanodavirus 
Phylogenetic studies are useful to identify virulence factors and produce epidemiological 
models to understand viral transmission pathways. Initial phylogenetic studies of the 
Betanodaviruses were based on the viral capsid protein or RNA 2 and indicated strong nt and 
aa distinction between the species (Nishizawa et al., 1997). However, the presence of 
reassortments between RGNNV, SJNNV and BFNNV suggests the phylogenetic studies should 
consider both the RNA 1 and RNA 2 (Toffan et al., 2017 and Oliveira et al., 2009).  
Phylogenetic comparisons between the Betanodavirus strains initially occurred through 
analysis of the nt sequence of RNA 2 or its translated capsid protein sequence. The RNA 2 of 
TPNNV and SJNNV regions are identical in nt length. BFNNV and RGNNV lack 6 bases at 
position 713 to 718 nt of the RNA 2 strand. Comparative similarity of a T2 region (nt 155 to 
1030) within the RNA 2 strand between the different species was 75.8 % or more at nt and 
80.9 % or more at aa level. Within T2 a highly conserved (>93 %) 134 aa region and highly 
variable T4 (62 %) 81 aa region was identified (Nishizawa et al., 1995). The T4 (nt 604 to 1030), 
T2 and base insertion or deletion at nt 713 to 718 were proposed as a site for species 
differentiation of the Betanodaviruses. The conclusions of that analysis supported the division 
of the 4 species originally defined by host species (Nishizawa et al., 1995).  
Comparison of the T4 region in a phylogenetic analysis of 25 Betanodavirus isolates collected 
in Japan resulted in the divergence of the Japanese isolated Betanodaviruses into 4 clusters 
containing 95 % or greater nt sequence similarity (Nishizawa et al., 1997). The clusters were 
defined as TPNNV, SJNNV, BFNNV and RGNNV. The majority of NNV isolates from Japanese 
flounder aligned within the RGNNV species and only a single isolate (JF95Hok) aligned with the 
BFNNV species (Nishizawa et al., 1997). Japan remains the only country to report VER isolates 
from all four of the recognised Betanodavirus species. Phylogenetic analysis of the region 
consisting of RNA 2 nt 169 to 987 was conducted on Betanodaviruses isolated from cultured 
fish in Korea (Cha et al., 2007). The classification supported the 4 species previously identified 
and proposed an additional 5th group consisting of a single isolate from a Turbot from Norway 
(TNNV-Norway AJ608266) (Johansen et al., 2004).  
Using deduced aa analysis encoded by the T4 region of 44 Betanodavirus isolates from various 
countries in Europe, Asia and the Mediterranean, a different classification nomenclature was 
proposed (Thiery et al., 2004). The classification consisted of 4 clusters and 5 subtypes namely 
Ia and Ib (RGNNV); IIa, IIb, IIc (BFNNV); III (TPNNV) and IV (SJNNV). The clustering within each 
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group was more related to the geographical source of the isolate than the host species (Thiery 
et al., 2004). Cherif et al. (2009) applied the phylogenetic clusters of Thiery et al. (2004) to 
investigate a number of NNV isolates in D. labrax and sea bream Sparus aurata from Tunisia. 
All isolates clustered within the RGNNV genotype. Four of the isolates were obtained from 
temperatures 15 to 19 °C, which is outside that typically observed for the RGNNV. In a novel 
report, nine different sequences were observed within a single farm. In contrast to previous 
observations, geno-grouping of the fish Betanodaviruses appeared to reflect an adaptation to 
a range of temperatures rather than geographic location or host specificity (Cherif et al., 2009). 
Recognising some discrepancy in the classification of Betanodavirus strains based on T4, some 
researchers report phylogenetic analysis including both RNA 1 and RNA 2 of the Betanodavirus 
genome (Toffolo et al., 2007). Analysis of the RNA 1 nt 121 to 1050 of SJNNV identified 25 
unique RNA 1. Analysis comparing RNA 2 from nt 388 to 894 of SJNNV that contained the 
species-specific 6 nt insert region identified 22 unique sequences. Phylogenetic division of the 
Betanodaviruses was possible using either RNA 1 or RNA 2 however, the divisions strongly 
contrasted (Toffolo et al., 2007). Using the RNA 1 strand the SJNNV, BFNNV and RGNNV or 
clades IV, II and I phylogenetic groupings were statistically well-supported (Toffolo et al., 
2007). A sister group relationship was proposed for the TPNNV, BFNNV and SJNNV or clades III, 
II and IV. Two of the Iberian isolates clustered within the SJNNV/IV when grouped by analysis 
of RNA 1. The same two were positioned in the RGNNV/I cluster when grouped by analysis of 
RNA 2. There was an absence of any evidence of recombination between different RNA 1 
segments however; recombination in RNA 2 between different isolates was observed. Toffolo 
et al. (2007) proposed both RNA 1 and RNA 2 must be considered for phylogenetic purposes 
with RNA 1 possibly being a better marker to assess the origin of a single isolate.  
Phylogenetic relationships between VER strains detected in the Iberian Peninsula, collectively 
termed IBNNV, indicated the presence of re-assortment between Betanodavirus species 
(Olveira et al., 2009). Comparing RNA 1, all IBNNV isolates clustered within 97 % nt sequence 
homology to the RGNNV species (Olveira et al., 2009). Comparison of RNA 2 indicated 
divergence with only 1 of the IBNNV strains aligning within the RGNNV isolates and the 
remaining 6 displaying stronger similarity to the SJNNV species. Genomic analysis of 
Betanodaviruses from cultured fish species in Malaysia also considered RNA 1 and RNA 2 
(Ransangan & Manin, 2012). All of the studied Betanodaviruses from Malaysia presented as 
nine clusters within the RGNNV species. Unlike Toffolo et al. (2007) the clustering was 
consistent between RNA 1 and RNA 2 analysis, which is expected in the absence of 
reassortment between multiple NNV species. 
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The limitations of the T4 region as a classification tool were not recognised until after 2004. 
Many of the sequences contained in the NCBI (1999 to 2004) are not complete and make 
retrospective phylogenetic studies with newly detected NNV strains difficult. A recent 
phylogenetic study was conducted comparing 189 RNA 1 Betanodavirus sequences (32 
RGNNV, 154 BFNNV, 1 TPNNV and 2 SJNNV) and 73 RNA 2 Betanodavirus sequences (54 
RGNNV, 8 BFNNV, 1 TPNNV and 10 SJNNV) (He & Teng, 2015). During the period the isolates 
were collected, the RNA 1 had a mean nt substitution rate of 3.60 per 10 000 nt per year 
compared to RNA 2 of 3.69. Within the RGNNV types substitution rates of 4.28 and 3.79 per 10 
000 per year were calculated for the RNA 1 and 2 respectively (He & Teng, 2015). Taxonomic 
divisions proposed by Nishizawa were supported by the analysis with the identification of 
subclades within the genotypes. Using the RNA 1, the RGNNV could be divided into 3 
subclades compared to 6 subclades using RNA 2 (He & Teng, 2015). 
To develop more effective means to understand the epidemiology of VER a greater quantity of 
genomic sequence information of the isolates is required. An understanding of the 
contributions the genomic sequences make in the progression of disease (pathogenesis) of 
VER could assist in developing strategies to overcome the disease. 
1.6 Viral Nervous Necrosis: The Disease 
1.6.1 Emergence of VER:  
VER, originally termed Whirling disease or Summer disease, emerged as a disease causing up 
to 88 % mortality in intensive larval fish hatcheries during 1983 to 1989 (Gallet de Saint Aurin, 
Raymond & Vianas, 1989). Clinical signs of VER in larval fish include loss of appetite, darkened 
colour, erratic and spiral swimming and hyperinflation of the swim bladder. In larval rearing 
systems, clinical signs are usually followed by mass mortality over 2 to 14 days (Moody & 
Crane, 2012).  
Histopathology of VER disease involves extensive vacuolation of the brain and retinal tissues. 
Viral particles were reported in association with VER histopathology in larval production 
systems of, Dicentrarchus labrax in the French Caribbean Islands (Gallet de Saint Aurin et al., 
1989), turbot, Scopthalmus maximus in Norway (Bloch et al., 1991), Japanese parrotfish, 
Oplegnathus fasciatus in Japan (Yoshikoshi & Inoue 1990), and barramundi, Lates calcarifer in 
Australia and Tahiti (Glazebrook et al., 1990) (Renault et al., 1991).  
Purification and partial characterisation of viral particles from striped jack Pseudocaranx 
dentex suffering VER was reported in 1992 (Mori et al., 1992). Based on the viral 
characteristics VER was proposed to be caused by new member of the Nodaviridae designated 
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Striped Jack Nervous Necrosis Virus (SJNNV) (Mori et al., 1992). SJNNV was the first nodavirus 
to be purified from a vertebrate during a time when no member of the Nodaviridae had been 
isolated from outside Australasia (Johnson et al., 2000). Experimental infection trials 
confirmed SJNNV as the aetiological agent of VER in P.dentex (Arimoto et al., 1993). Nishizawa 
(1995) provided viral genome and aa analysis to support the classification of NNV as a member 
of the Nodaviridae. Betanodavirus was officially accepted as a new genus in the family 
Nodaviridae in 1997 (ICTVonline.org/proposals/Ratification_1997.pdf). SJNNV became the 
type species of the Betanodavirus genus. Other species include Barfin Flounder Nervous 
Necrosis Virus (BFNNV), Redspotted Grouper Nervous Necrosis Virus (RGNNV) and Tiger Puffer 
Nervous Necrosis Virus (TPNNV).  
1.6.2 Host range:  
Betanodavirus isolates have been collected from larval and juvenile stages of over 157 marine 
and freshwater fish species in tropical and temperate climates (www.ncbi.nih.gov/). VER 
disease outbreaks have been reported from farmed cultures and wild fisheries (Koohkan et al., 
2012) (Breuil et al., 2000). In experimental infection trials, susceptibility of fish species has 
been classified as highly susceptible, less susceptible or resistant to NNV (Furusawa et al., 
2007). A similar pattern occurs in wild fisheries. The highly susceptible species display 
mortalities of 80 to 100 % in either larval or larval and later life stages. Most of the highly 
susceptible species are only susceptible to VVN during early larval stages. Except, the groupers, 
Epinephelus sp. and European seabass, Dicentrarchus labrax, are susceptible beyond the larval 
stages. Groupers up to 3 years old have been recorded with VER (Tanaka et al., 1998). Notably, 
there have been no reports of VER in Atlantic salmon, Salmo salar, despite the geographical 
presence of NVV where they are cultured and the fish being reportedly susceptible to 
experimental infection with BFNNV via intraperitoneal injection (Korsnes et al., 2005). Also 
notable in the Northern Australian aquaculture context is the absence of reported disease 
outbreaks in cobia, Rachycentron canadum which are being experimentally grown within 
marine systems in the same geographic range as barramundi and grouper. Chu et al. (2013) 
reported a case study of mortality exceeding 80% in cobia from 3 farms in Malaysia during 
2007. Fish displayed signs of VER which included the mass mortality and abnormal spiral 
swimming behaviour and “flashing” and were positive for the detection of NNV by RT-PCR 
(Chu et al., 2013). No similar reports have occurred from cobia aquaculture despite, in some 
circumstances in Australia, cobia being cultured in pond cages immediately adjacent to 
grouper suffering a VER outbreak (unpublished data). 
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Betanodaviruses have also been detected from a number of non-piscine hosts including the 
spiny lobster Panulirus versicolor (Gomez et al., 2006), Artemia sp, Copepod Tigriopus 
japonicas, shrimp Acetesinte medius, Charybdid crab Charybdis bimaculata, Southern 
humpback shrimp Pandalus hypsinotus , Mediterranean mussel Mytilus galloprovincialis 
(Gomez et al., 2008) and Japanese common squid Todarodes pacificus (Gomez et al., 2010). 
The detections were not associated with any clinical signs of disease and the role these 
alternate hosts play in the transmission of Betanodaviruses to fish species has not been 
demonstrated. There is increased awareness of the biosecurity threats posed by the 
bioaccumulation of NNV in molluscs as a reservoir for infection to cultured fish (Volpe et al., 
2017). Re-isolation of RGNNV from the hepatopancreas and detection of virus in surrounding 
water following experimental exposure to RGNNV was recently demonstrated from the Manila 
clam Ruditapes philippinarum (Volpe et al., 2017).  
1.6.3 Transmission of Betanodavirus 
VER has been experimentally induced in susceptible fish species through exposure to viral 
extracts via multiple routes including intramuscular injection (IM), intraperitoneal injection 
(IP), intranasal inoculation (IN), water bath exposure and co-habitation with infected 
individuals. Betanodavirus RNA was detected in developing embryos of E. coioides by PCR and 
in-situ RT-PCR suggesting a vertical transmission pathway within the hatchery system (Kuo et 
al., 2012). Likewise, BFNNV with a copy number of 103 per sample was detected from the 
gonads, eggs and fertilized eggs of Pacific cod Gadus macrocephalus (Mao et al., 2015). In the 
same study, food sources including Artemia, Chlorella and enhancer limacinum were negative 
for detection of Betanodavirus by PCR. In contrast, Whittington (2012) reported NNV was 
transmitted horizontally, from unknown source but not vertically in a larval barramundi 
hatchery system. Individual fish from susceptible species which survive Betanodavirus 
infection have been demonstrated to carry the virus. The sub-clinically infected fish are 
believed to act as a reservoir source for horizontal transmission of the virus to other fish. 
Within hatchery systems, VER has been effectively managed through strict management 
protocols which involve the quarantining larval fish production by disinfection of incoming 
water, fertilised eggs, hatchery equipment and workers. In the fish species that are only 
susceptible during larval stages, this strategy is very effective. For species, including groupers 
and European sea bass, which have a longer period of susceptibility that are cultured in 
outdoor pond or cage systems, the management of VER continues to be an issue.  
1.6.4 Progression of Betanodavirus infection  
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 In natural infections, the pathways involved in the spread of Betanodavirus from the site of 
infection to the nervous tissues have not been determined. Brain-infecting viruses can spread 
to the brain by either axonal transport from the skin or muscle to dorsal root ganglion or 
anterior horn cells and then to neurons and the CNS or can spread to the brain via the blood 
(Lu et al., 2008). Betanodavirus has been detected in the epithelial cells of skin and in the 
intestinal epithelium with concurrent detection in the nerve cells of the brain in the early stage 
of NNV infection (Chi, 2011). Infection via intranasal swab was reported to proceed through 
the nasal epithelium, pass through the olfactory nerve and olfactory bulb and invade the 
olfactory lobe (Chi, 2011). The pathway of Betanodavirus spread in zebrafish is proposed to 
occur via the blood (Lu et al., 2008). In contrast, no RGNNV or SJNNV was detected in blood 
samples in experimentally infected fish despite positive detection in the brain, spinal cord and 
eye of E. moora and Striped Jack, P. dentax (Banu et al., 2007). Ikenaga et al. (2002) observed 
SGNNV injected into the retinal ganglion cells was transported in the optic nerve to the axon 
terminal of the brain, where the virus proceeded to spread various regions of the brain. The 
virus can be consistently isolated from the eye and brain and with varying success from fin 
tissue, spleen, liver, stomach and heart (Chi, 2011). Brain and eye are the target tissues for 
virus isolation procedures in disease investigations (Moody & Crane, 2012). Histopathological 
changes in fish displaying clinical disease symptoms involve vacuolation of the nervous tissues 
with the absence of any notable inflammatory immune response (Tanaka et al., 2004). For 
specific descriptions of histopathology refer to the descriptions by Tanaka et al. (2004). 
1.6.5 Pathogenesis of Betanodavirus Infection and VER disease 
A number of factors reportedly modulate the expression of VER disease. Age of fish, salinity, 
water temperature and water sediment load are proposed to influence the development of 
disease. How the factors influence progression to disease is unknown. Environmental 
conditions are proposed to play a play a key role in switch form a carrier-state to acute phase 
mortality (Kara et al., 2014).  
1.6.5.1 Age of fish 
Larval fish are particularly susceptible to VER (Moody & Crane, 2012). In larval stages of highly 
susceptible marine species, mortalities of 80 to 100 % occur over 4 to 6 days from the onset of 
clinical signs (OIE, 2019). The period of larval susceptibility varies between species. Although 
other stressful age-dependent developmental events may contribute, presumably an 
immature immune system in the fish contributes to the mass deaths in the presence of 
Betanodavirus. Jamarillo et al. (2017) reported an age susceptibility pattern in juvenile 
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barramundi whereby only larval stages are highly susceptible to NNV. Juvenile barramundi, 
older than 5 weeks of age, develop a subclinical infection, whereas younger cohorts suffer 
clinical disease and mass mortality (Jaramillo et al., 2017). The immune pathway that may 
confer this change is susceptibility is unknown. The report of Jaramillo et al. (2017) is the only 
study to demonstrate the age-related conversion from susceptibility to a tolerance of RGNNV. 
Few studies encompass the development of immune function and Betanodavirus infection and 
VER disease. Some studies have detected and monitored changes in specific immune factors. 
In grouper, E. coioides, Down syndrome cell adhesion molecule (DSCAM) A and B and 
Myxovirus resistance protein (Mx) were monitored by qPCR for 27 days post-hatch (dph). 
DSCAM A and B displayed a modulating 7-day cycle peaking at 4- and 11-days post-hatch (Yew 
et al., 2012). Mx was detected at minimal levels until 6 dph whereby it continued to increase 
until 9 to 12 dph before reaching relatively stable levels for the next 14 days (Yew et al., 2012). 
Interferon-α was not detected in larval zebrafish during the time they display high 
susceptibility to VER disease (Lu et al., 2008). In Epinephelus bruneus, although primary 
lymphoid organs are present from days 1 to 12, the development of the immune system in is 
incomplete until 30 dph (Huang & Han, 2015). “Complete” immune system development was 
determined by histology of tissues rather than demonstration of functional capability (Huang 
& Han, 2015). The age-related factors which favour VER disease outbreaks require further 
investigation. 
1.6.5.2 Water Temperature 
1.6.5.2.1 Temperatures associated with natural disease outbreaks: 
In vitro the four Betanodavirus species display temperature range specificity.  
Disease outbreaks in the wild and experimental infections with strains of Betanodavirus 
indicate temperature is a modulating factor in VER disease (Ciulli et al., 2006). The modulating 
effects of temperature occur at ranges which were beyond those reported for in vitro growth. 
In the wild, a BFNNV strain has caused disease at temperatures between 4 to 15 °C (Tanaka et 
al., 1998). A SJNNV strain induced disease in striped jack larvae in water temperatures ranging 
from 18 to 27 °C (Tanaka et al., 1998). Natural outbreaks of disease caused by RGNNV disease 
tends to occur at both increased and decreased temperatures. In grouper species, increased 
mortalities from VER have been reported to occur with temperature decreases below 22 °C 
even though the RGNNV strain does not replicate well at this temperature range in vitro (Kara 
et al., 2014). A sudden drop in temperature induced VER in D. labrax which displayed no 
clinical signs when held at higher temperatures (Thiery et al., 1999). Vertical transmission of 
VER can occur in D. labrax at temperature below 15 °C (Breuil et al., 2002). In vitro growth of a 
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RGNNV strain isolated from the Adriatic Sea displayed growth over a temperature range of 15 
to 30 °C (Ciulli et al., 2006). Conversely in the Asian continent, grouper mortalities due to VER 
were noted in Japan and Taiwan when water temperatures exceeded 25 °C and 29 °C 
respectively (Kara et al., 2014). In an outbreak of VER caused by a RGNNV strain in Italy, the 
highest mortalities were observed in fish held at highest temperatures (28 to 30 °C). Lower 
mortalities were observed and ceased when the farmer lowered the temperature below 23 °C 
(Bovo et al., 2011).  
1.6.5.2.2 Temperatures associated with experimental challenge: 
In experimental infections some variation from temperatures has occurred in SJNNV and 
RGNNV and recombinants of these strains (Souto et al., 2015b). Immersion exposure of 
Senegalese sole to a RGNNV RNA 1/SJNNV RNA 2 natural re-assortment at a dose of 105 TCID50 
had reduced mortality and clinical signs at 16 °C compared to fish held in 18 °C and 22 °C 
(Souto et al., 2015b). Only 8.3 % mortality was recorded in infected fish held at 16 °C 
compared with >80 % at the other temperatures (Souto et al., 2015b). The detection of RNA 1 
indicated significantly greater copy number at 22 °C and 18 °C (1010) compared at 16 °C (106 to 
108) over the 30-day trial. Groupers infected at 16 °C and subsequently exposed to 
temperature increased to 22 °C displayed mortalities approaching 100 % (Souto et al., 2015b). 
Hyperactivity increased in fish 4 to 5 days after a temperature increase and earlier for fish 
which had been acclimated to 16 °C for longer than 15 days. Viral copies were detected in all 
fish infected at 16 °C however, viral load displayed changes over time and decreased from 2.7 
x 109 at 45 to 66 days post-challenge (dpc). Viral copy number in fish at 22 °C was in the 109 to 
1010 range depending on the period of time which the fish had originally been held at 16 °C 
(Souto et al., 2015b). Viral loads of 107 to 108 were observed in fish which died at 16 °C 
indicating that increased viral load did not cause the mortality. 
Challenge of larval fish with RGNNV at 28 °C induced 100 % mortality at 50 to 80 hpi (Lio-Po & 
de la Pena 2004). An experimental challenge of E. akaara juveniles with RGNNV caused 100 % 
mortality at 24 to 28 °C. At 16 to 20 °C mortality was reduced to 57 to 61 % and the time to 
onset of clinical signs was delayed. In addition, viral antigen was detected among survivors 50- 
dpc (Lio-Po & de la Pena 2004). Similar results were reported when juvenile sevenband 
grouper, E. septemfasciatus, were experimentally exposed to a RGNNV extract at different 
temperatures (Tanaka et al., 1998). In the experiment of Tanaka et al. (1998) none of the fish 
which survived RGNNV and were later held at 20 or 24 °C displayed a positive result using 
fluorescent antibody testing (FAT) against the capsid protein at 50 days post-challenge (dpc). 
In contrast, fish held at both the higher or lower temperatures were positive for VER by FAT. 
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 Experimental exposure to a greasy grouper NNV (GGNNV) strain induced 100% mortality in 
larval grouper at temperatures ranging from 24 to 32 °C (Chi et al., 1999). Fish held at a 
constant temperature of 28 °C displayed 100 % mortality by 50 hours post-challenge (hpc). In 
contrast, fish held at ambient temperature which ranged from 28 to 24 °C displayed 100 % 
mortality after 80 hpc (Chi et al., 1999). An RGNNV strain caused increased mortality in larval 
Australian bass M.novemaculata reared at 22 °C compared to 17 °C (Jaramillo et al., 2015). 
Testing on older resistant fish revealed no change in mortality occurred with increased 
temperature (Jaramillo et al., 2015).  
Temperature is a major factor for stimulating asymptomatic carriers to become symptomatic 
fish (Kara et al., 2014). VER was induced in sub-clinically infected zebrafish by increased water 
temperature (25 to 32°C) and crowding (10 to 40 fish/L) (Binesh 2014). The changes in 
mortality rate could be due to an alteration in fish anti-viral immunity induced by temperature 
rather than temperature modulated alterations on Betanodavirus replication (Tanaka et al., 
1998). Breuil et al. (2000) reported the detection of antibodies to nodavirus in the serum of 
adult D.labrax for 2 years post infection with antibody levels declining over winter. The effect 
of age and temperature on antiviral immunity was investigated in zebrafish (Dios et al., 2010). 
In larval Zebrafish, known to be susceptible to VER, anti-viral immune response genes 
including Mx, MDA-5, Interferon- (IFN-1), Toll-like Receptor 3 (TLR-3), Interferon regulatory 
factor 3 (IRF3) and Interferon- ϒ (IFN-ϒ), were very sensitive to low temperature (Dios et al., 
2010). Further investigation is required to elucidate the relationship between temperature and 
VER disease events. 
1.6.5.3 Salinity:  
VER occurs in freshwater, brackish and marine environments indicating a large salinity 
tolerance of the Betanodaviruses. Two strains of VER isolated from D. labrax in the 
Mediterranean lost infectivity after 6 months storage at 15 °C in freshwater compared with a 
TCID50 of 104 to 4.5 when stored in seawater of 20 or 37 ppt (Frerichs et al., 2000). An RGNNV 
strain caused varying levels of disease when injected into freshwater fish (Furuzawa et al., 
2007). According to some grouper farmers, mortality due to VER can be downregulated by 
decreasing the salinity of the sea water (Chi, 2011). In an experimental infection with a 
grouper NNV strain, mortality was reduced in fish acclimated at 15 ppt compared to those held 
at 30 ppt (Chen, 2014). 
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1.6.5.4 Organic load and Sediment 
Verbal reports from hatchery workers suggest VER outbreaks are preceded by periods of high 
sediment in inlet water (unpublished pers comms numerous aquaculturists). The association 
has not been investigated but could involve a number of mechanisms. Firstly, Betanodavirus 
particles shed by wild fish may directly attach to estuarine sediments which then enter the 
hatchery system during periods of high turbidity. The adsorption and detachment of enteric 
viruses in estuarine sediment is influenced by salinity and organic matter (LaBelle & Gerba, 
1979). No similar studies have been conducted on Betanodaviruses. In addition, higher 
sediment loads may induce stress in larval fish which could downregulate components of the 
antiviral immune system which protect against infection. High sediment loads negatively affect 
the efficacy of ozone and UV sterilisation protocols used to prevent VER. Levels of pesticides or 
other environmental contaminants are known to have adverse effects on the immune 
functioning of fish (Bols et al., 2001). The pesticides diuron, atrazine, hexazinone, tebuthiuron 
and ametryn have been detected in the Great Barrier Reef waters with greatest concentration 
in estuarine waters which are the intake waters for the vast majority of tropical finfish 
aquaculture systems in Northern Queensland (http://reefrescueresearch.com.au/news/183-
pesticide-dynamics-in-the-gbr.html). 
1.7 Managing VER in grow out fish aquaculture 
A major impediment to the successful management of VER in the grow-out culture of some 
fish species, groupers and D. labrax, is caused by the lack of understanding into the initiation 
of the disease. It is unknown if VER disease outbreaks on grow-out farms are caused by 
exposure of naïve individuals to Betanodavirus or a result of changes in the sub-clinical fish-
virus dynamic to favour progression of disease. The noting of factors associated with VER 
disease suggests some form of immune modulation must be involved. Regardless, considering 
the wide host range, presence of sub-clinical carriers and the wide environmental tolerance of 
the virus, if the first scenario is the cause of VER outbreaks on grow out farms it is unlikely 
exposure to Betanodaviruses can be prevented in open pond systems. Hence, managing the 
culture conditions to favour fish survival in the presence of Betanodavirus may be a more 
appropriate strategy. Attempts to manage Betanodavirus, and generally fish viral infections, in 
grow out aquaculture systems can be broadly categorised as either the production of: 
 anti-viral compounds which target virus replication or  
 Immuno-modulators which target fish immune function.  
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1.7.1.1 Anti-Viral Compounds  
The study of anti-viral compounds for application to fish aquaculture is very limited. With the 
exception of ribavirin, the anti-viral compounds which have been reported have only been 
investigated in vitro and none have been approved for use as commercially available and 
registered for use in aquaculture in Australia. Considering the lengthy process involved in 
registering compounds for aquaculture applications and the negative regard consumers have 
for chemical compounds in food, it is unlikely an anti-viral therapy will be available to 
aquaculture in the near future. In addition, considering the long culture period (6-10 months) 
of some grow out systems, it is likely multiple doses of any effective compound would be 
required. Nonetheless, research into such therapies may contribute towards improved 
understanding of the host-virus dynamic.  
Some compounds which inhibit endosomal acidification have been reported to inhibit RGNNV-
induced CPE e.g. NH4Cl, chloroquine and bafilomycin A1 (Adachi et al., 2007). Neuraminidase 
and tunicamycin blocked the attachment of DGNNV to SSN-1 cells (Liu et al., 2005).  
Ribavirin is a known inhibitor of RNA viruses and used as an anti-viral drug to combat human 
viral infections. Ribavirin (25 µM) inhibited Betanodavirus induced CPE by 54 % in GF-1 cells 
(Huang et al., 2015). Expression of RNA 1 and RNA 2, detected by RT-PCR, were decreased by 
approximately 80 % (Huang et al., 2015). The interaction between ribavirin and Betanodavirus 
was hypothesised to occur with Protein A at the region between AA 585 to 744. Based on 
comparisons of ribavirin binding with foot and mouth disease virus Protein A specific RGNNV-
ribavirin binding residues were proposed to be aa K586, F589, D590, N655, S646 and G647. All 
of the residues except N655 are located on the conserved motifs of the viral RNA dependant 
RNA polymerase motifs (Huang et al., 2015). Ribavirin was demonstrated to reduce mortality 
in Salmo salar caused by infectious salmon anaemia virus (ISAV) by 90% (Rivas-Aravena et al., 
2011). However, the drug is not approved for use in aquaculture. 
The development of a cell-based screening platform to assess anti-Betanodavirus compounds 
allowed the detection of forty-three compounds which reduced RGNNV–induced CPE by at 
least 50% (Huang & Han 2015). Only proadifen hydrochloride, which is a known inhibitor of 
neuronal nitric oxide synthase (NOS1) and cytochrome P-450, was further investigated. 
Effective compounds were listed and broadly categorised as antibacterial, antifungal, 
antimalarial, enzyme inhibitors, hormones, membrane transport modulators, neurotransmitter 
agents, phytochemicals, sterols, peripheral nervous system agents and the colouring agent 
erythrosine sodium. Interestingly, erythrosine sodium, syn. erythrosine B (FD&C Red No. 3) has 
been demonstrated to be a non-discriminant potent inhibitor of the protein-protein 
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interactions between: Tumor Necrosis Factor (TNF) -Receptor-TNFα, epidermal growth factor 
receptor (EGF-R–E) and cluster of differentiation (CD) CD40-CD154 (Ganesan et al., 2011). The 
mode of action of erythrosine sodium on Betanodavirus replication has not been determined. 
Considering erythrosine sodium is approved for use as a food dye this compound may be a 
promising anti-viral compound for aquaculture. 
Although the expense and unfavourable acceptance by consumers may limit the application of 
anti-virals to aquaculture applications, the knowledge gained from studies using anti-virals 
contribute to a greater understanding of the host-Betanodavirus dynamic. 
1.7.1.2 Immuno-modulation of the Fish host 
In open pond or cage aquaculture, options that modulate the fish immune system will be more 
achievable than attempts to directly managing the virus to prevent VER. Unfortunately, this 
study is being attempted when there is limited knowledge about the grouper anti-viral 
immune system. Nonetheless, there is some reported success in preventing VER via 
modulation of the fish immune system.  
1.7.1.2.1 Stimulation of the Non-specific (Cellular) immune pathway 
Early attempts to improve survival of fish following Betanodavirus challenge using immune 
stimulating compounds reported success. The compounds were essentially “mimics” of 
pathogens which stimulated the non-specific immune pathways recognition by pathogen 
recognition receptors (PRRs). The intramuscular (IM) delivery of poly I:C and interferon have 
been reported to prevent VER if delivered during “appropriate time frames” (Kuo et al., 2016). 
Unfortunately, the “appropriate time frames” were a short period prior to Betanodavirus 
exposure or the appearance of clinical signs which could be unknown in a fish culture 
situation. Additionally, the protective period provided by such compounds was a short lived, 
24 to 48 hours (Kuo et al., 2016).  
1.7.1.2.2 Stimulation of the specific (Humoral) Immune pathway  
Many report the successful reduction in mortalities due to NNV infection with an experimental 
vaccine. Vaccination is discussed in greater detail in Chapter 6. However, it is important to 
note that despite a long history of reported success in experimental systems, there are no 
vaccines commercially available in Australia or Asia. Pharmaq™ and HIPRA commenced the 
sale of the only vaccine against NNV available to Europe in 2018. Considering the demand and 
sizeable commercial value, the absence of a commercially available vaccine against NNV may 
indicate that the management of VER is more complicated than vaccination alone. 
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1.8 VER in Grow-Out Aquaculture systems. What determines 
Betanodavirus infection vs VER disease? 
An increasing body of data indicates changes or differences in immune function in the fish host 
contribute to the expression of clinical VER disease. Reports noting histopathological 
differences in carrier and diseased fish suggest a role of immunity. Vacuolation of the nervous 
tissue is invariably associated with fish displaying disease symptoms. The abundance of 
vacuolation of the nervous tissues and the absence of notable inflammatory response in the 
neural tissues is associated with other vertebrate diseases. Spongiform encephalopathy (SE), 
caused by prions PrPsc, is also characterised by histopathology by the vacuolation of neurons 
and adjacent glial cells, and the absence of any inflammation or immune response to the agent 
(Murray et al., p.599). One of the earliest descriptions of VER pathology noted the similarity 
with the histopathology induced during SE (Gallet de Saint Aurin et al., 1989). The observation 
that vacuolation, associated with an absence of any inflammation or immune response, leads 
to death is also reported in Semliki Forest Virus (SFV) infections (Fazakerley et al., 2006). 
Experimental inoculation of immuno-competent mice with an avirulent strain of SFV (avSFV) 
results in a strong inflammatory immune response (Fazakerley et al., 2006). Early necrotic cell 
death of oligodendrocytes, followed by apoptotic cell death of uninfected cells lead to the 
clearance of the virus within 18 days pi and the absence of vacuolation of the nervous tissues 
(Fazakerley et al., 2006). However, athymic nu/nu mice, which are deficient in the production 
of cytotoxic-T cells, display vacuolation of the nervous tissue and die when injected with AvSFV 
(Fazakerley et al., 2006). In such cases, priming of the immune system by IP injection of poly 
(I:C) abrogates viral infection in the neural tissues. Experimental exposure of mice to Herpes 
Simplex Virus (HSV) also involves immune v non-immune histopathology, which reflects death 
vs survival (Grubor-Bauk et al., 2008). Mice which are deficient in the expression of natural 
killer T-cells (NKT) display vacuolation of neurons (Grubor-Bauk et al., 2008). The brains of 
immune-competent mice display a mononuclear inflammatory infiltrate (Grubor-Bauk et al., 
2008). Treatment with activated CD8+T cells abrogated the infection in immune-incompetent 
mice (Grubor-Bauk et al., 2008).  
Similarly, with VER, there are a small number of reports in which “healthy fish” are verified to 
be VER positive but not displaying vacuolation in the brain. Gjessing et al. (2009) reported 
histopathological changes in the nervous tissues from “healthy” Atlantic cod that included a 
“diffuse cellular reaction”, few vacuoles, and VER immune-positively staining macrophage-like 
cells near nervous tissue. E. septemfasciatus which survived experimental VER challenge when 
sampled 2 months post-infection did not display vacuolation in the brain or retina, but the 
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tissues reacted positively by FAT (Lopez-Jimena et al., 2011). Similar results were reported 
from an RGNNV outbreak in Italy (Bovo et al., 2011). Hybrid bass (Morone saxatilis x Morone 
chrysops), held on a farm that experienced VER displayed low-level mortality (20 %) and 
inconsistent results for the detection of the virus. Whittington (2012) detected VER in 
subclinical carriers by qPCR and stated “histopathology can no longer be used as the sole 
screening test” for VER due to the absence of histopathological changes in subclinical carrier 
fish. However, this conclusion is challengeable because the detection of NNV by qPCR does not 
necessarily indicate the presence of a viable virus. 
 
Comparative analysis of the expression of immune factors also demonstrates a correlation 
between the development of immune competence and survival from Betanodavirus infection. 
Differential immune responses to VER in zebrafish juveniles compared to adults has been 
reported (Lu et al., 2008). Acute VER disease in larvae and juveniles is reportedly due to 
inactive interferon response in contrast to an active innate immune response during persistent 
infection in the adult stages (Lu et al., 2008). Interferon-α (IFN-α) and Mx were expressed in 
adult zebrafish brains within 4 to 20 hpi following injection with VER (Lu et al., 2008). In 
contrast, neither gene was expressed in larval fish with the same exposure. Adult fish were 
refractory to VER infection, and larval fish displayed 100 % mortality within 72 to 96 hpi. 
Injection of 1000U of IFN-α2a (Roche) into larval zebrafish 48 hours before VER injection 
protected against VER infection for 48 hpi (Lu et al., 2008). In developing human embryos, 
neuronal differentiation is associated with improved cellular responses to IFN1 and also an 
increase in type 1 interferon pathway components namely interferon regulatory factor (IRF-9) 
and interferon-α/β receptor βchain IFNAR2 (Farmer et al., 2013). The overexpression of signal 
transducer activator of transcription-2 (STAT 2) and interferon-α/β receptor βchain (IFNAR2) 
recapitulates the neuronal differentiation-dependant changes involving IFN-1 (Farmer et al., 
2013). Farmer et al. (2013) also noted that these developmental events might contribute to 
the age-dependent encephalitis caused by SFV. Regarding Betanodavirus, Huang et al. (2015) 
and Lu et al. (2008) noted changes in the expression of STAT-1/3 but neither measured STAT-
2.  
Additional studies report transcriptome analysis of the immune responses of carrier vs 
susceptible fish. Poisa-Beiro et al. (2008) investigated the interferon response to VER 
infected D. labrax and S.aurata. In S.aurata, which are not highly susceptible to VER, NNV was 
detected at high levels by RT-PCR in the blood but declined 3 dpi. High levels of NNV were 
detected in the brain 3 dpi. Up-regulation in the expression of TNF-α and Interleukin 1 (IL-1) 
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were detected in the brain of sea bream 3 dpi once the virus reached the target organ. 
Expression of Mx was 1300-fold in brain 3 days pi. Measurements from D. labrax exhibited a 
similar pattern; however, a lower expression of Mx (10x) was noted compared to controls.  
Thanasaksiri et al. (2014) investigated the effect of temperature on the expression of Mx and 
survival of sevenband grouper E.septemfasciatus to experimental infection with RGNNV. 
Rearing fish at temperatures between 15 to 30 °C for 2 weeks before experimental infection 
did not affect RGNNV (JN662462) RNA 2 copy number. However, there were differences in the 
relative levels of Mx mRNA expressed in the head kidney with rearing temperature and also in 
survival of fish for 14 days post-exposure to RGNNV. How the Mx expression levels in the head 
kidney compare to those in the brain, which is the target organ for NNV replication is 
unknown. Survival of fish was not improved at any temperature other than 25 °C (compared to 
15, 20 and 30°C) even though RGNNV copy numbers were 10 to 100-fold lower at the other 
temperatures.  
Nie et al. (2015) measured the involvement of Retinoic Acid Inducible Gene (RIG)-1 in Nuclear 
factor-kappa light chain enhancer of activated B cells (NF-ĸB) and IFN signalling in antiviral 
signalling. A RIG-1 homolog from zebrafish larva (DrRIG-1) was stimulated by poly I:C resulting 
in the significant activation of NF-kappaB, TNF-α, IL-8, Mx, Interferon Stimulate Gene -15 (ISG-
15) and viperin. However, the knockdown of Tripartite motif-containing protein-25 (TRIM 25) 
which is a pivotal activator for RIG-1 receptors suppressed the induced activation of the IFN 
signalling. (Nie et al., 2015). TRIM 25 has 3-N terminal domains, a coiled-coil domain (CCD) and 
a C-terminal domain (SPRY). To avoid IFN production, the NS1 of influenza virus interacts with 
the CCD domain of TRIM 25 to block RIG-1 ubiquitination. Another TRIM, TRIM 21 also 
stimulates the transcription factor pathways of NF-kappaB, AP-1, IRF3, IRF5 and IRF7. 
Antibody-coated viral particles activate TRIM 21, which binds to the Fc receptor and targets 
virions for degradation. The targeting of TRIMs by Betanodavirus would successfully mitigate 
both a humoral (antibody) and innate immune response. However, there are no published 






1.9 Modulation of the fish immune system. What other mechanisms 
could Betanodaviruses employ to combat the host immune 
response?  
A review of the immune response to Betanodavirus infections of marine fish was recently 
published (Chen et al., 2014). NNV is initially recognised by the innate immune system which 
through the detection of pathogen-associated molecular patterns (PAMPS), activates a range 
of intracellular signals to stimulate both an innate and cell-mediated immune response. The 
detection of antibodies with specificity against RGNNV in healthy fish indicates the humoral 
immune pathway is also activated. A neutralising antibody, RG-M18 mAB, required aa 195 to 
202 (VNVSVLCR) of the capsid protein as the minimal epitope for NNV recognition (Chen et al., 
2015). In the case of groupers and D. labrax, the immune responses, although ensuring 
survival, are insufficient to remove the virus, suggesting Betanodaviruses possess additional 
unknown mechanisms to avoid a functional immune response. The B1 and B2 proteins have 
been demonstrated to manipulate some components of immune pathways. However, 
mechanisms which allow Betanodaviruses, within the limitations of a small viral genome and 
the absence of other translated viral proteins, to avoid all of the immune pathways and persist 
in sub-clinical carrier fish have not been determined.  
The importance of viral encoded microRNA (V-miRNA) is recognised as a potent mechanism 
used by viruses to achieve viral replication, persistence, immune evasion and cellular 
transformation (Cullen 2009; Grundhoff & Sullivan 2011; Tycowski et al., 2015). V-miRNAs 
represent a genomically efficient way for viruses to regulate host immune responses. A V-
miRNA could target multiple genes in the same host or a highly conserved gene in multiple 
hosts (Weber et al., 2004). Additionally, V-miRNAs are known to target the expression of viral 
replication process and are involved in the Singapore grouper Iridovirus which encodes at least 
16 V-miRNAs the functions of which are being studied (Guo et al., 2013). In addition, nine v-
miRNAs have been detected during replication of the fish-infecting Megalocytivirus (Zhang et 
al., 2014). 
Nodavirus V-miRNAs have not been reported. However, the replication of short incomplete 
copies of Differential interfering-RNA (DI-RNA) by the RdRp has been detected in the early 
phases of nodavirus replication in vitro. During RNA replication, Flock house virus (FHV) 
produces, ~ 400bp dsRNA (DI-RNA) from the 5’ terminus of RNA 1 which serves as a Dicer-2 
substrate (Aliyari et al., 2008). Pyrosequencing of the dsRNA formed 4 days post-FHV infection 
detected 4371 small RNAs the majority of which have strong homology and presumably target 
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a region comprising the first 400nt of RNA 1 (Aliyari 2008). No functional roles for the DI-RNAs 
have been demonstrated. 
I propose the mass replication of the DI-RNAs could be an intermediate step in the production 
of V-miRNA which could serve to downregulate specific host genes such as those which 
regulate immune function or to regulate nodavirus replication. The lower expression of Protein 
A from RNA 1 compared to the capsid protein of RNA 2 despite both strands being transcribed 
in equal amounts supports the concept the RNA 1 transcripts could have functions beyond 
translation to protein A. 
1.10 Concluding comments  
The management VNN infections in grouper grow out culture is difficult. There are critical gaps 
in knowledge in many areas of the Betanodavirus-fish-environment dynamic that hamper 
progress towards preventing VER. Nonetheless, many fish diseases have been effectively 
managed by vaccination prior to the attainment of understanding of the mechanics of a 
specific pathogen-host dynamic (Gravningen et al., 2008). However, with the data presently 
available, there is poor understanding of the variation of strains of NNV that cause VER in 
tropical fish species in Australia. Insufficient knowledge of NNV strains represents a risk to the 
successful development of vaccines to prevent VER. Also, the paucity of information about the 
development of the grouper immune system creates a degree of uncertainty around the 
scheduled delivery of vaccines or other prophylactic measures. Finally, there has been no 
assessment to determine if the current RT-qPCRs that have been used to study NNV in 
barramundi and Australian Bass in Australia are fit for purpose to study NNV in groupers.  
This project aims to improve knowledge about the VNN strains that cause VER in North 
Queensland and apply this knowledge to the development of therapies to limit the impact of 
VER on grouper aquaculture. The project also aims to determine if the RT-qPCR (qR2T) (Hick & 
Whittington 2010) that is the current Australian New Zealand Standard Protocol for the 
detection of NNV, and an additional assay RT-qPCR (qR1T) (Hick & Whittington, 2010) are fit 
for purpose to study NNV in grouper. Finally, the project aims to test the efficacy of 
vaccination and dsRNA as treatments to prevent VER outbreaks in the Queensland giant 







The research questions posed by this study: 
1. What strains of Betanodavirus are associated with VER outbreaks of tropical marine 
fish species in Northern Queensland? 
2. Is RT-qPCR a useful tool to assist in the management of VER in giant Queensland 
grouper, Epinephelus lanceolatus in Australia? 
3. How effective is vaccination or dsRNA designed against the endemic strains of NNV in 
preventing disease? 
 
How the project aims were achieved: 
1. Positioning this research, an overview of VER disease in finfish. 
Achieved in Chapter 1: Literature Review 
2. Develop the laboratory skills required to complete project activities. 
 Achieved in Chapter 2: General Material and Methods 
3. Obtain full sequence of the Betanodavirus strains and determine the level of variation in 
strains that cause VER in Northern Queensland.  
Achieved in Chapter 3: Phylogenetic analysis of NNV strains in Australia. 
4. Investigate the genome sequences of the Betanodavirus strains and identify the presence of 
motifs that are critical for the development of prophylactic measures. 
Achieved in Chapter 4: Review of functional motifs of the Betanodavirus genome 
5. Implement qPCR analysis as a tool for the quantitative detection of Betanodavirus.  
Achieved in Chapter 5: Development of qPCR Standard controls.  
6. Develop prophylactic measures of experimental vaccine and dsRNA to confer protection 
against Betanodavirus that is present in NQ. 
Achieved in Chapter 6. Development of prophylactic measures against NNV 
7. Determine if exposure to RGNNV by cohabitation with/without co-exposure to a marine 
leech, Zeylanicobdella arugamensis leads to VER  
Achieved in Chapter 7: Experimental challenge via co-habitation with marine leech  
8. Measure the efficacy of the therapies to prevent VER via experimental challenge.  
 Achieved in Chapter 8: Measuring efficacy of prophylactic measures against NNV 
9. Determine if survival to experimental challenge is related to parentage assignment 
Achieved Chapter 9: Role of family in survival of VER in E.lanceolatus  
10. Refine the vaccination strategy to prevent VER via experimental challenge 





CHAPTER 2. GENERAL MATERIALS AND METHODS 
 
Background 
 This thesis is a culmination of three years of investigation. 
 Some of the procedures were conducted as a single task that align with multiple 
chapters of work. 
 Some procedures that were repeated many times were standardised as an 
operational procedure. 
 
Aims of this Chapter  
 Describe the laboratory protocols that align with multiple chapters of work. 
 Describe the protocols that were conducted as standard operational procedures 
throughout this thesis. 
 
2.1 Introduction 
This thesis is a compilation of three years of research. Throughout the project there were a 
number of protocols that were repeated many times. Standard operational protocols and 
laboratory worksheets were prepared for tasks that were repeated many times. In addition, 
one procedure, namely the preparation of viral extract, was completed once, yet utilised many 
times. The aim of this chapter is to describe the protocols that were performed as standard 
operational procedures and preparation of the viral extract used throughout this study.  
 
2.2 Molecular biology 
2.2.1 Collection of Betanodavirus positive material 
Betanodavirus extract was prepared from 3 separate, natural VER outbreaks that occurred in 
North Queensland fish farms during 2015-2016. Whole fish including gold spot grouper, 
Epinephelus coioides (Hamilton, 1822), juvenile barramundi, Lates calcarifer, and sub-adult 




Moribund fish were euthanized by lethal overdose of AQUI-S® and frozen at -20˚C. The 
Biosecurity Sciences Laboratory (BSL), Queensland Government Veterinary Laboratory, 
subsequently diagnosed VER. Eye tissue, up to a maximum of 500mg, was aseptically removed 
from fish displaying clinical signs and subjected to total viral nucleic acid extraction using the 
High Pure™ Viral Nucleic Acid kit (Roche) according to the manufacturer’s instructions. 
Remaining tissue was stored at -20˚C. 
2.2.2 Reverse transcription reaction/ cDNA synthesis 
Complementary DNA (cDNA) was reverse transcribed (RT) from RNA 1 and RNA 2 segments in 
nucleic acid extracts. cDNA was synthesized using a Maxygene thermal cycler (Axygen) in a 20 
µL reaction using random hexamers with the Tetro™ cDNA synthesis kit (Bioline) according to 
the manufacturer’s instructions. The reverse transcriptase (RT) thermal cycle consisted of 
incubation of 10 min at 25⁰C; 30 min at 45 ⁰C and an RT deactivation of 5 min at 85⁰C.  
2.2.3 Nucleic acid extraction 
Nucleic acid purification was conducted on 400 µL of viral extracts or dissected eye and brain 
tissue (maximum of 400mg) from clinically diseased fish. Extraction was completed using the 
High Pure™ Viral Nucleic Acid kit (Roche 11858874001) according to the manufacturer’s 
instructions. Purified nucleic acid was eluted into 100 µL RNAse free water and stored at -20°C. 
2.2.4 Polymerase chain reaction 
Multiple PCRs were performed using a Maxygene thermal cycler (Axygen). PCRs were 
performed as a 20 µL reaction with 2.5 µL of cDNA and 100 nM primer (Hick & Whittington 
2010) (see Table 1) in a MyFi™ DNA Polymerase Mix according to the manufacturer’s 
instructions ( BIO-21117 Bioline, NSW). The thermal cycle profile consisted of a 3 min 
incubation at 95⁰C followed by 45 cycles of 15 s denaturation at 95⁰C, 30 s of annealing 
temperature (Table 2-1 Tm primer), a 30 s extension at 72⁰C; and a final extension step of 5 








Table 2-1: Description of the primer and probe sequences used in this thesis. Including PCR 
assay type, primer name, primer nt sequence, RNA segment target, nt binding position the 
and melt temperature of primer and probe.  
Source of all primer and probe sequences Hick &Whittington (2010). * indicates 
amplicon product was used to prepare positive control standards for RT-qPCR. ~ 













RT-qPCR qR1T-F GCTACCGCCTGTTGACCTC 1 140 61 
 qR1T-R TTGTTTCTTCTCAGCGATGATGC 1 219 64 
 qR1T-Probe TGGCGAATCCTCAACACGTCC 1 171  
RT-PCR R1F1* CACTTACGCAAGGTTACCG 1 48 60 
 R1 F2 CACGGGTCACGTCAGTTCTA 1 419 63 
 R1R4 TCAACTCATGCATGTCCAC 1 523 60 
 R1F3 CACGGGTCACGTCAGTTCTA 1 935 63 
 R1R3 CTCAGAGATGTAAGTGACTG 1 998 52 
 R1R5* TCTGCTGCTCCTCGACATAC 1 1527 63 
 R1F5 AGCAGACCAAGCCGTTACAG 1 1541 64 
 R1F4 CGTGCAGTCGCCATTAAG 1 2295 63 
 R1R2 AATCTCTGACTGGGTATCAC 1 2339 55 
 R1R1 GAAGCGTAGGACAGCATAAAGC 1 3022 60 
RT-qPCR qR2T-F CTTCCTGCCTGATCCAACTG 2 401 62 
 qR2T-R GTTCTGCTTTCCCACCATTTG 2 476 61 
 qR2T-Probe CAACGACTGCACCACGAGTGG 2 454  
RT-PCR R2F1* CATATGGTACGCAARGGTGA 2 3 59 
  R2R1* CTCGAGTTAGTTTTCCGAGTCA 2 1023 59 




2.2.5 Gel Electrophoresis 
PCR amplicons were visualized by agarose gel electrophoresis. Agarose (Cat. 9010B, Scientifix, 
Victoria) gel was prepared and run in 1x TAE (40 mM Tris, 20 mM acetic acid, and 1 mM EDTA) 
buffer was stained with 0.05 μL ml-1 Gel Red (Cat. 41003, Biotium, Fisher Biotec, Australia). 
The gels were loaded with 20 μL of PCR product and subjected to 60 min at 100 volts with a 
Hyper Ladder 1 kb DNA ladder (BIO-33025, Bioline, NSW) (1 % gel). The gels were visualised on 
a UV transilluminator.  
2.2.6 Preparation of viral extract from natural VER outbreaks. 
Viral extract for experimental challenge was prepared from the E.coioides VER outbreak. 
Figure 2.1 displays image of pond culture and fish collected during the VER outbreak. The fish, 
of average body mass of ~600 g were cultured in cages in commercial earth ponds in North 
Queensland, Australia. Viral extract was prepared by separately pooling the brain and eyes 
from several fish into sterile phosphate buffered saline (PBS) (Sigma Aldrich®). Brain tissue (8.3 
g) was suspended in 57 mL and eye (18.9 g) was suspended in 100 mL of sterile PBS. Tissue in 
PBS was frozen and thawed thrice from -25˚C to 4˚C, and homogenized using an Ultra-Turrax T 
25 (IKA works) at 20,000 rpm for 5 min. Tubes of tissue were held in crushed ice throughout 
the homogenization. Tissue homogenate was clarified in a Sorval RC 6+ centrifuge (Thermo 
Scientific) using a F12s-6 x 500 LEX rotor for 10 min at 610 g at 4˚C. The supernatant was 
removed and further clarified by centrifugation for 10 min at 3 803 g at 4 ˚C. The supernatant 
was filtered through 0.45 µm and 0.22 µm filters (Sartorius). The extract was confirmed free of 
culturable bacteria by inoculation onto sheep blood agar and overnight incubation at 28 ˚C. 
Separate filtered supernatants from each tissue, herein termed  viral extract, was stored in 
sterile 50 mL centrifuge tubes at -20˚C.  
 
Figure 2-1: Pond culture and E.coioides collected from a natural outbreak of VER used to 
prepare viral extract. (a) Fish were held in cages within 1-hectare earthen ponds containing 
estuarine water. (b). Euthanased gold-spotted grouper, E.coioides, that exhibited signs of 





2.2.7 Cloning and sequencing of PCR products 
PCR amplicons were excised from gels using individual scalpel blades (SBLDCL, Livingstone, 
NSW) and purified using an Agarose Gel DNA Extraction Kit (Bioline). Purified amplicons were 
cloned into competent Escherichia coli JM109 cells (A1360, Promega, NSW) using the pGEM-T 
Easy Vector System (A1380, Promega, NSW), or One shot TOP10 chemically competent E. coli 
using the pCR4-TOPO TA vector (K4575-01, Life Technologies, VIC) as per manufacturer’s 
instructions. Transformed E. coli were grown for 16 - 18 hours at 37 °C on lysogeny broth (LB) 
(Bertani, 1951) agar (Appendix 1) supplemented with 100 g mL-1 or 50 μg mL-1 ampicillin (Cat. 
A9393-5G Sigma-Aldrich, NSW) for pGEM™ and TOPO™ clones respectively. Three white 
colonies were selected from each agar plate and cultured at 150 rpm (Bioline incubator shaker 
8500 Edwards Instruments, NSW) for 16 - 18 hours in lysogeny broth (Bertani, 1951) (Appendix 
1) supplemented with 100 g mL-1 or 50 g mL-1 ampicillin (A9393-5G, Sigma-Aldrich, NSW) for 
pGEM™ and TOPO™ cells respectively. Plasmid DNA was extracted using a High Pure™ Plasmid 
Isolation kit (11754777001 Roche, NSW) as per manufacturer’s instruction. Plasmid extracts 
were submitted for Sanger sequencing to Macrogen Inc. (Seoul, Korea) or the Australian 
Genome Research Facility (Brisbane, Australia) for sequencing analysis. Bioinformatic analysis 
was conducted to confirm Betanodavirus genome sequence and assess suitability of the 
plasmids for application in subsequent qPCR analysis. 
2.2.8 Bioinformatics analysis 
Sequencing data was analysed using Geneious 9.1 or Geneious Prime (created by Biomatters, 
available from http://www.geneious.com), and the tools available at National Centre for 
Biotechnology Information (NCBI). These included Basic Local Alignment Search Tool (BLASTn 
and BLASTx) and Open Reading Frame (ORF) finder tool using the default parameters of all of 
the programs (http://www.ncbi.nlm.nih.gov).  
2.2.9 Real-time PCR of viral extract  
All cDNA reactions were performed as previously described in 2.1.3. For quantification of viral 
copy number, real-time PCR was performed using a Rotor Gene 6000 system (Qiagen®). All 
qPCRs were performed as separate assays in 20 µL reactions using SensiFAST™ Probe No ROX 
master mix (Bioline) according to the manufacturer’s instructions including 2.5 µL of cDNA the 
primer (200 nM) and probe (5 nM) sequences ( Hick & Whittington, 2010; see Table 1). The 
thermal cycle profile consisted of a 3 min incubation at 95 ⁰C followed by 45 cycles of 15 s 
denaturation at 95 ⁰C, 30 s annealing and extension at 60 ⁰C. 
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2.3 Husbandry and handling of groupers  
2.3.1 Husbandry of groupers 
For experimental challenges, juvenile giant Queensland grouper, Epinephelus lanceolatus, 
were provided by a commercial hatchery, The Company One (Cairns, Australia). Fish were held 
under the conditions approved within the JCU institutional animal ethics permits outlined in 
the declaration of ethics (page iv). Experimental animals were held in recirculation systems 
that consisted of 10 replicate systems of 2 x 300 L tanks with aeration, water circulation and 
connected to a biological filter containing 200L of filter material and bio-wheels. The entire 
system was housed in an experimental room with 12/12h controlled light/dark cycle and water 
temperature was maintained between 24-28˚C. Saltwater was obtained from the Australian 
Institute of Marine Science. Water was collected from the ocean and subjected to 5 
treatments which included 5mm screen within a high-density polyethylene basket; a timex 
hydroclone that removed particles down to 120 µm; Arkal spin filter 120 µm discs; 
fractionation and a final ultrafiltration to 0.04 µm. Seawater concentration ranged from 26 to 
35 ppt. Fish were fed twice daily ad lib on commercial fish feed pellet appropriate to the size of 
the fish (Ridley AgriProducts Pty Ltd). Fish were acclimated for two weeks prior to 
commencement of any experimental procedures. 
2.3.2 Anaesthesia of groupers 
2.3.2.1 Sedation of groupers 
Fish were sedated to Stage 2 of fish anaesthesia (Coyle et al., 2004) using AQUI-S® anaesthetic 
(AQUI-S® New Zealand Ltd). 
Briefly fish were placed in a 40L Nally®Bin containing 30ppt seawater containing a working 
solution of 15-20mg/L of AQUI-S®. For sedation, fish were held for sedation until they reached 
a state of reduced swimming and breathing and partial loss of equilibrium. Fish retained 
reaction to touch stimuli. Fish were sedated with AQUI-S® (AQUI-S) during all procedures that 
were assessed as causing minor distress, which were principally all processes involving 
injection.  
For recovery fish were placed into a 40L Nally®Bin containing 30ppt seawater and gently 
assisted to swim in a figure 8 direction ensuring they were always moving in a forward-facing 
motion. When fish escape behaviour progressed beyond gentle, they were released into the 
secondary container in the recovery tank. The secondary container consisted of a 20 L plastic 
container with numerous small holes drilled into the container to allow water flow. When an 
entire tank consignment had been subject to procedures, they were transferred to their 
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experimental holding tank using the secondary container. Aeration of water was provided 
throughout the procedure. 
2.3.2.2 Euthanasia of groupers 
Fish were sedated to Stage 4 of fish anaesthesia (Coyle et al., 2004) using AQUI-S®. Briefly fish 
were placed in a 10L Bucket containing 30ppt seawater containing a working solution of 15-
20mg/L of AQUI-S. For euthanasia, fish were held until death. Aeration of water was provided 
throughout the procedure. 
2.3.3 Intramuscular injection of groupers 
All injection procedures, including vaccination and challenge with viral extract, were 
conducted as intramuscular (IM) injection on sedated fish. Fish were injected into the dorsal 
musculature using a sterile 25g x 5/8” Microlance™ needle (Becton Dickinson Ireland) attached 
to a 1mL Terumo® syringe (Terumo Philippines). The site of injection was at the posterior 
dorsal junction between the white and black marking on the juvenile E.lanceolatus (Figure 2.2). 
To prevent possible skin infection, a drop of Betadine® solution (10% povidone-iodine) was 
placed on the injection site immediately prior to and following injection. To reduce irritation to 
skin, fish were handled with clean wet hands and placed on a clean wet cotton clot during 
injection. The approximate length from the anterior end of the bottom jaw to the end of the 
tail was measured with a ruler. (Figure 2.2). Approximate weight of fish was measured with a 
portable 2kg digital kitchen scale (Propert).  
. 
 
Figure 2-2: Sedated juvenile E.lanceolatus with location of IM vaccine injection site indicated 
(Red arrow) and reference points of body positions (jaw to tail) used to determine 







2.3.4 Pre-trial experiments 
Prior to the commencement of each experimental challenge discussed in Chapters 7, 8 and 10, 
two experimental procedures were conducted namely: 
1. Confirmation of VNN free status of experimental fish. 
2. Confirmation of pathogenicity of the viral extract. 
Confirmation of VNN free status was determined by conducting RT-qPCR (as discussed in 2.1.9) 
analysis on two pools of brain and eye tissue from ten fish using qR2T i.e. four RT-qPCR 
samples including two samples each of pooled brain from five individual fish and pooled eye 
from five individual fish.  
Confirmation of pathogenicity of the viral extract was confirmed by challenging ten fish from 
each experimental cohort with 100µl IM injection of RGNNV extract prepared as described in 
2.1.6. Viral extract was injected in the approximate position of the vaccine injection indicated 
in Figure 2.2. The ten fish were held in the same experimental circulation systems under the 
conditions described in 2.2.1. Fish were monitored twice daily for signs of adverse health and 
euthanized by overdose to Aqui-S when more than one sign of VER, including erratic 
swimming, hyperinflation of swim bladder, disorientated floating, absence of feeding or severe 
lethargy became evident. Analysis by RT-qPCR was conducted on pooled brain and eye tissue 
as described in 2.1.9 to confirm detection of high copy number of RGNNV genome.  
2.4 Results 
2.4.1 Cloning and sequencing of PCR products 
Results of cloning and sequencing of PCR products are discussed in Chapter 3: Phylogenetic 
comparison of Betanodavirus genomes collected from North Queensland. 
2.4.2 Real-time PCR of viral extract 
Analysis of viral extract by RT-qPCR detected RGNNV with a Ct value of 13.95 (qR1T) and 10.64 
(qR2T) which equates to an estimated calculated viral copy number of 1.99 x 107 and 1.07 x 108 
copies mL-1 respectively. The average between each of the two copy number calculations, 6.36 
x 107 copies mL-1 was accepted in subsequent calculations for preparing viral extract for 
challenge studies. Viral extract was diluted to an approximate copy number of 6.36 x 104 mL-1 
in sterile PBS for challenge studies. Further discussion of RT-qPCR analysis is provided in 






2.4.3 Pre-trial experiments 
All cohorts of experimental fish were negative for the detection of RGNNV by RT-qPCR prior to 
the commencement of experiments. In all three pre-experimental pilot trials, IM injection with 
the viral extract lead to 100% morbidity in the challenged fish within 14 days post injection. 
The clinical signs of VER appeared suddenly at days 7-10 post challenge, followed by rapid, 
mass morbidity during the subsequent 1 to 3 days (Figure 2-3).  
 
Figure 2-3: Cumulative Morbidity (%) of E.lanceolatus v days post challenge during the three 











 The methods that were used as standard operational procedures namely husbandry 
and handling of fish, pre-trial experiments and a range of molecular biology 
protocols were described. 
 The protocols that were completed once but apply to multiple chapters of this 
thesis were described.  
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CHAPTER 3. PHYLOGENETIC COMPARISON OF BETANODAVIRUS 
GENOMES COLLECTED FROM VIRAL ENCEPHALOPATY AND 




Aims of this Chapter  
 
 At the commencement of this study there were 2 complete sequences of 
Betanodavirus RNA 1 and RNA 2 from Australian species, neither of which originated 
from North Queensland. 
 The capsid protein, which is encoded by RNA 2, has been demonstrated as the 
antigenic target of grouper antibodies to protect against VER. 
 There is variation in the capsid protein across the Betanodaviruses.  
 Knowledge of the genome sequences and level of variation in the RNA 2 of 
Betanodavirus strains that cause VER in Northern Queensland is required to guide 
decisions of vaccine development and design of dsRNA. 
 Knowledge of the genome sequences of RNA 1 is required to guide decisions for 
dsRNA design to attempt NNV knockdown. 
 PCR amplicons from RNA 1 and RNA 2 are required to prepare synthetic positive 
controls for the RT-qPCRs. 
 Obtain a viable viral extract from a natural VER outbreak in Northern Queensland. 
 Obtain RT-qPCR amplicons from the NNV strains associated with VER outbreaks in 
North Queensland. 
 Determine the complete sequence of both mRNA segments of Betanodavirus 
associated with natural VER outbreaks in marine finfish grow-out systems in 
Northern Queensland. 
 Compare the complete sequences of mRNA 1 to other sequences in the NCBI 
database to determine the species of Betanodavirus associated with VER in North 
Queensland. 
 Compare the complete sequences of RNA 2 to other sequences in the NCBI 




3.1 Introduction  
Knowledge of the RNA 2 segment sequence that encodes the capsid protein of strains causing 
VER in Australian grouper is critical to multiple decisions regarding vaccine formulation. In 
addition to ensuring targeted protection against Betanodavirus strains that are associated with 
VER outbreaks, herein referred to as NNV strains, knowledge of capsid protein sequence 
assists in determining: 
 the level of variation in NNV strains that cause VER;  
 the potential geographic market of an effective vaccine and  
 the duration for which the vaccine could be expected to be effective considering the 
typically rapid mutation rate of RNA viruses.  
Although North Queensland was among the first regions in the world to report VER outbreaks, 
there are few genome sequences of Australian NNV strains. At the commencement of this 
study, there were only two complete genome sequences of Betanodavirus from Australian 
species within the NCBI database, neither of which originated from Queensland (Hick & 
Whittington, 2010). There are a further eight partial sequences of RNA 2 segments collected 
from Australian species (Moody et al., 2009). 
The current species classification of Betanodavirus recognised by the ICTV, named with the 
original host names of striped jack, red-spotted grouper, barfin flounder and tiger puffer was 
initially based on analysis of a 606nt conserved region, termed T2 and a 289nt highly variable 
region, termed T4 of the RNA 2 (Nishizawa et al., 1997). The species divisions align with three 
distinct serotype divisions determined by antibody reaction to the capsid protein which is 
encoded by RNA 2 (Nishizawa et al., 1997, Johansen et al., 2004 and Mori et al., 2003) (Table 
3.1). Numerous serological studies have reported a lack of in vitro and in vivo cross-reactivity 
between two species namely the RGNNV and SJNNV (Mori et al., 2003; Chi et al., 2003 and 
Pascoli et al., 2019). However, there is some cross reactivity between RGNNV and BFNNV 
(Mori et al., 2003).  
In recognition of an expanded host range beyond those of the original species names, Thiery et 
al. (2004) proposed a division of the Betanodavirus into subgroup clusters based on analysis of 
the highly variable region (T4) of RNA 2. The cluster proposal retained TPNNV and SJNNV as 
distinct single clusters, Clusters III and IV respectively but further differentiated the RGNNV 
into two, namely Ia and Ib and BFNNV into three: IIa, IIb and IIc. The clusters, based on 
nucleotide comparison of the T4 region, also tended to align with temperature and geographic 




Table 3-1: Betanodavirus Type Species, Serotypes and Thiery cluster assignments based on 
conserved capsid protein amino acid 
 
 
Although the ICTV has not adopted the model proposed by Thiery et al. (2004), subsequent 
authors have applied the cluster proposal in taxonomic comparison of NNV strains (Olveira et 
al., 2009 & Moody et al., 2009). Phylogenetic comparison between NNV strains from 
Australian fish species are limited to two publications. (Moody et al., 2009 & Hick et al., 2013). 
Moody et al. (2009) reported a phylogenetic comparison between the T2 region of four 
Betanodavirus strains collected from tropical Australian species. Based on T2, all Australian 
strains clustered within the RGNNV assignment of Nishizawa (1994) or the equivalent 1a of 
Thiery et al. (2004). Comparative analysis between nine, smaller, T4 region sequences, divided 
the Australian strains into two clusters, Ia and Ic based on the Theiry et al. (2004) model. 
Moody et al. (2009) also noted the clusters retained some general geographic alignment which 
included strains from tropical and cold-water species (Figure 3-1) although this was not 








SJNNV Striped Jack Nervous Necrosis Virus PAN A IV
RGNNV Red spotted Grouper Nervous Necrosis Virus PDG C Ia,Ib
BFNNV Barfin Flounder Nervous Necrosis Virus PEG C IIa, IIb,IIIc
TPNNV Tiger Puffer Nervous Necrosis Virus PPG B III
*TNNV *Turbot Nervous Necrosis Virus PTG untested
*proposed as an additional species by Johansen et al. 2004




Figure 3-1: Unrooted phylogenetic tree produced from partial T4 region (289 nt) of RNA 2 
reproduced from Moody et al. (2009) including strain identifiers and source of strain. 
 
Due to the early focus on the T4 and T2 regions of RNA 2 for a taxonomic division of 
Betanodaviruses, most sequences published within the NCBI database before 2008 are 
incomplete genome sequences. Subsequent research indicated regions outside of T4 on RNA 2 
and also regions on RNA 1 that relate to virulence, infectivity and adaption to temperature 
increases (Costa et al., 2007; Hata et al., 2010; Souto et al., 2018 and Souto et al., 2019). 
Further, chimeric recombinants of RNA 1 and RNA 2 between RGNNV and SJNNV species have 
been detected in diseased fish (Olveira et al., 2009). Noting the inherent weakness in 
conducting comparative analysis based on the T4 or T2 region, more recent works have 
compared the entire RNA 1 and RNA 2 sequences of NNV. (Hick et al., 2013 and Olveira et al., 
2009). For Australian strains, comparative analysis including complete mRNA sequences 
obtained from VER outbreaks in Lates calcarifer in Northern Territory and Macquaria 
Ba94AUS and sequences 
indicated with  are 
sequences derived from 
Australian fish species.  
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novemaculata in New South Wales have been reported. (Hick et al., 2013). The authors formed 
a similar conclusion to Moody et al. (2009) regarding the taxonomic division of Australian NNV 
strains with an exception of aligning the Ba94Aus strain, collected from barramundi, within the 
tropical strains 1a rather than 1c temperate strains. (Figure 3.2). Although the divisions of 
Australian NNV strains tend to align with geographic source, the strain collected from striped 
trumpeter, Latris lineata, from Tasmania aligns more to the tropical species division. It is 
possible the divisions between 1a and 1c in Australian strains relate to other factors such as 
marine v freshwater systems. The striped trumpeter is a marine species whereas the 
Australian bass, M.novemaculata is a freshwater species. Although barramundi, L.calcarifer are 
naturally found in tropical waters, as a euryhaline species, it has been translocated into 
temperate regions in Australia where is cultured within systems that have access to naturally 
heated spring water or apply heated spring water to warm marine systems. There was no 
information in the NCBI database entry to indicate if the strain from barramundi collected 
from South Australia (T452934) was from a marine or freshwater system.
 
Figure 3-2: Summary of strain classification based on NNV RNA 2 sequences derived from 
Australian fish species (including strain reference identified and source). Modified from Hick 
et al. (2013). The “tropical” strains are aligned within 1a cluster (Black rectangle) and 
“temperate” strains aligned within 1c cluster (blue rectangle).  
 
Whilst there has been no detection of any Betanodavirus strain other than RGNNV in Australia, 
the division of strains into clusters indicates a degree of variability between Australian NNV 
strains. The scarcity of complete sequence data of tropical NNV strains within prior work and 
the large financial cost of vaccine production, necessitates careful investigation into the 
complete genome sequences of strains causing VER in tropical grouper species and other 
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species within their geographic range of grouper culture. This study reports on the complete 
mRNA sequence of Betanodavirus associated with natural VER outbreaks in marine finfish 
grow-out systems in Northern Queensland and their phylogenetic position within the 
collection of NNV strains affecting Australian fish species. Knowledge of the complete mRNA 
sequences of the strains of NNV that cause VER in grouper in North Queensland is required to 
ensure the therapies to be prepared within this project specifically target those strains that are 
present in Northern Queensland.  
3.2 Materials and Methods 
3.2.1 Collection of samples from natural VER outbreaks 
Samples of brain and eye were collected from fish from three aquaculture farms in Northern 
Queensland displaying clinical signs of VER. Viral Encephalopathy and Retinopathy was 
confirmed by the Queensland Government Biosecurity Sciences Veterinary Diagnostic 
laboratory (BSL) (farmers personal comms.). In this study, RT-PCR and sequencing analysis was 
performed to confirm VER. A summary of the sample source is provided in Table 3.3.  
3.2.2 Sequencing of Betanodavirus from natural disease outbreaks 
Total viral nucleic extracts were prepared by dissecting eye and brain tissues from frozen fish 
collected during natural VER outbreaks. Extraction was completed using the High Pure™ Viral 
Nucleic Acid kit (Roche 11858874001) according to the manufacturer’s instructions. Cloning 
and sequencing was conducted as previously described in 2.1.3 to 2.1.7 using the primers 
details in Table 2.1 (Section 2.1.4).  
3.2.3 Additional Sequences obtained for phylogenetic analysis 
Sequences of RNA 1 and RNA 2, were compared with strains obtained from the NCBI GenBank 
(http://www.ncbi.nlm.nih.gov/) nucleotide database including reference strains of 
Betanodavirus species and similar geographic source (Australia). Sequences of NNV from each 
of the reference strains of Betanodavirus species are indicated in Table 3.2. Sequences of NNV 
obtained from Australian fish were collected from the NCBI data base and other researchers as 






Table 3-2: Details of Reference strains and sequences of NNV type species used in this study 
including species, RNA segment, strain identification, NCBI reference number, length of 
sequence, host species, year and location of strain and publication relating to the sequence.  
Species Strain Id 
NCBI 
accession 




RNA-1           
RGNNV SGWak97 AY324869 3105 Red-spotted grouper Japan 1997 Iwamoto et al., 2001 
SJNNV SJNNV AB025018 3081 Striped Jack Japan 1999 Nagai & Nishizawa np. 
TPNNV TPKag93 EU236148 3112 Tiger Puffer Japan 1993 Okinaka *np. 
BFNNV JFwa98 EU236146 3100 Barfin Flounder Japan 1998 Okinaka *np. 
RNA-2           
RGNNV SGWak97 AY324870 1434 Seven Band grouper Japan 1997 Iwamoto et al., 2001 
RGNNV RGNNV AY690596 1432 Redspotted grouper China  
SJNNV SJNNV NC003449 1421 Striped Jack Japan 1999 Iwamoto et al., 2001 
TPNNV TPKag93 EU236149 1422 Tiger Puffer Japan 1993 Okinaka *np. 
BFNNV BF93Hok EU826138 1433 Barfin Flounder Japan 1993 Okinaka *np. 





























Table 3-3: Details of Australian sourced NNV sequences used in this study including species, 
RNA segment, strain, NCBI reference number, length of sequence, host species, year and 




length (nt) Host species Location and year Publication 
RNA-1           
P14-10380 KT390712 2871 E. lanceolatus QLD Aus 2014 Agnithortri et al. (2015) 
Lc3NQAus MH181161 3090 Lates calcarifer QLD Aus 2013 Condon et al. (2019) 
MnNNV12/06 GQ402012 2998 M. novemaculata NSW Aus 2006 Hick et al. (2013) 
LcNNV_09/07 GQ402010 2998 Lates calcarifer NT Aus 2007 Hick et al. (2013) 
Ec2NQAus 
 
3090 E. coioides QLD Aus 2015 This study 
El1NQAus 
 
3090 E. lanceolatus QLD Aus 2013 This study 
RNA-2           
T540844 EF591369 606 E. coioides QLD Aus 2005 Moody et al. (2009) 
T256901 EF591370 289 Latris lineata TAS Aus 2002 Moody et al. (2009) 
T442286 EF591371 832 
Cromileptes 
altivelis QLD Aus 2004 Moody et al. (2009) 
T342514 EF591372 832 Lates calcarifer QLD Aus 2003 Moody et al. (2009) 
T156700 EF591367 289 Lates calcarifer NT Aus 2001 Moody et al. (2009) 
T99180614 EF591368 832 
Oxyeleotris 
lineolata QLD Aus 1999 Moody et al. (2009) 
T452938 EF591366 294 Lates calcarifer SA Aus 2004 Moody et al. (2009) 
T451722 EF591365 294 M. novemaculata NSW Aus 2004 Moody et al. (2009) 
LcNNV_09/07 GQ402011 1017 Lates calcarifer NT Aus 2007 Hick et al. (2013) 
MnNNV12/06 GQ402013 1017 M. novemaculata NSW Aus 2006 Hick et al. (2013) 
P14-10380 KT390714 990 E. lanceolatus QLD Aus 2014 Agnithortri et al. (2015) 
Lc3NQAus MH017207 1017 Lates calcarifer QLD Aus 2013 Condon et al. (2019) 
Ec2NQAus 
  
E. coioides QLD Aus 2015 This study 
El1NQAus   
 
E. lanceolatus QLD Aus 2013 This study 
E. indicates Epinephelus M. indicates Macquaria. Sequences obtained within this study are 
indicated in bold. 
 
3.2.4 Sequence alignment 
Sequencing data was analysed as previously described in 2.1.6 and 2.1.7. The depth of 
sequence coverage was a minimum of 3 sequences reads per nucleotide over the entire 
published sequence. Phylogenetic comparison between sequences was conducted using the 
Geneious v9.1 software, using the default algorithm settings. Neighbourhood joining trees 





Complete mRNA sequences were obtained from the Lates calcarifer (ref Lc3NQAus) , 
Epinephelus coioides (ref Ec2NQAus) and Epinephelus lanceolatus (ref El3NQAus) VER 
outbreaks. The sequences from the Lates calcarifer outbreak were lodged in the NCBI 
nucleotide database as accessions MH181161 (RNA 1) and MH017207 (RNA 2) (Condon et al., 
2019). Phylogenetic analysis of RNA 1 and RNA 2 indicate all three NNV strains collected in this 
study display greatest homology to the RGNNV species.  
3.3.1 RNA-1  
Comparison of the complete mRNA of the RNA 1 segment from the VNN strains collected in 
this study indicate the strains display strong nucleotide sequence homology (99-97%) to each 
other (Refer to Table 3.4). Comparison with the Betanodavirus species type strains indicates all 
3 NQAus strains display strongest homology to the RGNNV reference strain (95-97%) with 
lesser homology to BFNNV (82%), SJNNV (82%) and TPNNV (82%) reference strains. (Figure 3.3 
and Table 3.4). Comparison with the other Australian strains in the NCBI database indicates 
strong homology between all of the Australian strains (95-98%) and the original RGNNV 























Created by Geneious Prime (Biomatters) http://www.geneious.com. Strains coloured pink are RGNNV aligned. 
Figure 3-3: Neighbour-joining tree of mRNA RNA 1 segment of the Betanodavirus from 






















Figure 3-4: Neighbour-joining tree of mRNA RNA 1 segment of Australian strains of 
Betanodavirus determined by the Tamura-Nei genetic distance model 
Created by Geneious Prime Biomatters http://www.geneious.com. Strains indicated in red were sourced within a 




Table 3-4: Displaying Percentage Homology between mRNA sequences of RNA 1 segments from the three NNV strains sequenced in this study 
(El2NQAus, Lc2NQAus and Ec2NQAus) in comparison to the NNV type species RGNNV, SJNNV, BFNNV and TPNNV including details of NCBI reference, 
host species and location and year of collection. 
Sequence Source details This study Species allocation and reference identifiers 
Strain NCBI ref. 
Length 
(nt) 
Host species Location 
El2NQAus Ec2NQAus Lc3NQAus AY324869 AB025018 EU236148 EU236146  
      RGNNV SJNNV TPNNV BFNNV 
El2NQAus    3030  E.lanceolatus 
QLD Aus 
2015 
  97.27 99.17 96.30 82.17 82.73 82.50 
Ec2NQAus   3029 E.coioides 
QLD Aus 
2014 
97.27   97.06 97.55 82.09 82.61 82.81 
Lc3NQAus  MH181161 3090 L.calcarifer 
QLD Aus 
2013 









96.30 97.55 95.69   82.12 82.62 82.83 
Striped Jack NNV 
(SJNNV) 
AB025018 3081 Striped Jack 
Japan 
1999 
82.17 82.09 81.95 82.12   82.62 83.08 
 Tiger Puffer NNV 
(TPNNV)  
EU236148 3112 Tiger Puffer 
Japan 
1993 








82.50 82.81 82.04 82.83 83.08 91.26   











Table 3-5: Displaying Percentage Homology and number of nucleotide differences between mRNA sequences of RNA 1 segments from NNV strains 
sequenced in this study (El2NQAus, Lc2NQAus and Ec2NQAus) in comparison to the other Australian-sourced strains of NNV including NCBI reference, 
host species, location and year of reference. 
Source of Sequence 
Global Zone, Habitat type and % homology in RNA 1 sequences 
Tropical Tropical Tropical Tropical Tropical Temperate Temperate 
marine marine marine marine marine freshwater marine 
Host species Location/Year 
Reference 
No.  
El2NQAus Lc3NQAus  KT390712  GQ402010 Ec2NQAus GQ402012 AY324869 
Epinephelus lanceolatus QLD Aus 2013 El2NQAus    99.20 98.83 97.98 97.27 96.38 96.30 
Lates calcarifer QLD Aus 2013 Lc3NQAus 99.20   98.78 97.70 97.06 96.03 95.72 
Epinephelus lanceolatus QLD Aus 2014 KT397012 98.83 98.78   98.19 97.49 96.17 96.20 
Lates calcarifer NT Aus 2007 GQ402010 97.98 97.70 98.19   97.13 97.20 97.03 
Epinephelus coioides QLD Aus 2015 Ec2NQAus  97.27 97.06 97.49 97.13   95.96 97.59 
Macquaria novemaculata NSW Aus 2006 GQ402012 96.38 96.03 96.17 97.20 95.96   96.63 
Seven Band grouper Japan 1997 AY324869 96.30 95.72 96.20 97.03 97.59 96.63   




3.3.2 RNA-2  
Comparison of the complete mRNA of the RNA 2 segment from the VNN strains collected in 
this study indicate the strains display strong nucleotide sequence homology (98-99%) to each 
other (Refer to Table 3.6). Comparison with the Betanodavirus species type strains indicates all 
3 NQAus NNV strains display strongest homology to the RGNNV reference strain (97-99%) with 
lesser homology to BFNNV (81-83%), SJNNV (77-78%) and TPNNV (77-78%) reference strains. 
(Figure 3.3 and Table 3.6). Comparison with the other Australian strains in the NCBI database 
reflect a similar pattern to that described by Moody et al. (2009) and Hick et al. (2013) 
whereby the majority of temperate strains display division from the tropical stains (Figure 3.5 
and Table 3.7). Within this analysis, although closely aligned with the other tropical strains (97-
98% homology), the freshwater strain collected from sleepy cod (EF591368), displays slightly 
less homology to the strains collected from the same geographic zone (97.98-99.65%). All 
other NQ region strains were collected from marine fish culture systems. The majority of 
Australian strains (Cluster 1a) align more closely to the E.septemfsciatus (Cluster 1a) strain 
collected from Japan in 1997 than those collected from the Australian “temperate”species 
within Australia (Cluster 1c). 
 
 
Figure 3-5: Neighbour-joining tree of mRNA RNA 2 segment of the Betanodavirus from this 
study aligned against the reference species strains of NNV including species and NCBI 
reference. 
Alignment determined by the Tamura-Nei genetic distance model, created by Geneious 





Figure 3-6: Neighbour-joining tree of mRNA RNA 2 segment of Australian strains of 
Betanodavirus from the NCBI database aligned against the strains collected from this study 
Determined by the Tamura-Nei genetic distance model created by Geneious version 9.1 using 
the default parameters. Biomatters http://www.geneious.com. Strains indicated in red were 







Table 3-6: Displaying Percentage Homology between mRNA sequences of RNA 2 segments from NNV strains sequenced in this study (El2NQAus, 
Lc2NQAus and Ec2NQAus) in comparison to the NNV type species including RGNNV, SJNNV, BFNNV and TPNNV, NCBI reference, length of sequence, host 
species, location and year of collection.  
Strains sequenced in this study are highlighted in grey and bold. 
Sequence Source details 
This study Species allocation and reference identifiers 
Ec2NQAus El2NQAus Lc3NQAus AY690596 AY324870.1 EU826138 NC_003449 EU236149 
Strain NCBI ref.  
Length 
(nt) Host species Location       RGNNV RGNNV BFNNV SJNNV TPNNV 






99.32 98.62 97.86 97.96 82.49 78.26 78.24 






98.72 97.58 97.87 81.88 77.86 77.65 
Lc3NQAus (this study) MH017207 1017 L.calcarifer 
QLD Aus 
2013 98.62 98.72 
 
98.23 98.33 82.50 78.32 78.20 






97.86 97.58 98.23 
 
99.44 82.47 78.46 79.29 
Redspotted grouper NNV 




1997 97.96 97.87 98.33 99.44 
 
82.73 78.59 79.28 
Barfin Flounder NNV (BFNNV)  




1993 82.49 81.88 82.50 82.47 82.73 
 
78.46 79.16 
Striped Jack NNV (SJNNV) NC_003449 1431 Striped Jack 
Japan 




Tiger Puffer NNV (TPNNV) 
TPKag93 strain EU236149 1422 Tiger Puffer 
Japan 






Heat map indicating closest relatedness by percentage similar (%) and number of different nucleotides. Sequences obtained in this study are indicated in 
bold and grey shading. Differences and homology of sequences collected in this study are enclosed by the rectangle. 
Table 3-7: Displaying Percentage Homology and number of nucleotide differences between mRNA sequences of RNA 2 segments from NNV strains sequenced in this study 
(El2NQAus, Lc2NQAus and Ec2NQAus) in comparison to the other Australian sourced strains of NNV from the NCBI database including Host species, NCBI reference, 
location and year of collection. 
 
 
Strains sequenced in this study are highlighted in grey and bold. 
 Temperate Tropical Tropical Tropical Tropical Tropical Tropical Tropical Tropical Tropical Tropical Tropical Temperate Temperate Temperate Zone
marine marine marine marine marine marine marine marine marine marine marine freshwater freshwater not recorded freshwater Habitat
Host species Location/Year Reference No. EF591370 EF591371 EF591367 EF591369 EF591372 KT397014 El2NQAus Lc3NQAus Ec2NQAus GQ402011 AY324870 EF591368 EF591365 EF591366 GQ402013
Latris lineata TAS Aus 2002 EF591370 99.65 98.62 99.31 99.31 99.31 98.96 98.27 98.96 98.62 98.62 96.19 85.81 85.81 85.81
Cromileptes altivelis QLD Aus 2004 EF591371 1 98.96 99.51 99.4 99.16 99.16 98.2 98.68 98.56 99.04 97.24 86.05 86.05 92.19
Lates calcarifer NT Aus 2001 EF591367 4 3 98.62 98.62 98.62 98.27 97.58 98.27 97.92 97.92 96.89 86.51 86.51 86.51
Epinephelus coioides QLD Aus 2005 EF591369 2 3 4 99.51 99.18 99.18 98.19 98.68 98.52 99.18 96.87 85.81 85.81 90.59
Lates calcarifer QLD Aus 2003 EF591372 2 5 4 3 99.28 99.28 98.32 98.8 98.68 99.16 97.36 86.05 86.05 92.43
Epinephelus lanceolatus QLD Aus 2014 KT397014 2 7 4 5 6 99.7 98.89 99.39 98.89 99.19 97.12 85.71 86.4 92.22
Epinephelus lanceolatus QLD Aus 2013 El2NQAus 3 7 5 5 6 3 98.72 99.32 98.62 97.87 97.12 85.37 86.05 92.33
Lates calcarifer QLD Aus 2013 Lc3NQAus 5 15 7 11 14 11 13 98.62 98.13 98.33 96.15 84.69 85.37 91.84
Epinephelus coioides QLD Aus 2015 Ec2NQAus 3 11 5 8 10 6 7 14 98.53 97.96 96.88 85.37 86.05 92.33
Lates calcarifer NT Aus 2007 GQ402011 4 12 6 9 11 11 14 19 15 98.82 96.76 85.71 86.4 92.33
Seven Band grouper Japan 1997 AY324870.1 4 8 6 5 7 8 22 17 21 12 97.48 85.71 85.71 92.33
Oxyeleotris lineolata QLD Aus 1999 EF591368 11 23 9 19 22 24 24 32 26 27 21 87.76 87.08 91.83
Macquaria novemaculata NSW Aus 2004 EF591365 41 41 39 41 41 42 43 45 43 42 42 36 98.64 97.96
Lates calcarifer SA Aus 2004 EF591366 41 41 39 41 41 40 41 43 41 40 42 38 4 97.96








Number of differences in sequence
Source of Sequence





Prior to this study, knowledge of the VNN strains present in Australia, were not sufficient to 
allow robust decisions to support vaccine development nor design targeted dsRNA for 
attempted knockdown of NNV. The acquisition of complete genome sequences of RNA 1 and 
RNA 2 collected from strains associated with VER outbreaks in marine aquaculture systems in 
North Queensland indicate the highest level of conservation to the RGNNV. Unfortunately, 
comprehensive comparison of RNA 1 segments across Australian species are limited. There are 
only three RNA 1 segment sequences from Australian species in the NCBI database ( Hick & 
Whittington 2010; Agnihotri et al., 2015). Nonetheless, within the comparison containing six 
sequences, the RNA 1 segments from Australian strains of NNV display a very high level of 
conservation, exceeding 97%, across the tropical geographic, and 96% across temporal zones.  
Similarly, the sequences of RNA 2 segments of NNV are highly conserved between strains that 
have been associated with VER outbreaks in Australia since 2001. High conservation extends 
not only across Australian strains but also across diverse geographic (Japan, China and the 
Mediterranean) and temporal sources (earliest strains collected in 1997). Previous researchers 
have noted the conservation of the capsid protein. The high level of conservation of RNA 2 
which contains the mRNA for the capsid protein, the antigen target for vaccine preparation, 
indicates a vaccine against the Australian strains could have wider global application.  
Temporally, the capsid protein gene has a low evolutionary rate (Thiery et al., 2004). In 
particular, the RNA 2 sequences obtained in this study display 97.8 to 98.3% homology to the 
RNA 2 segment of the type species for RGNNV, namely SGWak97, that was collected from 
E.septemfasciatus in Japan in 1997 (Iwamoto, 2001). The NQAus NNV strains collected in this 
study have less than 20 nucleotide differences from the original RGNNV strain or less than 1.31 
changes per 1000 nt per year. Considering the nucleotide differences translate to very few 
changes in the capsid protein during the past 17+ years, it is also likely a vaccine will be 
suitable for a long period of time. Further investigation regarding the conservation of the 








The following outcomes and conclusions were drawn from this Chapter: 
 
Data presented in this chapter was published:  
Condon K., Bochow S., Ariel E., and Miller T., (2019) Complete sequence of Betanodavirus from 
Australian barramundi, Lates calcarifer. Microbiology Resource Announcements 8. 
https://doi.org./10.1128/MRA.00081-19 
  
 NNV was confirmed to be present in high copy number in the viral extract. 
 Complete sequence of Betanodavirus RNA 1 and RNA 2 was obtained from three 
VER outbreaks in North Queensland. 
 Comparative phylogenetic analysis indicates the strains are of the RGNNV species. 
 Bioinformatic analysis indicates the RNA 1 and RNA 2 sequence and theoretically, 
the translated proteins are highly conserved in the RGNNV species associated with 
VER in tropical marine species in North Queensland. 
 Comparative analysis with RGNNV from the NCBI database indicates the RNA 1 and 
2 sequence and theoretically, translated proteins display remarkable conservation 
across a broad global species, geographic and temporal range. 
 Sequence of mRNA 2 was obtained for application to produce standard RT-qPCR 
control plasmids and recombinant protein expression. 
 Sequence of mRNA 1 was obtained which indicated the strains causing VER are pure 
RGNNV genomes and the lack of chimeric recombination with other NNV strains. 




CHAPTER 4. REVIEW AND IDENTIFICATION OF THE FUNCTIONAL 
MOTIFS OF THE BETANODAVIRUS GENOME 
Background  
 Amino acid motifs that are critical to the production of neutralising antibodies 
against RGNNV in grouper have been identified in the capsid protein. 
 Amino acid motifs that are linked with increased virulence, or critical to viral 
replication of Betanodavirus have been identified in the capsid Protein, Protein 1 
and B1 and B2 proteins. 
 Amino acid motifs that are linked with host species specificity have been 
identified in the RGNNV capsid protein structures. 
 Confirmation the strain of RGNNV to be used in this study contains virulence- 
associated motifs is required for vaccine preparation and to have confidence in 
the translation of the project results to industry application. 
 Knowledge of the functional motifs is required to direct targeted knockdown of 
the RGNNV using dsRNA.  
 
Aims of this Chapter  
 Confirm that motifs which are critical targets of neutralising for antibodies are 
present in the viral extract. 
 Confirm that the motifs which are critical targets for neutralising antibodies will 
be encoded by the gene sequence used for recombinant protein expression and 
vaccine preparation. 
 Confirm the viral extract being used in this project contains the factors that have 
been identified to be associated with virulence. 









Although the previous chapter identified a remarkable level of conservation in the genome of 
RGNN strains, there are also studies that identify significant loss in virulence associated with 
single amino acid mutations (Souto et al., 2015). Furthermore, there are a number of short 
amino acid motifs that have been determined to be critical to the production of neutralising 
antibodies in grouper species (Chen et al., 2015). In other fish species, including Senegalese 
sole, single amino acid mutations in the capsid protein have been demonstrated to 
significantly affect viral replication kinetics in SJNNV (Hata et al., 2010 and Souto et al., 2015). 
To ensure an effective translation of this project’s outcomes to the grouper aquaculture 
industry, it is important to ensure the therapies and challenges being conducted within this 
project are performed using the most virulent and competent viral strains. The production of a 
vaccine against a viral strain of reduced virulence would not be effective as a long-term 
management tool to prevent VER in grouper farms, in fact, it may contribute to the selection 
of more virulent strains within culture systems (Kennedy et al., 2016). 
In addition to the preparation of a vaccine, this project is attempting to apply dsRNA to 
prevent VER outbreaks. The targeted knockdown of portions of the viral genome that are 
critical to replication or disease is a fundamental requirement for the successful application of 
dsRNA as a therapy. A range of functional motifs have been identified in the Alphanodavirus 
and Betanodavirus genome.  
This work summarises the findings of previous researchers that have identified functional 
activity of specific regions of Nodavirus genomes. Considering the paucity of data available on 
Betanodaviruses, some Alphanodaviruses are included as a model for explaining the general 
replication characteristics of the Betanodavirus.  
The aim of this chapter is to identify motifs of the Betanodavirus genome that are critical for 
viral replication and virulence in grouper species and confirm the presence of such in the 
NQAus NNV strains that are being investigated in this project. The collective findings are 
illustrated in Figure 4.1 Schematic representation of the functional motifs for the 
Betanodavirus Protein A (p.85) and Figure 4.2 Schematic representation of the functional 
motifs of the Betanodavirus capsid protein (p.88) (Condon, this work).  
4.1.1 Viral Replication Characteristics 
Although the small size of the nodavirus genome would suggest a simple replication process 
the mechanism of viral and gene replication and expression involves a sophisticated regulatory 
system that is not completely understood (Petrillo et al., 2013). The restricted protein 
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encoding capacity of the small genome means the nodaviruses must utilise many host-
regulatory processes to complete the replication cycle (Castorena et al., 2010). Successful viral 
replication, in the case of nodaviruses, requires completion of several critical actions. The 
processes are presented as:  
 Attachment to susceptible host cells 
 Entry of viral particle to host cells 
 Formation of the replication complex 
 Expression of viral proteins 
 Replication of viral RNA segments 
 Formation of viral particles 
 Exit of viral particles from host cell. 
The processes do not occur as separate steps but rather a regulated system and presumably 
the inhibition of any of these critical actions could form the basis for the development of new 
treatments or therapies. For clarity, the processes will be discussed separately.  
4.1.1.1 Attachment to susceptible host cells 
All non-enveloped viruses use receptor mediated endocytosis to enter host cells (Chang & Chi 
2015; Smith & Helenius 2004). Three reports indicate the Betanodavirus mode of attachment 
to host cells (Liu et al., 2005) (Ito et al., 2008) (Chang & Chi 2015). A Sialic acid moiety of 
unknown location on the capsid of RGNNV is required for cell infectivity in vitro (Liu et al., 
2005).  
4.1.1.2 Entry of viral particles to host cells 
Although the mode of viral attachment is unknown, the mode of entry of the nodaviruses into 
cells has been determined. The Betanodavirus, Dragon Grouper NNV (DGNNV), penetrates 
Striped Snakehead (SSN-1) cells via a spherical pit and membrane-ruffling pathway suggestive 
of the use of macro- and micropinocytosis pathways (Liu et al., 2005). The inhibition of DGNNV 
replication was blocked in vitro by chlorpromazine, which suggests clathrin-mediated 
endocytosis as an entry pathway (Liu et al., 2005). This is the common pathway of cell entry by 
many unenveloped viruses and requires an acidic environment in the endosome (Liu et al., 
2005). 5-(N-ethyl-N-isopropyl) amiloride (EIPA) is a selective inhibitor of sodium/hydrogen ion 
exchange, disrupts glucose-induced acidification and is a micropinocytosis-specific inhibitor 
(Huang et al., 2014). EIPA reduced cell death in vitro and significantly reduced the expression 
of both RNA 1 and RNA 2 of RGNNV. The detection of RNA 2 was affected more significantly 
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than RNA 1 by EIPA (Huang et al., 2014). Following entry into cells, nodaviruses form viral 
replication complexes (VRCs) (Nagy & Pogany 2012).  
4.1.1.3 Formation of the Replication Complex 
All the characterised +ssRNA viruses assemble a viral replication complex (VRC) (Nagy & 
Pogany 2012). The expression of viral proteins, replication of the viral genome and packaging 
of viral particles occurs within the cell at a viral replication complex (VRC). The nodavirus VRC 
is located at the mitochondria and results in conformational changes in the organelle to form 
spherules, which are “viral replicating factories” (Kopek et al., 2007). The spherules appear 
between the outer and inner mitochondrial membranes and are invaginations of the outer 
mitochondrial membrane with interiors connected to the cytoplasm through small open necks 
(Kopek et al., 2007). Motifs on Protein A are responsible for the location of the VRC at the 
mitochondria. In the Alphavirus, Flock House Virus (FHV), spherule formation does not occur 
unless the viral RNA dependant RNA polymerase (RdRp) is active and a replication competent 
FHV RNA strand is present (Kopek et al., 2010).  
Docking of the Betanodavirus VRC in the mitochondrion relies on interaction between Protein 
A, secondary structures in the viral RNA strands and the modulation of host cellular co-factors 
(Weeks et al., 2010; Young et al., 2003). The interactions are not fully understood however, 
host cellular co-factors including heat shock proteins (Hsp) and phospholipids have been 
implicated. Heat shock protein 90 (Hsp90) and heat shock protein 70 (Hsp70) were recognised 
as important cytosolic chaperones for docking onto a special domain on the import receptor of 
the outer mitochondrial membrane (TOM) specifically Tom70 (Young et al., 2003). Hsp40, 
Hsp70 and Hsp90 have been implicated as important co-factors for nodavirus replication 
(Weeks et al., 2010). Deletion of a SSZ1 gene in yeast that encodes an atypical Hsp70, involved 
in translational fidelity as part of the ribosome-associating complex (RAC), resulted in a 30-fold 
increase in FHV3 RNA 3 accumulation (Weeks et al., 2010). Deletion of similar genes encoding 
RAC Hsp40 reduced FHV accumulation (Weeks et al., 2010).  
Hsp70 and Hsp90 have been implicated as important co-chaperones facilitating replication in 
several other RNA virus infections including human immunodeficiency virus (HIV) , Influenza A, 
severe acute respiratory syndrome (SARS) and hepatitis C (Mine et al., 2012). A plant infecting, 
+ssRNA virus, tomato bushy stunt virus (TBSV) like the Alphanodaviruses, replicates in yeast 
(Nagy 2015). In yeast, the formation of the VRC by TBSV requires the recruitment of a number 
of cellular co-factors including Heat shock protein 70 (Hsp70), proteosomal Rpn1 1p 
metalloprotease, eukaryotic elongation factor 1A (eEF1A), endosomal sorting complexes 
required for transport protein (Vps23p ESCRT), 60 Bro1p ESCRT-associated protein, Vps4p AA 
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A+ ATPase and Cdc34p E2 ubiquitin conjugating 61 enzyme (Nagy 2015). In addition, TBSV 
channels sterols and phospholipids to the sites of replication (Nagy 2015). The activation of 
TBSV RNA polymerase within the VRC was demonstrated to require Hsp70 and was enhanced 
by the phospholipids phosphatidylethanolamine (PE) and phosphatidylcholine (PC) (Pogany & 
Nagy 2015). The role of lipids in nodavirus VRCs has been reported as essential but rarely 
investigated (Castorena et al., 2010) (Qui et al., 2014a). FHV replication in Drosophila S2 cells in 
vitro was associated with the upregulation of several lipid metabolism genes (Castorena et al., 
2010). The down regulation of chaperone containing T-complex proteins (Cct), Cct1 and Cct2, 
that encode essential enzymes for phosphatidylcholine biosynthesis, supressed FHV RNA 
replication (Castorena et al., 2010). In contrast, formation of the VRC by WhNV was not 
improved with PE exposure (Qui et al., 2014a). WhNV Protein A was enhanced by 1, 1′, 2, 2′-
tetraoleoyl cardiolipin (CL), 1, 2-dioleoyl-sn-glycero-3-phosphate (PA) and 1, 2-dioleoyl-sn-
glycero-3 – (phosphoro-rac-(1-glycerol)) (PG) which are present in mitochondrial membranes 
(Qui et al., 2014a). Further research into the role of cellular chaperones in Betanodavirus and 
other viral infections is required.  
4.1.2 Expression of Viral Proteins  
In eukaryotic cells, many of the processes of RNA replication and capping which allow efficient 
protein translation to occur are contained within the nucleus (Ahola & Karlin, 2015). 
Considering their cytoplasmic location, nodaviruses must encode their own enzymes to ensure 
viral RNA replication and protein translation success (Ahola & Karlin, 2015). Nodaviruses 
express 4 proteins during replication namely Protein A, B1 and B2 and the capsid protein-α. In 
the positive sense ssRNA viruses, the RNA dependant RNA polymerase (RdRp) is always 
translated first (Miller & Koev, 2000). Protein A, B1 and B2 are expressed early in the infection 
stage and capsid protein-α later. Functional motifs of the RNA 1 strand are illustrated by Figure 
4.1  
4.1.2.1 Protein A:  
Protein A is ~1000 aa and contains multiple functional domains including nucleolar locating 
domains, mitochondrial targeting domains (MTD/MLS), a transmembrane domain (TMD), a 
RdRp, a self-interacting domain and an RNA capping domain (Bai et al., 2011). Additionally, 
upstream of the RdRp domain is a hypothetical methyltransferase-guanylyl transferase 
(MTase-GTase) region, which includes the MTD/MLs and TMD (Ahola & Karlin 2015). Wang et 
al. (2013) demonstrated Protein A also displays N-terminal transferase activity. Unlike many of 
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the +ssRNA viruses Protein A is produced as a single replication protein that is not cleaved into 
several functional proteins.  
4.1.2.2 Nucleolar Localising domains of Protein A 
The C-terminus of Protein A (aa 972 to 978) is similar in aa sequence (RPRRQRR) to the nuclear 
location signal (NLS) of HIV-1 Trans-activator of Transcription (Tat) and Rev proteins (Mezeth 
et al., 2007). No reason for a nuclear localisation signal in Protein A has been proposed. In 
addition, no Nuclear Export Signal (NES) has been proposed in the nodavirus genome (Guo et 
al., 2003a). 
4.1.2.3 Mitochondrial-interacting proteins of Protein A 
Early expression of Protein A coincides with the formation of the nodavirus viral replicating 
complex (VRC) (Miller & Ahlquist 2002). The VRC complex locates to the mitochondria via a 
mitochondrial locating signal (MLS) and embeds within the mitochondria via the mitochondrial 
transmembrane domain (TMD) (Miller & Ahlquist 2002). The RdRp is maintained in close 
association with both the spherule and the RNA strand by RNA binding motifs and RdRp self-
interacting motifs. Many of these tasks occur in vitro through amino acids within the MLS and 
MTD motif. In the nodavirus group, the mode of membrane association by Protein A is taxon 
specific (Ahola & Karlin 2015). In FHV the mitochondrial location signal (MLS), contained within 
the N-terminal end of Protein A (aa 1 to 46), is responsible for locating the VRC at the 
mitochondrion (Miller & Ahlquist 2002). Genetic replacement of the mitochondrial localisation 
sequence (MLS) region of FHV Protein A with an endoplasmic reticulum (ER) targeting 
sequence results in the formation of the VRC at the ER with increased viral protein production 
in vitro (Miller et al., 2003). Once localised to the mitochondria, a region within the N-terminal 
end of Protein A, termed the transmembrane domain (TMD) becomes inserted in the 
intermembrane space of the mitochondria and the C-terminus is exposed to the cytoplasm 
(Miller & Ahlquist 2002). In FHV, the TMD is predicted to be aa 15 to 36 
LLVGIATVSGCGAVVYCIS (Miller & Ahlquist 2002). One or more other regions, which were C-
terminal to aa 230, also possessed some MLS/TMD activity (Miller & Ahlquist 2002).  
Recently, both N-and C-terminal TMDs were studied (Qui et al., 2014b). In  Wuhan nodavirus 
(WhNV), a self-interaction of Protein A occurs between aa 1 to 254 and 255 to 480. The 
interaction occurred between 3 amino acid regions. Homotypic interactions between the same 
regions were noted for aa 1 to 254 (75 %) and 255 to 240 (55 %). The region aa 481-659 also 
formed heterotrophic interactions between aa 1 to 254 (30 %) and aa 255 to 480 (22 %). The 
self-interaction of Protein A was lost when mutations were created at K91A, W92A, R93A, 
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S163, R165A and Y169A. The mitochondrial membrane binding was not affected by the 
mutations (Qui et al., 2014b). Amino acid motifs between aa 660 to 839, which is within the 
RdRP domain, and aa 840 to 1014 of Protein A also display RNA binding activity that has not 
been fully investigated (Qui et al., 2014a). 
Protein A of GGNNV localised to intracellular membrane compartments in the cytoplasm (Guo 
et al., 2004). Bioinformatic analysis identified two hydrophobic aa residues that could 
hypothetically act as TMDs at aa 153 to 173 and 229 to 249 (Guo et al., 2004). The region 
consisting of aa 215 to 255 was demonstrated to contain an MLS and a TMD (229 to 249) (Guo 
et al., 2004). The MLS was not determined within the aa 215 to 255 region. The TMD mode of 
association was proposed be through embedding into the phospholipid bilayer of the 
organelle. In Atlantic Halibut NNV, four hypothetical transmembrane domains were identified 
(Mezeth et al., 2007). The regions consisted of aa residues 6 to 26, 148 to 169, 225 to 247 and 
647 to 665. Regions aa 6 to 26 and aa 225 to 246 were demonstrated to be MLS (Mezeth et al., 
2007). Proteins comprising aa 225 to 246, if expressed alone, localised to the golgi apparatus in 
some cells (Mezeth et al., 2007). 
4.1.2.4 MTase-GTase domain of Protein A 
In close association with the MLS and MTD is a proposed MTase-GTase domain. A MTase-
GTase domain is essential for RNA capping and is related to the formation of spherules (Ahola 
& Karlin 2015). Alphaviruses, another family of +ssRNA viruses that replicate in the cytoplasm, 
contain a unique type of RNA capping enzyme that has combined methyltransferase-guanylyl 
transferase (MTase-GTase) activity. The MTase-GTase structure, rather than the sequence, is 
proposed to convey the functional properties of the enzyme. The N-terminal moiety of the 
Alphanodavirus- Nodamura Virus Protein A (aa 1 to 460) is homologous in functional 
secondary structure to the Alphavirus MTase-GTase and contains a hypothetical membrane-
associating region (Ahola & Karlin 2015). MTase-GTase is comprised of the N-terminal core and 
the downstream “iceberg region” region (Ahola & Karlin 2015). The “iceberg region” is 
synonymous with the MLS/MTD domain already discussed. Ahola and Karlin (2015) did not 
refer to the region as a domain because it did not form a separate unit. Specific mutations 
within either the core or iceberg region can abolish the MTase-GTase activity.  
In the Betanodaviruses, a genus-specific insertion contributes to membrane association and 
mitochondrial targeting or “Iceberg region” (Ahola & Karlin 2015). This occurs in an area 
between aa 108 to 255 and concurs with the results of Guo et al. (2004). In FHV the C-terminal 
aa 1 to 200 were demonstrated to possess the ability to interact with components of the 
Protein A (Dye et al., 2005). Specifically, mutations to aa N203, W220, W222 and S231 induced 
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significant reduction in Protein A self-binding and RNA replication (Dye et al., 2005). Mutations 
introduced at aa Y207, W215 and E227 did not affect Protein A self-binding but did reduce 
RNA replication to 8, 5 and 4 % of wild type (WT) respectively (Dye et al., 2005). The Y207, 
W222 and S231 are conserved at the same location in the Betanodaviruses however; the E227 
is replaced with M227. The W222, S231 and M227 could relate in function as an MLS for the 
downstream MTD. Guo et al. (2004) or Ahola & Karlin (2015) did not solely differentiate the 
MLS function.  
 Between the MTD/MLS and self-binding motifs and RdRP motif of Protein A is a region that 
relates to temperature sensitivity in the Betanodaviruses (Hata et al., 2010). Temperature 
sensitivity of the Betanodaviruses involves a combination of RNA 1 and RNA 2. The region on 
the RNA 2 has not been investigated. The region on the SJNNV RNA 1 genome was located 
from nt 84 to 1419 or aa 1 to 445 Protein A (Hata et al., 2010). More specifically, the region nt 
1088 to 1419, aa 335 to 445 was particularly important in the temperature sensitivity of 
RGNNV (Hata et al., 2010). Souto et al. (2019) demonstrated point mutations of nucleotide 
sequence of SJNNV RNA 1 that lead to single specific amino acid changes to resemble that of 
RGNNV RNA 1 at aa 41, 48, 218, 223, 238 and 239 lead to reduced infectivity of the 
recombinant strain compared to the wild type SJNNV at 25 °C in experimental challenge in 
sole. The authors were not able to test if the aa changes improved infectivity at the RGNNV 
optimal temperature of 30°C due to the inability of sole to tolerate the higher water 
temperature.  
4.1.2.5 RNA dependant RNA polymerase of Protein A 
In the positive sense ssRNA viruses, the RNA dependant RNA polymerase (RdRp) is always 
translated first (Miller & Koev 2000). Betanodavirus RdRP was detected in the barramundi cell 
line from 12 hours post infection (hpi) with peak expression at 24 hpi and declining expression 
48 to 72 hours hpi (Wu et al., 2010). In Dicentrarchus labrax, Protein A of GGNNV was detected 
from 5 hpi, increased to 14 hpi and stabilised until 23 hpi whereby it slightly declined (Guo et 
al., 2004). The RdRp has an essential requirement for Mn2+ (1mM optimal and above 4mM 
inhibitory and an optimal performance at pH 8 to 9. (Guo et al., 2004). The nodavirus RdRP 
contain 6 motifs that are preserved in many ssRNA virus RdRps (Johnson et al., 2001). The 
conserved RdRp motifs have been identified in the Betanodavirus RdRP (Johnson et al., 2001). 
The RdRp can replicate the nodavirus genome in the absence of cellular co-factors (Wang et 
al., 2013). However, protein translation and virion formation rely on the formation of the VRC. 
The RdRp recognises the nodavirus genome via cis-acting elements and secondary structures 
rather than any sequence specific recognition factor (Wang et al., 2013). 
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4.1.2.6 Terminal Transferase in Protein A 
The RdRp is unable to replicate the viral genome if more than 3 nt are removed from the 3’ 
end of the negative strand of RNA 1 sequence (Wang et al., 2013). Protein A has terminal 
nucleotransferase (TNT) activity that adds nt to the 3’ sequence if 2 nt are missing (Wang et al., 
2013). The TNT recognises the last 191nt of +/-RNA 1. Adding additional nucleotides to the 3’ 
of the 191 nt sequence does not affect RdRp activity provided the addition be not too long 
such as that of an 18nt poly a tail. Like the RdRp, the TNT relies on the presence of the 3’ end 
of the positive or negative strand of RNA 1 and the presence of the GDD motif (Wang et al., 
2013). The location of the TNT motif on Protein A has not been determined. 
4.1.2.7 B1 Protein 
B1 is a 111 aa protein. B1 is dispensable for RNA replication in mammalian and yeast cells in 
vitro (Chen et al., 2009). In Betanodaviruses, B1 cDNA and B1 expression was detected at 12 
hours, peaked at 24 hours and declined over 72 hours post-transfection in 3 fish cell lines 
(grouper liver cells (GL-av), grouper fin cells (GF-1) and zebrafish liver cells (ZLE) (Chen et al., 
2009). B1 was demonstrated to be a novel anti-necrotic protein that may serve to maintain 
mitochondrial function to allow viral replication (Chen et al., 2009). How B1 prevents cell 
death has not been determined. However, it has been demonstrated to not be a member of 
the Bcl-2 family, which is a host-encoded antagonist of apoptosis (Chen et al., 2009).  
The aa 1 to 70 are highly homologous across the RGNNV, AHNNV and SJNNV strains studied by 
Chen et al. (2009). A N-glycosylation site is present at aa 16 to 19 (NKTS) as is a nuclear 
locating sequence (NLS) between aa 33 to 38 (PRRARAA). The PRRARAA aa sequence is 
retained by the grouper isolated RGNNV genotypes but present as a PRRART in the AHNNV 
and SJNNV genotypes. An additional NLS is located at aa 66 to 70 (KRPRR) (Chen et al., 2009). 
Although not demonstrated to be a result of the proposed NLS, B1 linked to a reporter protein 
were observed to be transported to the nucleus (Chen et al., 2009). The purpose of the nuclear 
transport has not been discussed in literature. Investigation into functional motifs in B1 
identified possible protein modification sites including a N’myristoylation site (aa 30 to 55 
GGVTAI), a protein kinase C phosphorylation site (aa 58 to 60 SRR), a protein kinase II 
phosphorylation site (66 to 69 TVIE) and a mitochondrial specific sequence (45 to 52 TFVISHAA 
A) (Su et al., 2009). Amino acid sequence between the Nodaviruses was not conserved within 
the hypothetical protein modification sites proposed by Su et al. (2009). When the nucleotide 
sequence identity of the B1 region RGNNV TN1 strain (EU118118) was compared with other 
species, there was a 92 to 96 % homology with other grouper isolated strains, 81 % with 
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AHNNV (AJ401165), and 70 % with SJNNV (AB025018) (Chen et al., 2009). No functional 
explanation for the homology between strains was proposed.  
4.1.2.8 B2 Protein 
B2 is a 75 aa multifunctional protein whose role in nodavirus replication has not been fully 
exposed (Petrillo et al., 2013). The protein is not required for viral RNA replication however it 
is required for accumulation of the viral RNA and the production of infectious virions (Settles & 
Friesen, 2008). B2 of RGNNV was expressed in grouper liver cells (GL-av) 12 hpi with increased 
expression between 24 and 72 hpi (Su et al., 2009). The B2 protein has been demonstrated to 
possess dsRNA-binding activity, pro-apoptosis properties, be involved in the formation of the 
VRC and promote translation of the capsid protein (Venter and Schneemann, 2008). There is 
little aa homology between B2 of the Alpha-and Betanodaviruses however due to their 
functional similarity some homologous regions have been identified (Ou et al., 2007). B2 plays 
a critical role in the silencing of the RNA interference pathway, which is involved in innate 
immune responses (Su et al., 2009). B2 binds dsRNA to both prevent the cleavage of long 
dsRNA by Dicer-2 and inhibit the loading of short interfering RNAs (siRNA) into the RNA 
silencing complex (RISC). 
B2 recognition of dsRNA occurs in a sequence independent manner. The mode of recognition 
relies on an A-type duplex RNA, specifically 2 successive minor grooves with an intervening 
major groove on the other side of the RNA duplex (Venter & Schneemann, 2008). The dsRNA 
binding activity of B2 is based on electrostatic forces (Petrillo et al., 2013). Mutation of 3 
positively charged aa including R36, L47and L62 to A or D reduced or inhibited the ability of 
FHV B2 to bind dsRNA. In the presence of the mutant viruses, the FHV RNA accumulated in 
cytoplasmic granules, preventing the translation of the RNA into protein (Petrillo et al., 2013). 
A substitution mutation in NoV B2 of aa R59 was defective in binding both 44bp dsRNA and 21 
nt siRNA (Aliyari et al., 2008). 
B2 also acts as a structural component of the VRC to limit the effect of the iRNA pathway to 
combat viral production (Aliyari et al., 2008). In RGNNV a mitochondrial targeting sequence 
(MTS) of B2 (aa 41 to 50) is reported as RTFVISAHAA (Su & Hong 2010). Residues critical to 
maintaining the dsRNA binding ability of Betanodaviruses have been identified (Fenner et al., 
2007). Arginine (R) residues, R26, R53 and R60 are essential for the binding of short 40-bp 
dsRNA (Fenner et al., 2007). R53 and R60 in GGNNV were essential for the accumulation of 
long (600bp) dsRNA in vitro (Fenner et al., 2007). An R55, which is only present in AHNNV, and 
GGNNV not SJNNV was also identified to have dsRNA binding ability (Fenner et al., 2007). The 
R53 and R60 were confirmed to be critical for B2 dsRNA binding and RNAi-inhibition in a 
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grouper isolated VER strain in Taiwan (Ou et al., 2007). Four aa residues were identified as 
necessary for the mitochondrial targeting of an RGNNV strain namely V44, I45, R52 and R53 
(Su & Hong 2010). Although no nuclear localisation signal has been identified Fenner et al. 
(2006) noted the accumulation of GGNNV B2 within the nucleus during the late stages of 
GGNNV infection. 
Comparative analysis of the 27 B2 Betanodavirus sequences published on NCBI reveal 
homology of 51/70 aa (73 %) across the entire protein (this work). Within B2 the first 50 aa are 
highly conserved displaying homology of 42/51aa (82 %). A motif of unknown significance at aa 
5-19 is completely conserved in the N-terminal arm of the Betanodavirus B2 aa 5-
QQAIDQHLVELEQLF-19 (this work). The E14 residue along with D24 facilitates long dsRNA 
binding (Fenner et al., 2007). In addition, the aa 16-20 LEQL is conserved between the 
Betanodaviruses and NoV (Ou et al., 2007 and this work). The MTS, aa 41 to 50 (Su & Hong 
2010), is almost completely conserved in the Betanodaviruses. All SJNNV species have a S48 
motif rather than H48. Three strains have a single aa change within the motif that has not 
been linked with any clinical change in VER. Only 8/24 (33 %) aa of the C-terminal end of B2 
are conserved. Conserved motifs are R53, L54, L57, R60, P52, E70, P71 and M72 (This work). 
The R59 motif identified by Aliyari et al. (2008) as essential for NoV B2 is conserved in all the 
25 Betanodavirus B2s except the BFNNV strains. An A69 motif is conserved between FHV, NoV 
and the Betanodaviruses, except AHNV. The effect of variation in these sequences on virulence 
or species specificity was not proposed.  
In vitro monitoring of capsid protein demonstrated B2 is necessary for efficient translation of 
the capsid protein (Petrillo et al., 2013). The translational efficiency was linked to B2 playing a 
role in ribosomal occupancy of RNA 2 (Petrillo et al., 2013). B2 has also been demonstrated to 
possess pro-apoptotic activity (Su et al., 2009). B2 upregulated the expression of Bax which is 
an antagonist of apoptosis leading to mitochondria-mediated necrotic cell death at the late to 




Figure 4-1: Schematic drawing of RNA 1, mRNA of Protein A indicating location (number) , function and amino acid sequence of functional motifs 




4.1.2.9 Capsid Protein  
The RNA 2/capsid protein of the Betanodavirus has been proven to determine host range 
(Iwamota et al., 2004). The Betanodavirus capsid protein has also been reported to possess 
Nuclear Location signal activity, pro-apoptosis activity and contain a motif that relates to 
species-specific virulence and the recognition of virus by neutralising antibodies (Guo et al., 
2003a; Ito et al., 2008 and Chen et al., 2015). A schematic diagram of the Betanodavirus capsid 
protein is presented in Figure 4.2. 
The Betanodavirus capsid protein consists of 340 aa. The translation of the capsid protein 
requires both UTRs of RNA 2 and the 5’UTR contains a Kozak sequence of ACAA TGG 
(3ANNATGG+4) (Huang et al., 2007). The capsid protein has a mw of ~37 to kDa which is 
slightly higher than that predicted by their amino acid sequences (Lin et al., 2001). The higher 
molecular weight is consistently observed and could possibly be caused by host cell factors 
causing polyadenylation in vitro (Huang et al., 2007). Expression of the capsid protein was 
reported to increase from 12 to 72 hpi and was significantly greater than the peak RdRP 
expression (Wu et al., 2010). Studies with recombinantly expressed mouse grouper NNV 
(MGNNV) indicated the capsid protein packages multiple RNA strands ranging in size from 100 
to 4500 nt (Guo et al., 2003b). Expression of the capsid protein of GGNNV in vitro induced 
activation of caspase-3-like and caspase-8-like proteases which ultimately leads to apoptosis 
via the “extrinsic” pathway (Guo et al., 2003b). The induction of apoptosis serves as a 
mechanism to release progeny virus from infected cells (Guo et al., 2003b). 
The Betanodavirus capsid protein displays an N-terminal arm aa 1 to 52, a highly conserved 
region T2 aa 83 to 216, a variable region T4 aa 235 to 351 and an area referred to as the C-
terminal arm aa 288 to 338. The N-terminal aa 23 to 31 RRRANNRRR of the capsid protein 
from GGNNV were demonstrated to perform nucleolar localisation (NLS) functions in both 
mammalian (Cos-7) and Asian seabass D.labrax (SB) cell lines (Guo et al., 2003a). The N-
terminal aa 2 to 10 RKGEKKLAK of GGNNV capsid protein also displayed NLS activity (Guo et 
al., 2003b). No role of the NLS in the replication of the Betanodavirus genome has been 
proposed. The N-terminal arm of the capsid protein contains a high percentage of basic 
residues and is involved in binding the negatively charged phosphate backbone of the viral 
genomic RNA within the capsid (Lu & Lin 2003). There are two stretches of RRR residues and 
D75 residue. The D75 residue represents a catalytic residue (Grotmol et al., 2000). The RRR 
residues are involved in the binding of the viral genomic RNA to the internal capsid wall of the 
host cell. The aa R23 to 25 and R 29-31 were critical in the formation of viral like particles (Lu & 
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Lin 2003). Also, within the N-terminal arm aa 127 to 140 is the highly conserved DxxDxD motif, 
which in the Betanodaviruses is FLPDPTDNDHTFDA, is responsible for calcium binding (Wu et 
al., 2008). 
Within the highly variable T4 region a 3 aa motif (254 to 256) is completely conserved within 
each NNV genotype (Nishizawa et al., 1997). The motif is responsible for neutralising epitopes 
that are associated with viral infectivity (Ransangan & Manin 2012). The species present as 3 
serotypes by analysis with monoclonal antibodies raised against the capsid protein (Mori et al., 
2003). The amino acid motifs and serotypes were discussed in Chapter 3 (refer to Table 3.1). 
The RNA 2 and/or the encoded coat protein controls host specificity in SJNNV and RGNNV 
(Iwamoto et al., 2004). Recombinant studies combining RNA 1 and different RNA 2 regions of 
SJNNV and RGNNV identified regions on RNA 2 which related to virulence (Ito et al., 2008). 
Virulence in striped jack and seven band groupers was retained when the RNA 2 segment nt 
693 to 1054 (RGNNV) and 694 to 1061 (SJNNV) was retained respectively. In vitro all the viral 
hybrids replicated indicating the loss in infectivity was related to a host factor rather than 
critical mutation in the virus. Significantly, in vitro activity was demonstrated via transfection 
with lipofectamine which facilitates entry of DNA or RNA to cells (Cardarelli et al., 2016) and 
by-passes the requirement of attachment and entry to cells. The loss of virulence in vivo could 
indicate the regions identified by Ito et al. (2008) relate to attachment and entry of host cells. 
However, other mechanisms could also account for the variation in infectivity between in vivo 
and in vitro studies. 
 In RGNNV the region between nt 694 to 758 (aa 223 to 245) appears to affect species 
specificity. In SJNNV, the region between nt 695 to 765 affects species specificity (Ito et al., 
2008). The nt and aa homology of the two viruses within the critical regions were 60 and 55 % 
respectively. How the region influences species specificity is unknown. Near this region a 
combination of either both or two single amino acid mutations of S247A or S270N in a SJNNV 
capsid protein lead to mortality of 60 % compared to 100 % compared to wild type virus in 
experimental infection of Senegalese sole (Souto et al., 2015). In vitro, the viral mutations 
reached similar viral titres albeit with slower replication kinetics (Souto et al., 2015a).  
The capsid protein may also have yet to be discovered functions. The formation of the VRC and 
the expression of B2 provide a mechanism that protects the viral RNA during synthesis 
following the expression of Protein A. However, no mechanism for the protection of the RNA 1 
strand prior to translation to Protein A has been proposed. Considering the capsid protein is 
the only viral-derived protein present in the host cell prior to Protein A translation it is likely 






Figure 4-2: Schematic drawing of RNA 2 mRNA of Capsid Protein indicating location (number) , function and amino acid sequence of functional motifs 




4.1.3 Replication of Viral RNA segments 
Replication of the Nodavirus RNA involves the production of multiple RNA species in addition 
to RNA 1, 2 and 3 (Venter & Schneemann 2008). Although packaged as separate strands, 
during replication, the RNA 1 and 2 are covalently linked as head to tail monomers (Rosskopf 
et al., 2010). Additional RNA species have been described as defective interfering RNAs (DI-
RNAs) and RNA dimers (Venter & Schneemann 2008). RNA dimers consist of head to tail 
junctions of RNAs 1, 2, 3 or 2 and 3 in both positive and negative strand RNA. DI-RNAs consist 
of genomic RNAs with internal deletions or sequence rearrangements. A 634 nt DI-RNA of FHV 
(DI 634) accumulates to higher levels than viral genomic RNAs (Dasgupta et al., 2003). No 
function has been demonstrated for the DI-RNA. An additional negative sense intermediary 
formed in the early replication cycle accounts for approximately 1 % of the RNAs replicated 
(Venter & Schneemann 2008). The production of the negative sense intermediary is 
independent of an external RNA primer and in the case of WhNV involves the recognition of 
the last 191nt on the 3’ of RNA 1 positive sense or last 201nt on the negative sense RNA 1 
(Wang et al., 2013). A D.labrax NNV (termed DIEV in the publication) intermediate, minus 
strand RNA, was detected in cell culture at 96 hours post-inoculation (hpi). Other researchers 
report the detection of minus strand RNA 1 of GGNNV in cell culture 12 hpi (Adachi et al., 
2007). 
How the RNA 1 strand locates and becomes stabilised in the cell prior to packaging in the 
capsid protein is not established beyond occurring within the VRC. The B2 protein has been 
shown to be in close association with the RNA 1 and plays a role in the protection of RNA 1 
from the RNA interference (RNAi) machinery. B2 is produced well in excess of RNA 1 and could 
perform additional roles in the replication of the Nodaviruses (Petrillo et al., 2013). 
Within the virion, RNA 1 and 2 of FHV form a single RNA that has been observed in gel 
electrophoresis. A covalent link is proposed to occur through a small section with nucleotide 
homology between the 3’ end of RNA 1 and 5’ end of RNA 2. Deletion of 5 nt from the 3’ end 
of RNA 1 prevents RNA synthesis in the case of FHV (Ball 1995). A single nt substitution of G at 
2960 to T in FHV leading to an amino acid change from R to L in the RNA 3 promoter region 
lead to an absence of B2 and significant downregulation in the translation of the FHV coat 
protein α (Petrillo et al., 2013). The recruitment of RNA 1 by Protein A at the VRC in WhNV was 
demonstrated to rely on the presence of a stem loop structure with nt 50 to 118 of RNA 1 
being critical (Qui et al., 2014a). The binding ability was increased with increased Protein A 
concentration with the minimal ratio of Protein A: RNA 1 being 10: 1 (Qui et al., 2014a). The 
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recruitment of RNA 2 by Protein A in the VRC was also dependant on the presence of a stem 
loop structure that is located in nt 123 to 164 of RNA 2 (Qui et al., 2014a).  
4.1.3.1 RNA 1 
Betanodavirus RNAs are of similar function and structure to that of the Alphanodaviruses. RNA 
1 is the mRNA for the RdRP (Protein A). The sub-genomic RNA 3 is also present on the 3’ end of 
the RNA 1 and is the mRNA for the B1 and B2 proteins. Both the RNA 1 and 2 molecules are 
required for infectivity and the viral strands are self-replicating in vitro in the absence of 
complete virions. The presence of RNA 1 and RNA 2 was detected in vitro at 24 hours post-
infection (hpi) and RNA 3 at 96 hours pi (Delsert et al., 1997). Delsert et al. (1997) further 
noted that the RdRp was associated with the mature capsid. The RNA 1 nt sequence of 
Betanodaviruses displays ~80 % homology across the genus. Within each species/genotype 
approximately 90 % nt homology exists although it should be noted that a large proportion of 
the strains in the NCBI database have not been assigned to genotype level. Within the first 
~40nt of RNA 1 of the Betanodaviruses a TPNNV specific insert exists at nt 27 to 34 
(UAACUGAA). The insert is positioned in the UTR of RNA 1. No reference to the insert has been 
located in the published literature. As TPNNV has not been reported since 2007, it could be 
inferred that TPNNV displays low virulence and adaptability compared to the RGNNV, SJNNV 
and BFNNV. 
4.1.3.2 RNA 2 
The RNA 2 strand consists of ~ 1435 nt and contains one open reading frame (nt 27 to 1043) 
flanked by a 5’ 26 nt non–coding/untranslated region (NCR/UTR) and a 3’ 392nt UTR (Huang et 
al., 2007). Secondary structures within the RNA 2 C-terminal region (UTR), also referred to as 
“cis-acting elements”, are required for RNA 2 replication. The secondary structures in UTRs are 
required by the RdRP of many RNA viruses to allow the recognition and processing of RNA in 
viral replication (Taufer et al., 2008). Conserved secondary structures were predicted by 
computer modelling to be present in the 3’ terminus of RNA 2 in the nodaviruses including 
FHV, NoV, SJNNV and GGNNV (Taufer et al., 2008). The 50 nt of the 3’ terminal RNA 2 of FHV 
were sufficient to direct the replication of complementary RNA (Albarino et al., 2003). 
Similarly, in NoV, 50 nt (1287 to 1336) at the 3’ end of the RNA 2 is sufficient to direct the 
RdRP to replicate a complementary RNA (Rosskopf et al., 2010). RNA 2 also forms head-to-tail 
dimers during RNA replication (Qia et al., 2011). The dimers are approximately the same size 
as the RNA 1 and can be difficult to distinguish on gel electrophoresis (Qia et al., 2011). The 
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RNA dimers of NoV form between the 5’ terminal 17 nt and the 3’ terminal 54 nt of RNA 2 
(Rosskopf et al., 2010). 
4.1.3.3 RNA 3 
The replication of RNA 3 has been described for the Alphanodaviruses. The replication of RNA 
3 does not involve an intermediary negative sense sequence. In the Alphanodaviruses Flock 
House Virus (FHV), Pariacoto Virus (PaV), Nodamura Virus (NoV) and Wuhan Nodavirus 
(WhNV), RNA 1 and sub genomic RNA3 (sgRNA3) form homodimers during replication (Qia et 
al., 2011). It is proposed that RNA 3 binds to viral RNA to prevent the formation of 
incompatible dsRNA that may affect the formation of the capsid (Schneemann 2006). The 
homodimers consist of negative strand RNA 1 and positive strand sgRNA3 which results in the 
initiation of sgRNA3 transcription. The promoter for transcription of sgRNA3 is located on the 
negative strand of RNA 1. In the case of WhNV, the promoter is located within nt 2758 and 
2769 on RNA 1. The production of sgRNA3 also requires the presence of secondary structure 
that includes the transcription start site of B1 (Qia et al., 2011).  
Transcription of RNA 2 suppresses the transcription of sgRNA3 (Qia et al., 2011). The 
suppression of sgRNA3 by RNA 2 is proposed to occur through RNA 2 having 3 regions of 
nucleotide complementarity to the negative strand of RNA 1, which both restrict the formation 
of the secondary structure of RNA 1 and also bind directly to the sgRNA3 promoter region (Qia 
et al., 2011, Wang 2010). By annealing to the sgRNA3 promoter site on the negative to strand 
RNA 1, RNA 2 impairs the recognition of the sgRNA3 promoter by the viral RdRp (Wang et al., 
2013). The mechanisms of replication of RNA 3 in the Betanodaviruses have not been 
described.  
4.1.4 Formation of viral particles 
Nodaviruses do not form empty capsids but package RNA into the capsid being either viral or 
seemingly random in origin with the final product having approximately the same 
sedimentation rate as that of the nodavirus virion (Gopal et al., 2014). The capsid protein 
packages one molecule of RNA 1 and RNA 2 into progeny particles. The RNA 3 is not packaged 
into virions (Gopal et al., 2014). RNA packaging into virions occurs approximately 30 minutes 
after synthesis of the capsid protein. Optimal capsid formation in the Betanodaviruses occurs 
at pH 8.0 that correlates well with the normal pH of ocean water (pH 8.4) (Lin et al., 2001). The 
capsid consists of 180 copies of the capsid protein α (Gopal et al., 2014).  
The Betanodavirus capsid protein is produced as a single protein. Functional motifs have been 
identified on the capsid at aa 23 to 25, 29 to 31, 83 to 216, 127 to 140, 187 to 201 and C-
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terminal aa 4 to 11 (Lu & Lin 2003). At the N-terminal the RRR motifs at aa 29 to 31 and less so 
aa 23 to 25 and were critical for viral particle formation in vitro (Lu & Lin 2003). Wang (2010) 
investigated the role of 35 residues at the N-terminus of the DGNNV. R30 and R31 are 
important for particle formation and particle stability (Wang 2010). Effects of R29 were 
negligible (Wang 2010). 
The middle region of the capsid protein aa 83 to 216 is proposed as the site of folding to form 
the T=3 capsid. Within this region a conserved aa 140 to 147, AL/FQATRGA, is encoded by less 
frequently present codons and may serve to slow the ribosomal traffic rate to avoid 
interference with the folding of the capsid protein (He & Teng 2015). Folding of the single 
protein to form a functional capsid involves disulphide bonding at highly conserved residues 
C187 and C201 (Krondiris & Sideris 2002). Amino acid analysis of the coat protein of the 
Betanodaviruses indicates the DxxDxD motif, which is important for capsid formation, is 
positioned at aa 127 to 140. Within aa 127 to 140 of DGNNV aa 130 to 135 of the capsid 
protein was identified as the calcium binding ligand. Point mutations of aa D130, D133 and 
D135 resulted in a 50, 100 and 50 % reduction in viral particles respectively (Wu et al., 2008). 
Motifs C115 and C201 are essential for capsid formation of DGNNV and for thermal stability of 
viral particles (Wang 2010).  
In the DGNNV capsid protein, N-and C-terminal motifs are involved in the viral particle 
formation (Lu and Lin 2003). Deletion of the C-terminal aa 4 to 11 (328GTVCTRVD335) reduced 
viral particle formation to just 4.5 % of wild type (Lu and Lin 2003). Although viral replication 
and packaging occurs in membranes associated with the mitochondria, the capsid protein lacks 
MLS (Mezeth et al., 2007). Signals for mitochondrial targeting maybe present in the UTR of 
RNA 2 (Mezeth et al., 2007). The covalent linkage proposed by Rosskpf et al. (2010) between 
the RNA 1 and RNA 2 would facilitate localisation of the capsid protein to both the 
mitochondria and replicated RNA 1 and 2. How the ssRNA viruses in general regulate viral 
production with protein synthesis and capsid formation and packaging has not been 
determined. A form of viral sensing of cellular co-factors in the sub-cellular environment is 
proposed to regulate the actions within the VRC (Nagy 2015).  
4.1.5 Exit of viral particles 
The exit of viral particles from the host cell by Betanodaviruses has not been extensively 
studied. The fore-mentioned induction of apoptosis by either the capsid protein or B2 would 
facilitate the release of progeny virus from infected cells. The action of B2 to upregulate 
expression of the pro-apoptotic gene Bax which induced loss of mitochondrial membrane 
potential and mediated necrotic cell death of 44 % of cells at 72 hpi, is a mechanism that 
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would facilitate exit of viral particles (Chen et al., 2009). Although cell-to-cell transport is 
reported for many neurotropic viruses, no such movement of viral particles between cells has 
been demonstrated in the Betanodaviruses. 
4.1.6 Undescribed mechanisms 
Acknowledging the limitation of a small genome, the Betanodaviruses complete infection and 
replication in a very efficient manner. Although the untranslated region of RNA-2 represents a 
relatively large proportion of the genome (~10% of whole genome and ~30% of RNA 2 
segment), limited attention has been directed to the role of the UTR in viral replication. 
Recently Souto et al. (2018) demonstrated the importance of the 50 terminal nucleotides of 
the 3’ end of the genome in forming the stem loop structure that is essential for replication. 
The nt region 1398-1421 was broadly identified as more critical in forming the stem loop 
structure and mutations at 1408 and 1408-1412 but not 1412 alone. Through in vitro studies, 
the functional role of 1408-14212 was demonstrated to affect the interaction with the 3’ 
NCR/UTR of RNA 2 (Souto et al., 2018). Moreover, the significant attenuation of virulence in 
Senegalese sole through mutation of 1408-1412 indicated the region also plays a role in 
interaction for RNA 2 with host cellular proteins (Souto et al., 2018). 
The importance of viral encoded microRNA (V-miRNA) is recognised as a potent mechanism 
used by viruses to achieve viral replication, persistence, immune evasion and cellular 
transformation (Cullen 2009; Grundhoff & Sullivan 2011; Tycowski et al., 2015). V-miRNAs 
represent a genomically efficient way for viruses to regulate host immune responses. A V-
miRNA could target multiple genes in the same host or a highly conserved gene in multiple 
hosts. Additionally, V-miRNAs are known to target the expression of viral replication process 
and are involved in the Singapore grouper Iridovirus which encodes at least 16 V-miRNAs, the 
functions of which are being studied (Guo et al., 2013). In addition, nine v-miRNAs have been 
detected during replication of the fish-infecting Megalocytivirus (Zhang et al., 2014). 
Nodavirus V-miRNAs have not been reported. However, the replication of short incomplete 
copies of Differential interfering-RNA (DI-RNA) by the RdRp has been detected in the early 
phases of nodavirus replication in vitro. During RNA replication, FHV produces, ~ 400bp ds RNA 
(DI-RNA) from the 5’ terminus of RNA 1 which serves as a Dicer-2 substrate (Aliyari et al., 
2008). Pyrosequencing of the dsRNA formed 4 days post-FHV infection detected 4371 small 
RNAs the majority of which have strong homology and presumably target a region comprising 
the first 400nt of RNA 1 (Aliyari 2008). No functional roles for the DI-RNAs have been 
demonstrated. The mass replication of the DI-RNAs could be an intermediate step in the 
production of V-miRNA which could serve to downregulate specific host genes such as those 
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which regulate immune function or to regulate nodavirus replication. The lower expression of 
Protein A from RNA 1 compared to the capsid protein of RNA 2 despite both strands being 
transcribed in equal amounts supports a proposal that portions of RNA 1 may have regulatory 
roles conferred by the RNA rather than translated protein. 
4.1.7 The importance of the functional motifs in the context of this study 
There are few studies investigating the functional motifs of the Betanodavirus genome that 
discuss multiple motifs across multiple Betanodavirus strains. Rather many studies investigate 
a small portion of the genome in a single strain of NNV. Although this review has identified a 
large number of motifs that are important for replication, it must be noted that the images 
prepared are a collective representation from many articles. The aim of this chapter is to 
confirm the presence or absence of the many functional motifs identified in the literature in 
the three NQAus NNV strains of RGNNV obtained within this study. Confirmation of the 
functional motifs serves a three-fold purpose namely: 
1. It confirms the presence of the motifs noted from literature are present in strains 
beyond those used in the published reports. 
2. It ensures the viral extract being used in this project to test therapies is theoretically 
competent and virulent. 
3. It ensures the therapies developed in this project are targeted and tested against a 
competent and virulent strain of RGNNV. 
4.2 Materials and Methods 
4.2.1 Genome annotation and illustration 
The aforementioned critical motifs identified by previous researchers were annotated into the 
complete RNA 1 and RNA 2 segments obtained from sequencing using the Geneious 
bioinformatic program. Although the Geneious program is a very useful tool for bioinformatics, 
the illustration of the overall genome annotation is not easily reproduced in printable, 
readable single page format from Geneious. Hence, additional schematic maps of RNA 1 and 
RNA 2 were prepared (Figures 4-1 and 4-2). 
4.2.2 Identification of critical motifs in the E.coioides RGNNV viral extract strain. 
The critical motifs identified by previous workers were annotated into the RGNNV species type 
strain using the Geneious bioinformatic program (Biomatters, available from 
http://www.geneious.com). The sequences of the viral segments obtained from the three 
NQAus NNV strains described in Chapter 6 were aligned against the RGNNV reference genome 
described in Chapter 3 using a Geneious global alignment with default parameters. The region 
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of the RNA 2 that translates into the species specificity region identified by Ito et al.(2008) 
were compared for all of the Australian strains described in Chapter 3. The conservation or 
lack thereof motifs in the strains collected in this study were recorded.  
4.3 Results 
4.3.1 Genome annotation and illustration 
A summary of the functional motifs from the translated amino acid sequence from the 
Betanodavirus are illustrated in Figures 4.1 and 4.2. 
4.3.1.1 RNA 1, mRNA of Protein A 
All of the motifs that are translated from the mRNA of RNA 1 and identified in the literature as 
critical for viral replication in the RGNNV species were conserved in each of the three strains 
investigated in this study. (Table 4.1). The motifs that have been identified as essential for viral 
replication complex formation were 100% conserved in the species sequenced in this study (aa 
6 through to 249 in Table 4.1). A common aa motif of SGxxxxV was retained between the 
RGNNV, and all of the Betanodaviruses and some Alphanodaviruses in the Mitochondrial 
location signal motif (aa 6-26 in Table 4.1). The RdRP motifs, where identifiable, were 
conserved (aa 594-740 in Table 4.1). Two regions in the Protein A sequence (aa750-761 and 
780-791) were also 100% conserved across the three strains sequenced in this study. No 
reference to the potential function of these motifs has been identified (Refer to Table 4.1). All 
motifs proposed as critical in the B1 and B2 protein were also conserved (Table 4.1). The TVIE 
motif proposed as a protein kinase II phosphorylation site (aa 66 to 69) identified by Su et al. 
(2009) was not identified in any of the strains or the RGNNV reference sequence. 
4.3.1.2 RNA 2, mRNA of Capsid Protein 
All of the motifs that are translated from the mRNA of RNA 2 and identified in the literature as 
critical for viral replication in the RGNNV species were conserved in each of the three strains 
investigated in this study (Table 4.1). Most critically to this project, the minimal essential 
epitopes required for antibody production in grouper namely, aa 181-212 VNVSVLCR were 
identified (Chen et al., 2015). The region of the RNA 2 identified by Ito (2008) which relates to 
species specificity of the RGNNV strains was conserved between the RGNNV reference strain 
and all 3 NQAus NNV strains collected in this study (Figure 4.3). Within the Ito et al. (2008) 
region, a difference of 3aa across all of the Australian collected sequences was identified 
(Figure 4.3). Immediately adjacent to the region of Ito et al. (2008), an additional motif GAVF 
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was also conserved within the strains of this study and the RGNNV reference genome (Figure 









Table 4-1: Conserved motifs critical for replication of the RGNNV genome identified from translated mRNA of RNA 1 obtained from this study. Including strain, function, amino acid sequence and 
location on the protein. 
Function Stem loop structure Mitochondrial Location Signal 
aa motif 6 – 26
Sequence in literature DVDYY MRRFEFALARMSGAAFCVYTGYRLLTSKWLADRVEDYRQRVI 
Ec2NQAus E.coioides  this study 160-164 DVDYY MRRFEFALARMSGAAFCVYTGYRLLTSKWLADRVEDYRQRVI 
El3NQAus E.lanceolatus  this study 160-164 DVDYY MRRFEFALARMSGAAFCVYTGYRLLTSKWLADRVEDYRQRVI 
MI181161 L.calcarifer this study 160-164 DVDYY MRRFEFALARMSGAAFCVYTGYRLLTSKWLADRVEDYRQRVI 
Function
Transmembrane Domain of 
Viral Replication Complex
A:  Acid motif B:  SG.T motif
C:  GDD motif: NTP 
binding
D:  Basic motif Motif 7 & 8
aa motif 229 – 249 594-599 655-660 695-697 740
Sequence in literature ITGVTAICSFLYTKLGIAPFG DxxxxD SGxxxT GDD Lysine or Arginine
Ec2NQAus E.coioides  this study ITGVTAICSFLYTKLGIAPFG DYSKFD  SGSALT GDD L 
El3NQAus E.lanceolatus  this study ITGVTAICSFLYTKLGIAPFG DYSKFD  SGSALT GDD L 




Ec2NQAus E.coioides  this study
El3NQAus E.lanceolatus  this study
MI181161 L.calcarifer this study




Protein kinase C 
phosphorylation 
site
Protein kinase II 
phosphorylation site
Nuclear Location signal
aa motif 869-899 912-918 984-988 929-931 66 - 69 946-950
Sequence in literature NKTS PRRARAA RPRRQRR SRR TVIE KRPRR
Ec2NQAus E.coioides  this study NKTS PRRARAA RQRRR KRSRR not found KRPRR
El3NQAus E.lanceolatus  this study NKTS PRRARAA RQRRR RRSRR not found KRPRR
MI181161 L.calcarifer this study NKTS PRRARAA RQRRR RRSRR not found KRPRR
Function Conserved in all the Betanodaviruses Conserved with NoV




aa motif 5-20 16 - 20 26 41 - 50
Sequence in literature QQAIDQHLVELEQLF LEQL R26 RTFVISAHAA 
Ec2NQAus E.coioides  this study QQAIDQHLVELEQLF LEQL R27 RTFVISAHAA 
El3NQAus E.lanceolatus  this study QQAIDQHLVELEQLF LEQL R27 RTFVISAHAA 
MI181161 L.calcarifer this study QQAIDQHLVELEQLF LEQL R27 RTFVISAHAA 
Function N’myristolyation site Mitochondrial specific sequence
aa motif 30 -55 38-47 R60 V44 I45  R52
Sequence in literature GGVTAI TFVISHAAA R60 V44 I45  R52
Ec2NQAus E.coioides  this study 26-31 GGVTAI TFVISHAAA R60 V44 I45  R52
El3NQAus E.lanceolatus  this study 26-31 GGVTAI TFVISHAAA R60 V44 I45  R52
MI181161 L.calcarifer this study 26-31 GGVTAI TFVISHAAA R60 V44 I45  R52
Function Mitochondrial targetting 1000bp (long) ds RNA binding motifs and anti- RNAi
aa motif 53 53,60
Sequence in literature R53 R53 R60
Ec2NQAus E.coioides  this study R53 R53 R60
El3NQAus E.lanceolatus  this study R53 R53 R60
MI181161 L.calcarifer this study R53 R53 R60
Sequence Id. 
Protein A













B2 Protein (72aa) 1 frame shift from Protein A mRNA continued
Description not 
sufficient for alignment



















B1 Protein (111aa) same reading frame as Protein A


















Function Binds with viral RNA
aa motif 23-25 23-25 29-31
Sequence in literature RRR RRR RRR
Ec2NQAus E.coioides  this study RRR RRR RRR
El3NQAus E.lanceolatus  this study RRR RRR RRR
MI017207 L.calcarifer this study RRR RRR RRR
Function Nucleolar localization signal
Required for capsid formation and 
thermal stability of capsid
50% reduction in viral particle
aa motif 23-31 115 130 & 135
Sequence in literature RRRANNRRR C D 
Ec2NQAus E.coioides  this study RRRANNRRR C D
El3NQAus E.lanceolatus  this study RRRANNRRR C D
MI017207 L.calcarifer this study RRRANNRRR C D
Function 100% reduction in viral particles
Proposed to slow ribosomal 
processing
Required for capsid 
formation and thermal 
stability of capsid
Minimum essential epitopes for 
antibody target 
Region within Ito  et al. 2008; 
SGIV homology; GTPAse 
homology
aa motif 133 140-147 201 181-212 223-245
Sequence in literature D AL/FQATRGA C VNVSVLCR LSTND
Ec2NQAus E.coioides  this study D ALQATRGA C VNVSVLCR LSTND
El3NQAus E.lanceolatus  this study D ALQATRGA C VNVSVLCR LSTND
MI017207 L.calcarifer this study G ALQATRGA C VNVSVLCR LSTND
Function
Mutation lead to reduction in 
mortality by 40%
Serotype/Species determinant
C terminal region. Viral particle 
formation
aa motif S247>A 252-254 328-335
Sequence in literature S PDG GTVCTRVD
Ec2NQAus E.coioides  this study S PDG GTVCTRVD
El3NQAus E.lanceolatus  this study S PDG GTVCTRVD
























Table 4-2: Conserved motifs critical for replication of the RGNNV genome identified from translated mRNA of RNA 2 obtained in this study including strain, function and 




Figure 4-3: Nucleotide sequence and translated amino acid sequences of Australian strains of NNV aligned with Ito species specific region including strain identification, 





Acknowledging previous works and targeting therapies that are directed at critical motifs may 
improve the efficacy in preventing VER outbreaks. This study reviewed the collection of 
literature on the functional motifs of the Betanodavirus genome and confirmed the majority of 
the motifs that have been identified as critical have been conserved in the NQAus RGNNV, 
strains collected in this project. No similar review and confirmation of the motifs across an 
entire RGNNV Betanodavirus genome has been published. The conservation of motifs 
identified from the translated mRNA-1 indicate all of the motifs considered essential for viral 
replication have been retained by the strains in this study. Specifically, the mitochondrial 
location signals and motifs that are essential for the formation of the viral replication complex 
were identified. The RdRP motifs were also conserved. Individual motifs that locate the B1 and 
B2 proteins to the VRC and nucleus and also ensure binding of dsRNA to prevent the 
degradation of the viral genome by host factors were also identified. Interestingly, four 
additional motifs were identified to be conserved between the species in this study and the 
RGNNV reference genome. Two motifs namely 750-761aa QSPLRTLLKLHTT and 780-791aa 
YLVTDSKTPFIG were identified by Johnson et al. (2001) to be conserved in both 
Alphanodaviruses and Betanodaviruses (specifically: Flock house virus, Nodamura virus, 
SJNNV, Black beetle virus and Pariacoto virus) but had not previously been identified in the 
RGNNV. In the same study the authors also identified aa 969-971 RGG motif conserved across 
the same species but the RGG motif was not identified in this study. No function for any of the 
three motifs were proposed. The other two motifs noted as highly conserved in this study are 
aa 5-20 QQAIDQHLVELEQLF of the B2 protein and within this motif a LEQL motif. The LEQL is 
conserved within the Betanodaviruses and the Alphavirus, Nodamura Virus, which significantly 
has a wide host range including insects, pigs, suckling mice and hamsters (Gant et al., 2014). 
No function of this motif has been reported in the literature relating to Nodavirus replication. 
However, an LEQL motif is an important epitope recognised by the endoplasmic reticulum 
aminopeptidase (ERAP 1) to target Major Histocompatibility complex class 1 presented 
epitopes for degradation. ERAP 1 is stimulated by interferon (Hearn et al., 2009). The LEQL 
motif is also an important epitope of TRIM 21 which is a member of the Tripartite motif 
superfamily (Al-Majdoub et al., 2013). TRIM 21, in particular, is expressed upon interferon 
stimulation and is also an important component of innate immunity and neurological disorders 
(Al-Majdoub et al., 2013). Kim et al. (2017) reported the upregulation of TRIM 21, 29, 39, 25, 
14, 16 and 47 following infection of Sevenband grouper to NNV. In vitro upregulation of TRIM 
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21 in human microglial cells attenuated the replication of Japanese encephalitis (JE), via 
regulation of the type 1 interferon response (Manocha et al., 2014). JE is similar to NNV in that 
it affects the brain of host species. Damage due to inflammation is associated with mortality in 
many neurotropic viruses. Additionally, TRIM 21 is activated by antibody-coated viral particles, 
binding to the Fc receptor and targets virions for degradation. It is possible the LEQL motif of 
the B2 performs roles not currently identified to prevent both the innate and adaptive immune 
response to RGNNV infection. The targeting of TRIMs by Betanodavirus B2 would be a very 
efficient mechanism to successfully mitigate both a humoral (antibody) and innate immune 
response. However, no work has been published relating to TRIM and B2 protein. Petrillo et al. 
(2013) noted, B2 is produced well in excess of RNA 1 and could perform additional roles in the 
replication of the Nodaviruses. 
The majority of the motifs proposed to be critical for viral replication that are associated with 
the translated RNA 2 were also identified in all three strains of RGNNV studied. Importantly for 
the vaccine development, the motifs of the capsid protein that were identified to be critical for 
neutralising antibody production in grouper were present in all three strains obtained in this 
study (Chen et al., 2015, discussed in Chapter 1.8). The region identified by Ito et al. (2008) to 
confer virulence in host species was also conserved between all strains collected within this 
study. Notably comparison with all of the Australian collected strains indicated a variance of 3 
amino acids within the Ito et al. (2008) region. Specifically, at aa 233-237 an LSTND motif is 
present in all of the strains identified as “tropical (1a) strains” in Chapter 3. Whereas LATSD 
was conserved in the sequences assigned to the 1c cluster (Section 3.1). No mechanism for 
how the sequences may impact on host or environmental selection have been identified. Also, 
immediately adjacent to the PDG motif which confers the Betanodavirus serotype assignment 
an additional motif variation was noted between the Australian strains. Within Australian 
RGNNV strains, the four strains that slightly differentiate from the other Australian strains 
based on nucleotide comparison of RNA 2 (Chapter 3) display a GAIF motif. Interestingly, the 
tropically freshwater cultured sleepy cod, O.lineolata sourced strain displayed a hybrid pattern 
of motifs. The O.lineolata strain retained the LSTND motifs of the tropical 1a strains yet shared 
the GAIF motif of the “temperate Ic strains”, proposed by this worker to possibly reflect a 
freshwater habitat rather than temperate v tropical division (Chapter 3). Investigating how 
these motifs affect virulence to different species, or the same species within different habitats 
is beyond this study. However, confirmation that the strains in this study have the retained of 
the factors that have been identified to affect viral replication or host specificity provides 
confidence to advance further work using the strains collected. Confirmation of the protein 
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motifs is rarely considered in experimental challenge experiments. Although analysis 
completed in Chapter 3 indicated the RGNNV genome segments were highly conserved, 
between 13-21 nucleotide differences were noted between the Australian strains collected in 
this study and also the RGNNV reference genome (Table 3.2). Considering a single nucleotide 
variation could also translate to change in a critical protein motif, it was important to confirm 
the conservation of the motifs in the strains being used in this project. Variation on a single 
motif could lead to reduced virulence, which if were transferred into the project would reduce 
the effectiveness in translation of the outcomes of this study to industry. Lin et al. (2007) 
reported a relative percent survival of 80-90% in 35 dph E.septemfasciatus larvae when 
challenged by bath exposure to VVN at following 17 days of feeding with Artemia that been 
orally loaded with E.coli expressing a recombinant NNV capsid protein (Lin et al., 2007). 
However, the control fish displayed between 44-69% survival which is unusually high 
compared to similar reports of experimental challenge with this species. High survivals in 
control groups following RGNNV exposure have not been reported in any other research 
publication involving larval grouper. Despite the impressive survival and obvious economic 
benefit of this approach as a vaccination strategy, these results have not been translated to a 
commercial product. Although it cannot be confirmed, it is possible the strain of RGNNV used 
in the study was less virulent, possibly through lacking a motif that confers increased virulence. 
From the analysis completed in this chapter, considering all of the strains hosted the critical 
motifs, and the volume of infectious material available, the RGNNV extract prepared from 
E.coioides (Ec2NQAus) is considered an acceptable source of NNV for the remaining study in 




















Data from this Chapter is planned for publication entitled “Review of the functional motifs of 





















 The motifs demonstrated to critically impact on viral replication or host specificity in 
Betanodaviruses have been identified. 
 The motifs have been confirmed to be present in the strains used within this 
project. 
 The production of a recombinant vaccine based on the RNA 2 sequence of the 
E.coioides RGNNV strain will contain the antigenic epitopes that were identified as 
critical to the production of neutralising antibodies by grouper recognised by Chen 
et.al., (2015) 
 dsRNA can be specifically designed to target functional motifs that are confirmed to 
be present in the strain used in this project. 
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CHAPTER 5. DEVELOPMENT OF QPCR STANDARD CONTROL 
MATERIAL TO ALLOW INITIATION OF VALIDATION OF RT-
QPCR ASSAYS TO DETECT AUSTRALIAN STRAINS OF 
REDSPOTTED GROUPER NERVOUS NECROSIS VIRUS 
(RGNNV).  
Background  
  Hick & Whittington, (2010) reported the development of RT-qPCR, qR2T, that 
detects RNA 2 of RGNNV in two Australian sourced NNV strains. 
 The qR2T assay is the assay recommended in the Australian and New Zealand 
Standard Diagnostic Protocols for the detection of NNV. 
 The assay has not been validated as fit for purpose on grouper tissues. 
 There are various novel biotechnology applications that aim to produce NNV 
vaccine via delivery of the viral capsid protein. 
 Some biotech applications aim to produce an antigen that can be delivered via 
oral dispersal of the antigen within larval fish feeds. 
 The widespread dispersal of RNA 2 constructs into the fingerling production 
systems will confound the current method of verification of freedom from RGNNV 
with the RT-qPCR targeting the RNA 2 segment. 
 Due to discovery of chimeric reassortment between RNA 1 and RNA 2 of SJNNV 
and RGNNV some researchers advocate the application of qPCRs that target both 
viral segments to study VER outbreaks. 
  Hick & Whittington (2010) reported an additional RT-qPCR that detects RNA 1 of 
RGNNV but did not extensively validate the assay. 
 
Aims of this Chapter  
 Develop RT-qPCR control material to assist in the validation of the currently 
recommended Australian and New Zealand Standard Diagnostic Protocol RT-qPCR 
that targets RNA 2 for the detection of the RGNNV from grouper brain and eye 
tissue. 
 Develop RT-qPCR control material to assist in the validation of an additional assay 
that targets the RNA 1 for the detection of the RGNNV genome from grouper 





The absence of a sound understanding of the factors that trigger VER disease outbreaks in 
grouper grow-out aquaculture, currently limits management options to the stocking of ponds 
with fingerlings that are free of NNV. The development of reverse transcriptase quantitative 
polymerase chain reaction (RT-qPCR) assays has significantly improved the opportunity for 
industry to obtain NNV free fish (RT-qPCR negative) and rapidly diagnose a VER disease 
outbreak (RT-qPCR high load positive). Detection by RT-qPCR is the only method currently 
recommended for all applications including targeted surveillance of larvae, juveniles and adult 
fish and presumptive and confirmatory diagnosis of VER disease (Anon. OIE 2018). The OIE 
Aquatic Animal Manual describes two RT-qPCR assays to detect NNV that have undergone 
significant validation namely the qR2T ( Hick & Whittington 2010) and RNA 2 assay (Anon. OIE 
2018). The area targeted by each assay overlap on the redspotted grouper nervous necrosis 
virus (RGNNV) RNA 2 segment. The qR2T assay, is incorporated into the Australian New 
Zealand Standard Diagnostic Procedures (ANZSDP) for the detection of NNV (Hick & 
Whittington, 2010; Moody & Crane 2012; Anon. OIE 2018). The RNA 2 assay was developed by 
the OIE Reference Laboratory for VER and has been adopted for proficiency testing across five 
European laboratories (Panzarin et al., 2010; Anon. OIE 2018;). Both assays are reported to 
detect all NNV species although qR2T is noted to optimally target RGNNV ( Hick & Whittington, 
2010 and Anon OIE 2018).  
With their emergence as high value aquaculture species, the economic impact of VER in sea 
bass aquaculture has prompted the development of two commercially available vaccines to 
protect against VER (ALPHA JECT micro® 1 Noda PHARMAQ and ICTHIOVAC® VNN HIPRA 
Laboratories). The ALPHA JECT micro® 1 Noda vaccine is a cell culture- derived- formalin-
inactivated antigen reported to induce effective immunity against the RGNNV genotype. The 
ICTHIOVAC® VNN is inactivated Betanodavirus strain 1103 (HIPRA Laboratories 
https://www.hipra.com/portal/en/hipra/animalhealth/species/fish ). To avoid stress 
associated with injectable vaccines, several biotech applications have been attempted with 
oral delivery of recombinant NNV capsid protein (Cho et al., 2017 and Gonzalez-Silvera et al., 
2019). Oral vaccination, through consumption of recombinant yeast, Saccharomyces cerevisiae 
expressing RGNNV capsid protein induced the production of neutralizing antibodies in 
Epinephelus septemifasciatus (Thunberg, 1793) (Cho et al., 2017). The inclusion of TOPO® 
transformed E. coli with RNA 2 segment of RGNNV into diet was recently reported to provide 
protection to sea bass against viral challenge with RGNNV (Gonzales-Silvera et al., 2019). 
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Although oral delivery offers advantages of practicality of delivery and reduced handling of 
fish, it may lead to inaccurate assessment of fish health status if the recombinant RNA 2 
genome segments are detected by RT-qPCR. The potential development of orally delivered 
vaccines based on expressed proteins from RNA 2 constructs necessitates an RT-qPCR 
targeting the RNA 1 segment to differentiate between NNV infected fish and those exposed to 
orally delivered recombinant capsid proteins. Further, the discovery of strains of NNV that 
consist of chimeric recombination of RGNNV and SJNNV segments highlights a need to apply 
assays that detect both RNA segments in epidemiology studies, particularly in zones where 
more than one genus of NNV is endemic (Panzarin et al., 2016).  
 RT-qPCRs that detect the RNA 1 have been described but not widely adopted in Australia ( 
Hick & Whittington, 2010 and Baud et al., 2015). Neither the qR1T or qR2T assay was validated 
for application on grouper tissues. The OIE Aquatic Animal Health Manual notes that it is 
important to revalidate an assay when it is being applied beyond the scope of the original 
intended purpose of the assay such as application to an additional host species (OIE Anon. 
2014). The recommendations of the OIE are also adopted by authorities in Australia that 
oversee quality control in testing for aquatic animal pathogens namely, the sub-committee for 
aquatic animal health (SCAAH) and the National Association of Testing Authorities (NATA). The 
validation of an assay is a step-wise process. Initial steps determine if the assay platform is the 
best fit for purpose format. For reasons of quantitation, high throughput, rapid turnaround, 
sensitivity and specificity, RT-qPCR is the assay of choice for many applications in aquatic 
disease management. An initial step in the implementation of an assay is to produce stable 
qPCR controls, of sufficient volume and stability that can be applied to monitor the 
performance of the assay over time (Fig 1. Anon OIE 2017).  
The aim of this chapter is to develop the standard positive controls for the qR1T and qR2T 
assays of Hick & Whittington, (2010). These controls are required to support further 
application of the assays within the activities of this project to assess the effectiveness of 
prophylactic measures against RGNNV; to gain a better understanding of the pathogenesis of 
VER in grouper and to validate the assays as suitable for application beyond the scope which 
was demonstrated by Hick & Whittington (2010). 
5.2 Materials and Methods 




Synthetic control for quantitative real-time polymerase chain reaction was prepared from PCR 
amplicons obtained from NNV infected fish. Positive PCR amplicons were produced using the 
primers R1F1/R1R5 and R2F1/R2R1 described by Hick & Whittington (2010) (Table 5.1). The 
amplicons were visualised and cut from agarose gels as described in Chapter 2.1.4-2.1.7. The 
PCR product was cleaned using a High Pure PCR Product Purification Kit (11732668001 Roche, 
NSW) as per manufacturer’s instructions. Purified PCR product was cloned into One Shot TOPO 
chemically competent E. coli using the pCR4-TOPO TA vector (Cat. K4575-01 Life Technologies, 
VIC) as per manufacturer's instructions. Transformed E. coli were grown overnight at 37 °C on 
lysogeny broth (LB) (Bertani, 1951) agar supplemented with 50 g mL-1 ampicillin (Cat. A9393-
5G Sigma-Aldrich, NSW). Three white colonies were picked from the agar and grown overnight 
at 37 °C in LB supplemented with 50 g mL-1 ampicillin (Cat. A9393-5G Sigma-Aldrich, NSW) 
and shaken (Bioline incubator shaker 8500 Edwards Instruments, NSW) at 150 rpm. Plasmid 
DNA was extracted using a High Pure Plasmid Isolation kit (Cat. 11754777001 Roche, NSW) as 
per manufacturer's instruction. Plasmid extracts were submitted to Macrogen Inc. (Seoul, 
Korea) for sequencing. Sequence analysis confirmed the respective plasmids were the RNA 1 
and RNA 2 derived products. The clones and extracts became the positive plasmid controls for 
the quantitative real-time PCRs (qPCR).  
 
Table 5-1: Details of primer sequences used to produce RT-qPCR control sequences including 
assay type, primer name, primer sequence, primer target, primer position and expected size 
of positive amplicon. 
 
 
5.2.2 Standard curve preparation from plasmid controls 
A standard curve was prepared for the qPCR using the positive plasmid controls generated 
from section 5.2.1. The clones were cultured for 18 hours in 30 mL of LB supplemented with 50 
μg mL-1 ampicillin (Sigma-Aldrich) at 150 rpm (Bioline incubator shaker 8500). A 100 μL aliquot 
of culture was added to 12 x 10-fold serial dilutions while the 30 mL culture was frozen at -80 
°C to prevent further bacterial growth. Copy number was calculated by plating triplicate 20 μL 
qR1T R1F1* CACTTACGCAAGGTTACCG 1 1
R1R5* TCTGCTGCTCCTCGACATAC 1 1525
qR2T R2F1* CATATGGTACGCAARGGTGA 2 3









Source of All primer sequences Hick & Whittington (2010)





aliquots of each dilution on LB agar plates supplemented with 50 μg mL-1 ampicillin (Sigma-
Aldrich) and incubating for 18 hours. The number of white colony forming units (CFU) were 
counted for each dilution and used to calculate the plasmid copy number in the 30 mL culture, 
assuming one CFU represents one plasmid copy.  
5.2.3 RT-qPCR analysis of standard control serial dilutions 
The 30 mL culture that was frozen during the CFU counting procedure was thawed and 
plasmid DNA extracted and eluted in 100 μL elution buffer as previously described (3.3.4). A 50 
μL aliquot of DNA extract was used to prepare 9 x 10-fold serial dilutions in DEPC-treated 
water (BIO-38030, Bioline) and stored at -20 °C for qPCR. A 2.5 μL aliquot of each serial dilution 
was used as template in the qR1T and qR2T RT-qPCRs to construct the quantified standard 
curve. The qPCR mix consisted of 2.5 μL DNA extract in Bioline SensiFAST probe No ROX mix 
(BIO-86050) prepared according to the manufacturer’s specifications, containing Forward and 
Reverse Primer (20 pmol) and Probe (5 pmol) per reaction (Table 5.2). The qPCR was 
completed on a Qiagen Rotor-Gene™ with thermal cycling consisting of 95 °C for 3 mins 
followed by 40 cycles of 95 °C for 15 s and 60°C for 25 sec. Fluorescence was acquired at the 
60°C for 25 sec step of each cycle using the green and yellow filters of the machine.  
 
Table 5-2: Primer and Probe sequences used in RT-PCR assays including assay type, primer 




5.3.1 Confirmation of sequence of the RNA 1 and RNA 2 plasmid 
Plasmid sequences were confirmed to be 100% homologous to the E.coioides RGNNV strains 
discussed in Chapter 3. Although shorter sequences would have been sufficient to act as qPCR 





RT-qPCR qR1T-F GCTACCGCCTGTTGACCTC 1 140 61
qR1T-R TTGTTTCTTCTCAGCGATGATGC 1 219 64
qR1T-Probe TGGCGAATCCTCAACACGTCC 1 171
RT-qPCR qR2T-F CTTCCTGCCTGATCCAACTG 2 401 62
qR2T-R GTTCTGCTTTCCCACCATTTG 2 476 61
qR2T-Probe CAACGACTGCACCACGAGTGG 2 454
Source of All primer and probe sequences Hick & Whittington (2010)
~ Position with reference to  NCBI GQ904198/RNA-1 or GQ904199/RNA-2
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controls, the longer sequences were selected to align more closely with the characteristic of 




5.3.2 Plate count of CFU of each dilution of plasmid controls 
A number of the serial dilutions of plasmid contained too many colonies to allow accurate 
counting of colonies. The plates that contained less than 100 colonies were used to calculate 
the plasmid CFUs. Plate counts indicated the stock cultures of each plasmid contained ~ 12.6 x 
109 (RNA-1) and 13.8 x 109 (RNA-2) CFU mL-1. 
5.3.3 Quantitative real-time polymerase chain reaction 
The target sequences were detected in the standard curve dilutions from 100 to 109 range for 
qR1T and 100 to 108 range for qR2T. The standard curves prepared displayed a strong linear 
correlation between estimated plasmid copy number and Ct value (R2 value=0.99 in each 
assay). (Figure 5.1). The qR1T assay had a reaction efficiency of 98% which was slightly less 
than that of qR2T (99%) (Figure 5.1). The Cycle threshold value, plasmid copy number and 
typical standard series amplification curve for the RNA 1 and RNA 2 segment plasmid control 





Figure 5-1: RT-qPCR amplification curves of qR1T (a) and qR2T (b) and linear correlation 
between Ct value v plasmid copy number determined from bacterial plate counts of qR1T 




The data collected in this study indicates the RT-qPCR assays that detect RNA 1 (qR1T) and 
RNA 2 (qR2T) perform consistently to accurately detect the specific segments of the Ec2NQAus 
genome on the standard constructed DNA plasmid controls. The operational range of each 
assay detected a minimum of ~10 copies of the plasmid target. In this study, consistent Ct 
values were obtained for plasmid dilutions targeted by each assay across a gene copy number 
ranging from ~10 to 108 copies mL-1. Although a calculated copy number greater than 108 is 
detected by both assays, there is considerable variation in the calculated copy number at 
higher concentration of plasmid (data not shown) and higher concentrations were not 
included in the standard curve regressions. As the calculated copy number that applies to such 
high concentration of plasmid genome would only be detected in severe VER outbreaks where 
management decisions are not reliant on accurate discrimination between a 108 or 109 or 10 
copies of viral genome, the omission of the high copy number control within the standard 
curve is not expected to be a major impediment to the application of either RT-qPCR assay.  
The OIE devotes a chapter in the Manual of Diagnostic Tests for Aquatic Animals to discuss the 
principles and methods of validation of diagnostic assays for infectious diseases (OIE 2019). 
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Whilst Hick & Whittington, (2010) validated the performance of the qR2T assay against the 
criteria discussed in the OIE Aquatic Manual, their analysis was based on cell cultures and 
barramundi derived tissue samples. In addition, very limited assessment of the qR1T assay that 
targeted the RNA 1 was performed. Neither assay has been reportedly applied to grouper 
species ( Hick & Whittington 2010). The OIE recommends validation and verification of assay 
performance is conducted when analysis is applied to tissue matrix that is beyond that which 
the assay was validated (OIE 2017).  
One of the initial steps in assay validation is the implementation of standard positive controls 
(OIE 2017). This current work has developed a plasmid containing the respective target 
sequences to act as a standard control for each assay. The use of a constructed plasmid as a 
standard curve control reduces laboratory biosecurity risk by avoiding a need for staff to 
handle viable viral particles and also negates a need for cell culture capability within a 
laboratory. However, further monitoring of assay performance on a similar analyte matrix to 
that which it will most typically be applied, namely eye and brain tissue of known NNV status, 
is required for assay validation (OIE 2017). The stepwise approach to assay validation which 
has been adopted in this project is typical within the framework recommended by a number of 
authorities responsible for animal health laboratory standards including the OIE, the sub-
committee for animal health laboratory standards (SCAAHL) and the National Association of 
Testing Authorities (NATA) in Australia (OIE 2017). The development of the standard controls 
discussed in this chapter are a crucial requirement for managing the quality of the quantitative 
data that will be collected in this project. Further application of the assays on grouper brain 
and eye tissues to monitor the pathogenesis of VER and to assess the efficacy of prophylactic 
measures against RGNNV will be discussed within subsequent chapters of this thesis. 
5.5 Conclusion 
The following outcomes were achieved in this chapter: 
 
 
 Standard plasmid controls for RT-qPCRs to detect RNA 1 (qR1T) and RNA 2 (qR2T) of 
RGNNV described by Hick & Whittington, (2010) were developed.  
 Both assays, qR1T and qR2T were demonstrated to detect the respective standard 
plasmid controls. 
 The linear regression of standard curve preparations was determined for each 
assay, with high correlation between Ct value and calculated copy number.  
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Data collected in this chapter contributed to the validation documentation to support 
application by the JCU AquaPATH laboratory for NATA accreditation in the field of animal 




CHAPTER 6. DEVELOPMENT OF PROPHYLACTIC MEASURES TO 




Aims of this Chapter  
 
6.1 Introduction 
The development of a vaccine that prevents VER outbreaks in E.lanceolatus is a primary goal of 
this study. Vaccination strategies that prevent VER have been reported with varying success in 
experimental settings (Tanaka et al., 2001;Nishiwawa et al., 2012; Kai and Chi 2008). Various 
antigen presenting configurations have been developed to produce vaccines against VER. 
Antigen configurations include the presentation of live virus (Nishizawa et al., 2012), 
inactivated virus (Kai and Chi 2008), recombinantly expressed DNA or capsid protein (Tanaka 
et al., 2001), provision of virus-like particles in live Artemia (Lin et al., 2007) recombinantly 
expressed virus-like particles (VLPs)( Lai et al., 2014) and most recently, viral capsid protein 
expressed in a cell-free system (Kim et al., 2015). All strategies report improved survival 
measured over a period of weeks. Some studies don’t include viral challenge but rather detect 
 Grouper in grow out pond culture are susceptible to NNV for the entire duration of 
pond stocking. 
 VER outbreaks in pond grow out impose severe mortality and economic losses that 
threaten the viability of the grouper aquaculture industry in Australia. 
 A number of experimental vaccines to prevent VER have been reported. 
 There is no VER vaccine available for use in Australia. 
 The capsid protein has been demonstrated as the target of neutralising antibodies.  
 Treatment with dsRNA has been proposed as a treatment for difficult to prevent 
viral diseases.  
 To develop a recombinant clone and express RGNNV capsid protein. 
 To prepare a vaccine containing the recombinantly expressed capsid protein. 
 To develop a dsRNA construct to knock-down replication of RGNNV. 
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the expression of immune components following vaccination (Lai et al.2014). Despite the 
reported progress, there is no vaccine approved for use or commercially available for use in 
Australia.  
Previous research into immunization and the potential of dsRNA as an additional option to 
prevent VER is discussed within this chapter. In addition, the methods used to prepare 
experimental therapies that will be evaluated as a means to prevent VER within this project, 
namely a vaccine and dsRNA constructs, are described.  
 
6.1.1 Live Virus Vaccine 
“Vaccinating” fish with live virus at a lower rearing temperature has been reported as an 
effective way to reduce mortality to subsequent Betanodavirus exposure (Nishizawa et al., 
2012). Seven-band grouper “vaccinated” with live RGNNV at 104.3 TCID50 displayed no 
mortalities at 17 °C compared with ~47 % mortality in fish held at 20 °C and 93-100 % in fish 
reared at 23 °C and 26 °C respectively (Nishizawa et al., 2012). NNV titres varied over the 21-
day trial period at the different rearing temperatures. Nishizawa et al. (2012) hypothesised the 
slower replication of NNV in fish at lower water temperature enabled sufficient time for the 
fish to mount an effective immune response before NNV reached critical a threshold level of 
1010 TCID50 and death occurred. The long-term outcome of this vaccination strategy was not 
investigated. 
6.1.2 Inactivated-Virus Vaccine 
Protection from VER has been reported through the use of vaccination based on the IM or IP-
injection of formalin-inactivated (Yamashita et al., 2009) and binary ethylenimine (BEI)-
inactivated (Kai & Chi 2008) RGNNV. Survival, antibody presence and antibody titre in the 
formalin-inactivated vaccinated fish exposed to challenge dose of 105 TCID50 was dependant 
on the dose of RGNNV in the vaccine. Yamashita et al. (2009) did not measure the neutralising 
antibody level in vaccinated fish over a period beyond 28 days. As NNV is believed to be 
endemic in the waterways around Japan, fish would likely been exposed to NNV which would 
serve as a natural booster in immunity (Yamashita et al., 2009). 
6.1.3 DNA vaccine: recombinantly expressed viral protein 
Protection from NNV infection has been reported through the use of vaccines based on 
recombinantly expressed Betanodavirus capsid protein since 2000/2001 (Nakai 2002 and 
Tanaka et al., 2001). Tanaka et al. (2001) reported the successful vaccination of seven band 
grouper (28 g) against RGNNV using IM. injected recombinantly expressed coat protein (60 µg 
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fish-1) and challenged by intramuscular injection 20 days post vaccination (dpv). Vaccinated 
fish that were challenged with a dose of 104.4-5.4 TCID50 displayed 65 % mortality compared to 
the control fish which suffered 100 % mortality within 4 days post challenge (dpc) (Tanaka et 
al., 2001). Vaccinated fish exposed to a lower challenge dose 103.4 TCID50 had 10 % mortality 
compared to 85 % mortality in the unvaccinated group. Results of fluorescent antibody testing 
(FAT) on the lower challenge dose survivors revealed only 1/18 of the vaccinated fish was 
positive for the detection of VER capsid protein compared to 1/3 control fish. Neutralising 
antibody titres were detected in the vaccinated fish peaking at 1:400-1:500 at days 20 to 30 
and declining to 1:200 to 1:260 at days 70 to 110 dpv (Tanaka et al., 2001). The minimum 
neutralising antibody giving protection is approximately 1:200 to 300 (Yamashita et al., 2009). 
The application of recombinantly expressed capsid protein to protect against VER continues to 
be reported with no advance towards the production of a commercial vaccine (Vimal et al., 
2014a). Most recently a vaccine based on an IM injection (50 µg fish-1) of recombinantly 
expressed RGNNV capsid was reported to provide 76 % relative percent survival (RPS) to 
juvenile L.calcarifer (10 to 15 g) (Vimal et al., 2014a). No mortalities occurred in the vaccinated 
group until 16 days post-VER challenge. Mortality in the non-vaccinated group was 80 % at the 
same time point. Notably mortalities in the vaccinated group were on an upward trend from 
day 22 until when the trial was terminated at day 30 post-VER challenge. Serum collected from 
vaccinated fish displayed anti-viral activity capable of neutralising 50µl of 102 TCID50 in D. 
labrax kidney cells (Vimal et al., 2014a). Using the same plasmid attached to chitosan-
tripolyphosphate (CS/TPP) in an oral vaccination (feed) survival of ~50 % was achieved in L. 
calcarifer following injection with RGNNV (Vimal et al., 2014b). Immunofluorescent detection 
of the plasmid demonstrated the nanoparticles were delivered to the gills, heart, intestine, 
muscle and liver. Antibodies against RGNNV were detected in serum diluted 1:1000 (Vimal et 
al., 2014b). Unlike the previous report, all of the fish injected with RGNNV displayed relatively 
good survival until day 15 (~70 %) suggesting the exposure to plasmid offered some degree of 
protection against VER. However, from day 15 mortality in all of the control groups displayed a 
marked increase which reached approximately 80 to 90 % at day 30 pi. The mortality in the 
CS/TPP “vaccinated” group displayed an upward trend at day 30 pi. Considering the upward 
trend observed in both experiments at 30 dpi the long-term protection offered by the vaccines 
is questionable, but could perhaps be improved by boosting. 
6.1.4 Viral Like particle (VLP) Vaccine 
Viral like particles (VLP) formed by the expression of RGNNV RNA 2 in E. coli have been used as 
experimental vaccines to prevent VER. VLPs, IM-injected (1 to 10 µg-1 fish) into malabar 
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grouper and dragon grouper (average body weight {abw}~20g) lead to the production of 
specific antibodies within 4 weeks post-injection (Liu et al., 2006). The innate immune 
response of grouper following exposure to RGNNV VLPs was measured in orange-spotted 
grouper E. coioides (0.36 g) (Lai et al., 2014). VLP injection (1.5 µgg-1 FBW) was demonstrated 
to be effective in the production of neutralising antibodies. Titres detected within one-week 
post-exposure could neutralise more than 108 TCID50 of virus in vitro (Lai et al., 2014). Changes 
in the expression of humoral (CD4, MHC11a) and cellular (TCR-β, MHC1a, CD8, CCC3) immunity 
factors, members of the antiviral pathway (Mx, TNFR14, ISP16), and the cellular chaperone 
HSP90, were recorded in various organs. The immune factors measured from the brain and 
eyes displayed minor increases in expression levels. Measurements in the kidney, spleen and 
liver displayed varying responses, none of which were prolonged beyond 48 hours (Lai et al., 
2014). As the fish were not exposed to viral challenge, the significance of the differential 
immune response data cannot be determined. The lack of detectable changes in the brain and 
eye could indicate the VLPs were never presented to those organs. Nonetheless, the data 
provides some indication the capsid protein of RGNNV stimulates both cellular and humoral 
immune pathways. 
6.1.5 Cell-free vaccine production 
The commercial production of vaccines based on recombinant technologies is reportedly 
hindered by the tedious and labour-intensive processes involved in production (Kim et al., 
2015). Kim et al. (2015) reported such issues can be overcome through the production of a 
RGNNV capsid based vaccine using cell-free protein synthesis (rNNV-CP). Seven band groupers 
(20 g) were injected with rNNV-Cp (20µg fish-1) followed by injection with NNV 102.8 TCID50 , 
two weeks later. Seventeen days post-VER challenge 10% of vaccinated fish displayed 
mortality comparing favourably to 50 % of unvaccinated fish (Kim et al., 2015).  
 
6.1.6 Consideration of path for approval of use of a vaccine against VER 
The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates the 
registration of veterinary vaccines in Australia (https://apvma.gov.au/node/1108). The 
registration process is lengthy, and in some cases, requires demonstration of compliance 
across multiple authorities. Vaccines containing cell-culture derived antigen must be prepared 
in compliance with Australian Government Department of Agriculture and APVMA (pers. 
comms from APVMA). There are no fish cell lines in Australia with approval for vaccine 
production. Consequently, in Australia, the development of vaccines containing antigens 
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produced from recombinant expressed viral proteins is underway and considered an attractive 
longer-term approach to viral vaccine production of fish species (Norwood, 2018).  
 
6.1.7 dsRNA as an alternative or complement to vaccines 
Many vaccines have been reported with varying success in reducing mortality due to VER. 
However, all report the reduction, rather than elimination, of NNV titres over the short term 
(Kim et al., 2015). Based on previous reports, successful vaccination of grouper although 
preventing disease expression, results in the production of sub-clinical carriers following 
exposure to NNV (Kim et al., 2015). Considering the factors which lead to VER in grow out 
grouper systems are unknown; vaccination may not be the remedy to the challenge NNV poses 
to aquaculture. If disease in grow out grouper is caused when naïve individuals are exposed to 
Betanodavirus, vaccination will be a useful management tool. However, if disease outbreaks 
are due to other modulating factor/s inducing sub-clinical fish to express disease, vaccination 
may not be the solution to prevent losses due to VER in grouper grow out aquaculture. The 
limited availability of any commercially produced vaccine against VER, despite their reported 
successful application in experimental conditions since 2001, suggests the pathogenesis of VER 
disease in grouper grow-out culture is more complex than anticipated. 
Attempts to combat human RNA viral infections have led to the development of vaccines by a 
variety of protocols. Although often safe and effective in the short term, many fail to be 
effective long-term and require multiple doses which are not cost effective. The production of 
live-attenuated vaccines, although overcoming the need for boosting, presents some risk in 
that RNA viral genomes are particularly unstable and vaccine strains could become virulent. 
Additionally, in human applications, there is a lack of success in producing vaccines which are 
protective against a variety of viruses that, like VNN, display phases of latency such as Epstein 
Barr virus, Human Immunodeficiency Virus and Herpes Simplex Virus (HSV) or a range of 
viruses that sequester in neural tissues such as Dengue Fever, Zika virus and West Nile virus. 
The use of specific microRNAs, termed dsRNAs, is emerging as effective means to overcome 
the limitations of vaccines (Heiss et al., 2010). Successful downregulation of a multitude of 
viruses has been reported in vitro using synthetic RNA (sRNA) to prime the RNAi pathway 
vaccines (Heiss et al., 2010). There are no reported attempts to down-regulate Betanodavirus 
replication using sRNA. However, when Grouper Heat Shock Protein 70 (GHsp70), which was 
discussed in Chapter 3 as an important site for viral attachment to cells, was silenced with 
iRNA, NNV expression of RNA 2, as measured by SYBR green RT-qPCR, was reduced (Chang & 
Chi 2015). Although Chang & Chi (2015) report the target of the iRNA was GHsp70 the 
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designed iRNA (iRNA sequence: CGGUGUUCCUCAGAUUGA) conserved regions of homology 
with many RGNNV RNA 1 sequences (eg. KP455643.1) (Table 6.1). Successful knockdown of 
NNV RNA may have been achieved by direct action of the iRNA on NNV replication rather than 
knockdown of the critical Hsp70. 
 
Table 6-1: Shared homology between anti GHSP-70 iRNA and Spotted grouper RNA 1 
segment (NCBI reference KP455643.1), including homologous sequence, nucleotide position 
and orientation and functional motif of NNV genome (if known). 
Source of sequence and alignment Details of homology to RGNNV genome 
GHsp70 iRNA SGNNV (KP455643.1) (RNA1) nt/nt % Function on VNN Protein A if known 
2 GGTGTTCC 9 550 GGTGTTCC 557 
 8/8 
+/+ 100 Region associated with temperature sensitivity 
9 CTCAGAT 15 248 CTCAGAT 254 7/7 +/+ 100 Region associated with temperature sensitivity 
10 TCAGATT 16 745 TCAGATT 739 7/7 +/- 100 Mitochondrial location signal of Mezeth 
4  TGTTCCT 10 1663 TGTTCCT 1657 7/7 +/- 100  
12 AGATTGA 18 2354 AGATTGA 2360 7/7 +/+ 100  
5  GTTCCTC 11 2963 GTTCCTC 2957 7/7 +/+ 100 B1/B2 
 
 Effective prevention or treatment of viruses requires the dsRNA to have exact complementary 
alignment to the viral target gene sequence to ensure the target sequence is loaded into the 
RNAi silencing complex (RISC) and template degraded rather than translated into protein 
(Chakraborty et al., 2017). It is equally important to ensure that the gene in target is essential 
for viral replication or virulence and the dsRNA does not have off-target effects such as down-
regulating host genes that are required to retain health (Chakraborty et al., 2017). 
In Chapter 4 the processes known to occur during replication of NNV and the genome regions 
that translate to the functional motifs of the genomes of the NNV strain being used in this 
study were identified. As discussed in Chapter 4, the mRNA 1 is the first strand translated 
during viral replication. The initial stages of viral replication occur within viral replicating 
complexes that are contained within the mitochondrion. Also, during the early stage of viral 
replication, the B2 protein is expressed. B2 binds short and long dsRNA and inhibits iRNA 
activity presumably by preventing any viral genomic material that is not within the VRC from 
being targeted by Dicer-1 and also abrogate the genome recognition by Argonaute and 
prevent loading of viral genome into the RNA Silencing Complex for degradation. B2 is 
downregulated when the capsid protein mRNA is upregulated. Additionally, the capsid protein 
isn’t reported to locate within the protection of VRC.  
Because of the forementioned processes this study considered the capsid protein mRNA to be 
theoretically more accessible during viral replication and therefore it was considered a target 
for dsRNA. Specifically, the region that encoded the LSTND motif, contained within the species 
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specificity region identified by Ito et al. (2008). The motif was retained by the RGNNV 
reference genome and the NQAus NNV strains that display virulence to the tropical grouper 
species in Northern Queensland (Chapter 4.3 and 4.4). Examination of the nucleotide region of 
this motif indicates, changes to host specificity associated with this region may not be related 
to the translated amino acids but alternately affect species specificity through action a viral 
micro-RNA that targets host immune factors (Weber et al., 2004; Workenhe et al.2010; Shen 
et al.2015; Tycowski et al.2015). An align two sequences function within the NCBI tools using 
the nucleotide sequence that encodes this region namely, CTTTCCACAAATGACTTCAAGTC 
indicated the first 12 nt sequence encoding for LSTND is conserved with Singapore Grouper 
Iridovirus https://blast.ncbi.nlm.nih.gov/Blast.cgi. A BLASTx search with the nucleotide 
sequence that encodes this region reveals a 22nt region (CTTTCCACAAATGACTTCAAGTC) 
22/23nt homology in the plus/minus orientation to Haplochromis and teleost species 
interferon-induced very large GTPase 1-like mRNA. Additionally, smaller 8 to 12 nt regions of 
this sequence display 100% homology to the mRNA of various immune factors of Epinephelus 
sp. including RAB7 GTPase (JQ08543.1), TLR3 (HQ857748.1), Tumour necrosis factor 2 
(HQ011926.1), interleukin enhancer binding protein factor 2 (HM185492.1) beta-2 
macroglobulin (HQ441036.1). The homology may be coincidental, however Mx, which is a 
GTPase is one of the immune factors known to be significantly upregulated and associated 
with survival to NNV in sea bream S.aurata) (Poisa-Beiro et al. (2008) mentioned p.44 Chapter. 
1.8). Carballo et al. (2016) demonstrated prior infection of D.labrax with SJNNV (which has 
variance to RGNNV at this nucleotide- aa region) increased survival to RGNNV exposure from 
24% to 96%. Mx was significantly upregulated in the SJNNV exposed fish compared to the 
RGNNV exposed fish. No mechanism for the ensued protection or differential immune 
response was provided. There is a reported lack of cross-protection by neutralising antibodies 
between SJNNV and RGNNV (Pascoli et al., 2019). One mechanism of improved survival against 
SJNNV may be a loss in ability by the SJNNV to downregulate Mx through mismatch to the 
target gene if this region acts as a v-miRNA. 
 Extending on the novel use microRNA to combat viral infections, Heiss et al. (2010) recently 
reported that engineering of a neurotropic flavivirus to include microRNAs (mir-9 or mir-124a) 
that are exclusively expressed in neural tissue, was sufficient to restrict their replication in the 
CNS of immunodeficient mice. The application of microRNA to combat Betanodavirus warrants 





The aims of this investigation are twofold namely: 
1. Prepare the expressed capsid protein from the Ec2NQAus NNV strain described in 
Chapters 2 through to 4. 
2. Prepare dsRNA constructs designed to down regulate targeted portions of the virus 
will be employed in viral challenge studies (Ec2NQAus NNV).  
6.2 Materials and Methods 
6.2.1 Nucleic acid extraction and reverse transcriptase polymerase chain reaction 
Nucleic acid extraction and RT-PCR was performed as described in 2.1.2 to 2.1.4 using primers 
R2F1/R2R1 ( Hick & Whittington 2010) (indicated by * in Table 2.1). 
6.2.2 Cloning into replication plasmids 
PCR products of complete mRNA of RNA 2 were cloned into TOPO vectors as previously 
described in Chapter 2.1.7. 
6.2.3 Confirmation of clone sequence 
Ten plasmid extracts containing the DNA sequence of the complete mRNA strand of RNA 2 
segment were screened by PCR using the primers R2F1/R2R1 ( Hick & Whittington 2010) 
(indicated by * in Table 2.1). Amplicons of the expected size were cut from agarose gels and 
purified using the Bioline gel PCR purification kit. Amplicons were subjected to PCR 
amplification using the primers that contained an additional EcoR1 target (on the R2F1 primer) 
and a Hind111 target (on the R2R1 primer). The amplified segment was ligated into the PRSET 
B expression backbone that contained T7 promoter, Lac operon, ribosome binding site state 
codon, capsid protein sequence, stop codon and T7 terminator (GeneART ThermoFisher) 
according to the manufacturer’s instructions. An aliquot of the purified PCR product was 
submitted to AGRF for sanger sequencing analysis. Sequence was confirmed to have 100% 
homology to the EcNQAus NNV strain and also contain the T7 promoter, Lac operon, ribosome 
binding site state codon, capsid protein sequence, stop codon and T7 terminator in 
appropriate location to ensure correct reading frame for protein expression (codon 
optimisation). 
6.2.4 Cloning into expression vector and protein expression 
The DNA amplicon containing the N-terminal histone tag, T7 promoter, Lac operon, ribosome 
binding site state codon, capsid protein sequence, stop codon and T7 terminator were cloned 
into BL21 (D3) Chemically competent E.coli following the manufacturer’s instructions for heat 
shock method (ThermoFisher C60003). Five cultures were prepared from single cloned 
colonies and incubated in 50ml SOC media under protein induction by 0.4 mM IPTG for 6 
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hours. After incubation, 1ml of culture was subjected to plasmid extraction and subjected to 
PCR analysis using the T7/T3 primer set. Three cultures that were contained high copy number 
of the target amplicon (determined by correct size) were harvested by low speed 
centrifugation at 5000g x 10 mins, resuspended in 5ml RNAse free PBS and frozen at -20°C.  
6.2.5 Purification of Capsid Protein  
Protein was extracted from the frozen cultures prepared as described in 6.2.6. Protein was 
extracted using the B-PER®Bacterial Protein extraction reagent as per the manufacturer’s 
instructions (90079 ThermoFisher Scientific). Briefly, 10mL of B-PER II Reagent, containing 20ul 
of lysozyme and 20ul of DNase was added to the bacterial pellet and incubated at RT for 10-
mins. Solutions were centrifuged at 15, 000 g x 15mins. Total protein extracts were viewed 
with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). Fifty microlitres of 
each protein extract were mixed with 2 x loading dye and loading buffer and boiled for 5 mins. 
Samples were loaded to a polyacrylamide gel and the electrophoresis chamber (BioRad), 
containing Tris-glycerine-SDS buffer was subjected provided with electrical current at 150 V for 
~ 1 hour. Gels were fixed in silver fixative and washed 5 times for 1 minute. Gels were then 
stained by 10-minute incubation in silver nitrate solution (0.1% AgNO3 in distilled water), 
washed three times in distilled water and developed for sufficient time to allow resolution of 
bands (by eye). Gels were rinsed three times in 6.25% of acetic acid solution (in distilled 
water). Gels were patted dry and photographed with I-phone. I-phone images were 
downloaded and edited to display the protein ladder and the rows that allowed visualisation 
of protein bands. The soluble capsid protein fraction was purified from the total protein 
fraction by affinity chromatography using nickel-nitrilotriacetic acid (Ni-NTA) spin purification 
kits (3mL) according to the manufacturer’s instructions (88229 ThermoFisher Scientific). The 
concentration of purified protein was determined using the Pierce BCA protein assay kit 
following the 96 well plate protocol (23225 ThermoFisher Scientific) following the 
manufacturer’s instructions.  
6.2.6 Preparation of Vaccine 
Vaccine and Placebo vaccine were prepared using Freund’s incomplete adjuvant. Viral vaccine 
was prepared by combining 15ml of purified capsid protein diluted to 500 mg mL-1 with sterile 
phosphate buffered saline (PBS) and 15ml Freund’s incomplete adjuvant (Sigma F5506). The 
mixture was homogenised using a sterile homogenized using an Ultra-Turrax T 25 (IKA works) 
at 20,000 rpm in 3 x 10-minute intervals minutes until adjuvant emulsified. Triplicate tubes of 
vaccine were prepared. The mixture was contained within 3 x 50ml sterile tubes and held 
within a beaker containing ice during the homogenisation process. Placebo vaccine was 
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prepared by combing 15ml of sterile PBS and Freund’s incomplete adjuvant (Sigma F5506) and 
homogenising until emulsification as described for preparation of vaccine. Vaccine was stored 
at 3°C overnight prior to use.  
6.2.7 Preparation of dsRNA to target RGNNV genome. 
Constructs of synthetic dsRNA were purchased from Integrated DNA technologies. A dsRNA 
construct with homology to the prawn virus Penaeus merguiensis hepandensovirus PmeDV 
which had no homology to NNV was used as the non-specific dsRNA construct, and herein 
refered to as the non-NNV construct (Owens et al., 2015). The NNV spec designed and 
purchased from the Integrated DNA technologies custom dicer-substrate siRNA design tool 
from the region of RNA 2 nt 721 to 780 of Ec2NQAus. 
(https://sg.idtdna.com/site/order/designtool/index/DSIRNA_PREDESIGN). The design tool 
selected the sequence cacaaaugacuucaaguccauccuc as the positive sense strand as a construct 
design. Sense and anti-sense contructs were purchased and prepared according to the 
manufacturers’ instructions. Briefly, individual constructs were provided as tubes containing 
lyophilised ssRNA constructs 20 x 10 nmol (minimum yeild) (NNV specific) or 3 x 10 nmol 
(minimum yeild non-NNV specific) individual positive and negative strand constructs. 
Constructs were resuspended in RNAse free water at a concentration of 100pmol µl-1.. On the 
day of injection into experimental fish, the constructs were combined in equal volume and 
incubated for 2 hours to allow annealing to dsRNA. Fish were injected IM with 100µl of 50pmol 
µl-1 dsRNA. 
6.3 Results 
6.3.1 dsRNA Construct design 
The alignment of the positive strand of the dsRNA corresponds to the RNA 2 segment nt 722 to 
738 which is the mRNA encoding the LSTND motif of the viral capsid protein (Figure 6.1). 
  
Figure 6-1 Alignment of the positive strand of the dsRNA construct designed to target the 





6.3.2 PCR Amplification of the mRNA encoding the Capsid Protein 
Nine of the ten plasmid extracts that were screened for the DNA sequence equivalent to the 
capsid protein mRNA were positive for the sequence (Figure 6.2). Plasmids 5, 6 and 7 were 
selected for progression to capsid protein expression protocols.  
 
Figure 6-2 Image from gel electrophoresis screening of plasmid extracts for DNA sequence 
equivalent to the capsid protein mRNA. MW indicates molecular weight marker (200bp increments). 
Lanes 1 to 10 are amplicons (or lack thereof) from plasmid extracts analysed by PCR using R2F1 and R2R4 primers of 
Hick & Whittington (2010). Lane 11 is amplicon from positive control (Ec2NQAus NNV viral extract). NTC indicates 
no template control. Red arrow indicates positive amplicon of expected size in positive control (1034nt).  
6.3.3 Purification of Capsid Protein  
The total protein fraction from the 3 cultures selected for expression were examined using SDS 
PAGE (Figure 6.3). The 42kDA protein of the capsid protein was evident as the darkened band 
with IPTG expression. The capsid protein purified from the Ni-NTA spin columns were adjusted 
with sterile PBS to a final concentration of 1000µg ml-1. Purified protein was frozen at -60°C 
until use. 
 
Figure 6-3 Silver stained SDS PAGE gel from protein purification of recombinant expression of capsid 
protein. M indicates Protein marker ladder with labelled protein bands. Lane 1, 2 and 3 are total protein 




Vaccine and dsRNA constructs targeting the NNV capsid protein/mRNA were produced in this 
study. In Australia, the application of vaccines produced from recombinant expressed viral 
proteins is underway and considered an attractive longer-term approach to viral vaccine 
production for fish (Norwood, 2018). Interfering RNAs syn dsRNA are considered some of the 
most important biopharmaceuticals as future medicines (Chakraborty et al., 2017). In addition 
to the aligning with the target sequence and not having off-target effects on host genes, the 
success of dsRNA treatment is determined by effective delivery of the dsRNA construct 
(Chakraborty et al., 2017). However, the design and delivery of dsRNA has not been applied to 
many studies involving fish (Gotesman et al., 2015). Considering the lack of understanding 
relating to dsRNA in fish, the design and delivery of dsRNA into a fish host in this project is 
considered highly experimental. This study has adapted a dsRNA approach that was used to 
reduce viral load in crustaceans (Owens et al., 2014).  
The design and preparation of dsRNA and a vaccine based on expressed recombinant NNV 
capsid protein has been discussed in this chapter. The effectiveness of either/both of these 
agents as prophylactic measures to prevent VER in E.lanceolatus following experimental 
challenge are described in chapters 8 and 10.  
6.5 Conclusion 
The aims of this chapter were met in the following manner: 
 
  
 Complete sequence of the RNA 2 segment of RGNNV obtained from diseased E.coioides 
was cloned into the expression vector. 
 Capsid protein was expressed, purified and incorporated into a vaccine. 




CHAPTER 7. EXPERIMENTAL CHALLENGE VIA CO-HABITATION 
WITH MARINE LEECH, ZENYLANICOBDELLA ARUGAMENSIS 
Background  
 Challenge of fish via injection does not represent the natural pathway of 
transmission of NNV in natural disease outbreaks.  
 Experimental reproduction of VER outbreaks simulating a more natural route of 
exposure, namely co-habitation with infected individuals or water borne exposure 
does not yield consistent results.  
 Although naturally occurring disease outbreaks are reported following periods of 
“stress”, a trigger that consistently induces VER in aquaculture systems has not 
been identified.  
 In temperate finfish aquaculture, leeches have been proposed as vectors of viral 
disease. 
 Infestation by the marine leech, Zeylanicobdella arugamensis, has been reported 
to affect the health of grouper within earthen ponds in North Queensland.  
 Some authors report the detection of NNV from blood of infected fish. 
 Whilst Z.arugamensis have been reported to be vectors of marine fish 
trypanosomes, there has been no reported investigation of their role in 
transmission of viruses.  
 
Aims of this Chapter  
 Investigate if RGNNV can be transmitted to fish held in a co-circulation system 
with fish exposed to  by IM challenge. 
 Investigate if exposure to the marine leech, Zeylanicobdella arugamensis, in 
combination with co-habitation with RGNNV infected fish leads to RGNNV 
infection or VER outbreaks in juvenile E.lanceolatus. 
 Investigate if the marine leech, Zeylanicobdella arugamensis, has potential to act 
as a vector of RGNNV.  
7.1 Introduction 
Although injection methods induce a consistent expression of VER, they are artificial and do 
not reflect a natural infection path leading to outbreaks of VER (Kim et al., 2018). Ideally, 
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challenges to assess the efficacy of vaccines should mimic the natural path of infection. Whilst 
natural disease outbreaks, which presumably do not involve an intramuscular injection of 
NNV, often lead to mass mortality, the reproduction of VER via co-habitation with infected 
animals and water borne exposure is inconsistent and leads to reduced levels of mortality and 
disease in fish that are aged beyond the larval stages (Anderson & Moody 2004, Kim et al., 
2018). Anderson and Oakey (2008) stated: “Our feeling is that the project test results do not 
support the suggestion that nodavirus infections are readily transmitted from one adult 
barramundi to another sharing the same tank.” Attempted bath exposure of freshwater fish 
species (silver perch, golden perch and sleepy cod and Barcoo grunter (6 and 12-week-old) to 
VNN did not display any signs of infection despite morbidity of 46%, 15%, 98% and 7%  when 
fish were exposed via injection (Anderson and Moody 2004). RGNNV has been isolated in cell 
culture and detected by RT-qPCR in water containing fish with clinical VER (Jaramillo et al., 
2017). Hodneland et al. (2011) added brain homogenate from severely infected sea bass to an 
aquarium containing 15 sea bass (40g) and co-habitated fish with IM injected sea bass (1:3 
ratio infected: cohabitated). None of the cohabitated fish displayed clinical signs or were 
positive for the detection of RGNNV RNA 2 by RT-qPCR during the 5-week incubation period. 
Whereas 85% of the IM infected fish died within 10 days. Fish exposed to brain homogenate in 
the water displayed 33% mortality from day 17-35 post exposure (Hodneland et al., 2011).  
The inconsistency in disease expression via water exposure to viruses, including NNV, in 
experimental systems compared to the process that leads to natural disease outbreaks is 
proposed to be due to the presence of “a stress event” as a precursor to trigger natural 
disease outbreaks. The “stress events” remain largely un-investigated beyond simple 
manipulations of water temperature and salinity or retrospective studies that identify risk 
factors (Juniar et al., 2018). Artificial attempts to mimic stress and induce immunosuppression 
of Atlantic cod, Gadus morhua by injection with prednisolone-acetate failed to induce disease 
following IM challenge with NNV isolated from Atlantic halibut, Hippoglossus hippoglossus 
(Korsnes et al., 2009). Conversely, exposure to tributyltin, a component of boat hull anti-foul, 
lead to increased mortality, with lower exposure dose to RGNNV in Japanese medaka Oryzias 
latipes (Kitamura et al., 2017).  
Parasite infestations are frequently encountered in marine fish culture systems and, in high 
numbers, may place a stress burden on host fish. Infestation of grouper and barramundi by the 
marine leech Zeylanicobdella arugamensis have occurred within marine farm grow-out 
systems in Northern Queensland (Vaughan, 2018). This leech has a wide geographic range and 
infection of marine groupers have been reported from Philippines, Sri Lanka, Malaysia, 
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Singapore, India, Japan, Iran and China (Murwantoko et al., 2018). In temperate fish farming 
systems leeches have been implicated as vectors of some viruses (Salimi and Abdi 2016 and 
Steinbauer et al., 2019). Although no viral transmission studies have been conducted with the 
species, Z.arugamensis has been demonstrated to be an efficient vector of the marine 
trypanosome, Trypanosoma nudigobbi (Hayes et al., 2014.) The case of VER in cobia described 
by Chu et al. (2013) noted the presence of Z.arugamensis along with monogeneans (Benedenia 
sp.) and copepods (Caligus sp.). Yet, there was no suggestion of any role the parasites may 
have played in relation to the mortalities and there are no published reports of attempts to 
detect viruses from leeches from tropical finfish aquaculture systems (PubMed, Science Direct, 
Google scholar, Scopus databases accessed 2.08.19). In addition to directly transferring 
viruses, the feeding action of leech and fish scraping and rubbing behavioural in response to 
leech infestation can cause disruption of the protective skin-scale-mucus barrier. Disruption of 
the physical barrier of skin, scales and mucus by parasites render fish susceptible to secondary 
infection by disease-causing organisms such as bacteria, fungi and viruses (Francis-Floyd, 
2018). Dermal abrasion prior to water borne exposure to Vibrio harveyi was required to induce 
disease in an experimental challenge of juvenile hybrid groupers E.fuscoguttatus x 
E.lanceolatus (abw 4.15g) (Shen et al., 2017). Infestation with Z.arugamensis, and secondary 
infection with pathogenic bacteria such as Vibrio alginolyticus has been associated with 
mortalities in grouper (Ravi & Yahaya, 2017). The aim of this study is to investigate potential 
experimental challenge models for future studies to test the efficacy of therapies developed in 
Chapter 6 to prevent VER. Models include exposure to RGNNV through a shared circulation 
system (co-circulation). The potential of the marine leech, Z. arugamensis to compromise the 
skin-mucus barrier, act as “a stress factor” or vector to induce VER under co-circulation will 
also be investigated. 
7.2 Materials and Methods 
7.2.1 Culture of marine leech, Zeylanicobdella arugamensis 
Culture of marine leech Z. arugamensis was kindly conducted by JCU PhD Candidate Dr David 
Vaughan. Approximately 100 leeches were provided for the experiment. Prior to exposure to 
the experimental fish, leeches were removed from the E. coioides host fish and starved for 24 
hours. 
7.2.2 Fish culture, viral challenge and co-circulation system 
Thirty juvenile groupers, E.lanceolatus were dispersed evenly into a system consisting of 3 x 
60L tanks that were immediately adjacent to each other and sharing the same biological 
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filtration and recirculation system. There was no shield to prevent aerosol spread between 
tanks. (Figure 7.1). Water, temperature, light and fish feeding conditions were as described 
previously in section 2.2. For the viral challenge, ten fish from one tank (Tank C Figure 7.1) 
were sedated and challenged by IM injection of 100 uL of RGNNV viral extract (6.36 x 104 mL-1) 
as described in 2.2.2. Fish from the RGNNV challenged tanks began displaying clinical signs of 
VER from day 8 post IM injection. One fish was sampled from the IM challenge group (Tank C) 
at day 4 prior to the onset of clinical signs. When fish began displaying signs of VER at day 8, 
fifty leeches Zeylanicobdella arugamensis were added to two of the tanks, namely the RGNNV 
challenged tank (Tank C Figure 7.1) and another tank on the same recirculation system (Tank A 
Figure 7.1). The leeches had been starved for 24 hours prior to their addition to the tanks 
(provided by Dr David Vaughan). Fish were observed twice daily for signs of VER. When fish 
displayed multiple signs of disease (two clinical signs e.g. not feeding and inflated swim 
bladder), they were removed from the system and euthanased as described in 2.2.1. Any 
leeches that were attached to euthanased fish were removed and stored in separate 1.5ml 
RNase free microcentrifuge tubes and frozen at -20°C until the end of the experiment. The 
experiment was terminated at 40 days post IM challenge. All remaining fish were euthanased 
at day 40 post IM challenge. All leeches present on fish or in the tank system were stored in 
pools of 5 animals and frozen at -20°C.  
 
 
Figure 7-1: Diagrammatic illustration of the experimental aquarium system for co-circulation 
Each tank (A, B, C) contained 10 fish within a 60-litre tank. Water circulated between the tanks from a shared bio-
filter (D). Tank A fish were exposed to 50 Z.arugamensis from the onset of clinical signs of VER in Tank C fish. 
Tank B fish had no exposure to Z.arugamensis nor RGNNV other than that which occurred within the 
recirculation system. Tank C fish were exposed to an IM challenge of RGNNV and at the onset of clinical signs 
were exposed to 50 Z.arugamensis. 
7.2.3 Nucleic acid extraction, CDNA synthesis, RT-qPCR. 
Total nucleic acid (TNAs) was extracted from whole eye and whole marine leeches collected 




qR2T, were conducted on TNAs as previously described in 2.1.3 and 5.2.3. Leeches were 
extracted in pools of 5 collected from fish when they were euthanased.  
7.3 Results 
7.3.1 Expression of VER in juvenile E.lanceolatus. 
The fish that were challenged by IM injection of viral extract (Tank C) displayed clinical signs of 
VER (Figure 7.2). Clinical signs of VER, including hypertrophy of the swim bladder, abnormal 
swimming behaviour and lack of feeding were evident in the RGNNV injected + leech exposed 
group from 8 days post IM challenge (Figure 7.2). No clinical signs of VER were evident in fish 
from either of the co-circulating tanks for the 40 days of the experiment (Figure 7.2). Leeches 
were observed attached to the fish in Tank A and C (leeches added to the tanks) but no 
leeches were observed in the Tank B (no leeches added to the tank) during the course of the 
experiment.  
 
Figure 7-2 Cumulative morbidity (%) of fish from each tank following IM challenge of Tank C 
fish v days post viral challenge. Tank A contained fish exposed to leeches and on co-circulation with IM 
challenged fish in Tank C. Tank B contained fish on circulation with IM challenged fish in Tank C. Tank C contained 
fish challenged with IM injection of viral extract and exposed to leeches from the onset of clinical signs of VER.  
7.3.2 Detection of RGNNV by RT-qPCR 
RGNNV was detected using qR1T and qR2T from the eye tissue of all fish in the IM challenged + 
leech experimental group (Table 7.1). RGNNV was detected in the eye tissue of the grouper 
that was killed at day 4 post challenge (4 days prior to clinical signs). RGNNV was not detected 
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from the eye of fish that were not subjected to IM challenge (Table 7.1) nor any of the leeches 
collected during the experimental period (Table 7.1). 
 
Table 7-1 Cycle threshold values from each RT-qPCR from eye and leech samples collected 
from the three experimental groups at various days post challenge by IM injection. 
 
(grouper) and (leech) indicates type of sample analysed by RT-qPCR 
7.4 Discussion 
Waterborne exposure, which reflects the route of infection in natural disease outbreaks, 
would be the preferred model for disease experimental challenges to induce VER and test the 
efficacy of prophylactic measures. However, variable morbidity and mortality have been 
reported from waterborne and co-habitation exposure to NNV (Anderson & Moody 2004). In 
this study, VER disease was not observed when juvenile groupers were held on a shared 
circulation system for 40 days with a cohort of fish that displayed 90% morbidity following IM 
challenge with RGNNV extract. Furthermore, RGNNV was not detected from the eye or brain 
of-fish held in co-circulation using qR1T or qR2T. In contrast, fish challenged by IM injection of 
viral extract had signs of disease from day 8 post challenge and cycle threshold values of NNV 
in the range of 14.72 to 20.58 and 11.48 to 16.56 were detected from eye tissue using qR1T 
and qR2T respectively. Further attempts to promote NNV infection and induce VER disease by 
introducing an infestation of the leeches, Z.arugamensis were also unsuccessful. Leeches have 
been proposed as mechanical vectors of viruses of fish for many years (Ahne, 1985). Spring 
Viremia of Carp virus was isolated from the leech Piscicola geometra (Ahne, 1985). Viral 
Haemorrhagic Septicaemia Virus was isolated and detected by RT-PCR from the leech 
Myzobdella lugubris (Faisal & Schulz, 2009). Infectious Pancreatic Necrosis Virus was detected 
by PCR from two leech species, Hemiclepsis marginata and Hirudo medicinalis (Salimi & Abdi 
2016). Salmonid alphavirus was detected by PCR from Piscicola geometra (Steinbauer et al., 
2019). In this study, RGNNV was not detected by RT-qPCR from any leech collected from fish 
displaying clinical signs of VER or from fish within the same co-circulation system as diseased 
Assay 
Target 0 4 8* 9 10 11 12 13 40
RNA 1 qR1T nd 30.2 20.6 16.9 15.3 16.3 15.3 14.9 nt
RNA 2 qR2T nd 27.7 16.6 13.4 12.0 12.8 12.0 11.7 nt
RNA 1 qR1T nd nt nt nt nt nt nt nt nd
RNA 2 qR2T nd nt nt nt nt nt nt nt nd
RNA 1 qR1T nd nt nt nt nt nt nt nt nd
RNA 2 qR2T nd nt nt nt nt nt nt nt nd
RNA 1 qR1T nd nd nd nd nd nd nd nd nd
RNA 2 qR2T nd nd nd nd nd nd nd nd nd
RNA 1 qR1T nd nd nd nd nd nd nd nd nd
RNA 2 qR2T nd nd nd nd nd nd nd nd nd







 IM challenge (leech)
Co-circulation + leeche (leech)
Days post challenge
* indicates day clinical signs of VER became evident




Co-circulation + only (grouper)
Co-circulation + leeche (grouper)
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fishes. Presumably, one of the requirements for leeches to act as mechanical vectors of viral 
infections relies on the presence of the virus in the blood cells of infected fish. Reports on the 
detection of NNV from the blood of infected fish are inconsistent. Korsnes et al. (2009) 
reported the detection of NNV from the blood of Atlantic cod, Gadus morhua. Yet, no 
detection from blood cells have been reported by others (Valero et al., 2018). The inability to 
induce RGNNV infection or VER disease via co-circulation with diseased fish, either with or 
without an additional burden of leech infestation indicates waterborne transmission of NNV is 
not a robust model for future studies to test the efficacy of prophylactic measures. Although 
injection challenge by-passes one of the primary immune barriers of the fish, investigation into 
efficacy of prophylactic measures developed in Chapter 6 are proposed to be conducted using 
IM challenge with RGNNV 
 
7.5 Conclusion 
The following outcomes and conclusions were discussed in this chapter: 
 
  
 RGNNV was not transmitted to naïve fish on a co-circulation system with VER 
diseased fish during a 40-day experiment. 
 Exposure of fish to the marine leech Zeylanicobdella arugamensis in addition to co-
circulation with VER affected fish did not lead to infection with RGNNV in juvenile 
E.lanceolatus.  
 The inability to detect RGNNV from leeches which fed on VER affected animals 
indicates Z.arugamensis is not likely to be an effective vector of RGNNV.  
 As VER was not induced via co-circulation or co-exposure to a leech “stress event”, 
no effective method of water borne challenge has been identified for future trials. 
 Although not mimicking the natural route of infection, challenge by IM injection is 
the only consistent challenge model available for continued testing of the efficacy of 





CHAPTER 8. TESTING EFFICACY OF PROPHYLATIC MEASURES 
AGAINST VIRAL ENCEPHALOPATHY AND RETINOPATHY (VER) 





Aims of this Chapter  
 
 A vaccine containing the recombinantly expressed capsid protein of RGNNV 
has been prepared for assessment as a prophylactic measure to prevent VER 
(Chapter 6).  
 dsRNA designed to target RGNNV RNA 2 has been prepared as an 
experimental compound to prevent VER (Chapter 6).  
 Due to reported inconsistency to induce VER by waterborne or co-habitation, 
challenge by IM injection with RGNNV is the preferred method of challenge 
within the scope of this project. 
 The pathogenesis of VER from exposure to disease expression has not been 
well described in grouper.  
 Synthetic plasmid controls have been prepared to support monitoring of the 
qR1T and qR2T assays towards both tracking the pathogenesis of VER and 
validation of both assays for application on grouper tissues. 
 To test the efficacy of vaccine and dsRNA preparations to prevent infection 
and disease in juvenile E. lanceolatus following IM challenge with RGNNV viral 
extract. 
 To assess the performance of the qR1T and qR2T assays to detect RGNNV 
from grouper derived brain and eye tissue following experimental challenge 
by IM injection with RGNNV. 
 To track the pathogenesis of RGNNV from exposure to disease expression by 







In grouper aquaculture, stocking of ponds with NNV-free fingerlings does not prevent 
economically catastrophic VER outbreaks during grow-out stages of production. There is an 
urgent need to develop prophylactic measures to combat NNV infection in grouper grow-out 
systems. Despite numerous reports of successful vaccination against NNV in various 
experimental formats, there are few commercial transfers for application by industry.  
 
 The management of VER in grouper aquaculture is hampered by gaps in knowledge of both 
the development of the juvenile grouper immune system and the pathogenesis of VER. This 
study has prepared a vaccine and dsRNA as potential therapies to prevent RGNNV infection. 
Although monitoring of the juvenile grouper immune system is beyond the scope of this study, 
tracing the progression of the disease following IM challenge is possible with RT-qPCR. Despite 
the need to improve knowledge and the availability of validated, sensitive, specific, 
quantitative, rapid turnover and high throughput RT-qPCR assays, very few published reports 
have applied RT-qPCR to investigate the pathogenesis of VER (Jaramillo et al., 2017; Hodneland 
et al., 2011; Lopez-Jimena et al., 2011; Panzarin et al., 2010). Only one article details the 
application of RT-qPCR to grouper species (Kim et al., 2018). 
8.2 Materials and Methods 
8.2.1 Fish husbandry  
Six hundred juvenile giant grouper, E.lanceolatus (abw 18g 𝜎 ~2 g, range 11.3 g to 23.6 g; aged 
84 days post hatch) were provided by a commercial hatchery. Water temperature ranged 
between 24 to 28 ⁰C and salinity ranged from 26 to 35 ppt. Fish were weighed, tagged with 
streamer tags to allow individual identification (Hallprint) (Refer to Figure 8.1) and fed ad lib 
twice daily with a commercial fish feed pellet (Ridley AgriProducts Pty Ltd). Fish were 
acclimated for two weeks prior to commencement of experimental procedures. Two weeks 
(98 dph) and six weeks (126 dph) after acquisition, fish were injected with the experimental 
treatments. All fish from the same experimental group were held in the same tank system until 
IM challenge. Fish were sedated for all treatments involving injection, according to JCU Animal 





Figure 8-1. (A) Image of juvenile E.lanceolatus with tag and (B). multiple tagged fish within a 
recovery tank after injection with RGNNV extract  
 
8.2.2 Experimental design and vaccination 
Fish were distributed into ten experimental groups. The experimental groups were duplicates 
of five experimental treatments that were subsequently challenged with either PBS or RGNNV 
extract. The five groups consisted of treatments prepared as described in Chapter 6. In 
summary the experimental treatments were: (1) Placebo vaccinated with Adjuvant + PBS, (2) 
vaccinated with recombinant expressed capsid protein (500mg mL-1) + adjuvant, (3) vaccinated 
with recombinant expressed capsid protein (500mg mL-1) + adjuvant and a dsRNA (50pmol µl-1 
dsRNA) construct with homology to RGNNV, (4) injected with a dsRNA (50pmol µl-1 dsRNA) 
construct with homology to RGNNV, (5) injected with a dsRNA (50pmol µl-1 dsRNA)  construct 
with no homology to RGNNV. All injections were the same approximate body position as 
described in Chapter 2.2.3. 
 
8.2.3 Experimental Challenge with RGNNV extract 
Two weeks after the booster (140 dph) treatments or equivalent placebo treatments, fish 
were challenged with virus by either intramuscular injection with 50 µL RGNNV extract 
(calculated copy number 6.36 x 104 mL-1 of viral extract prepared in 2.1.6) or 50 µL sterile PBS. 
Fish were then redistributed into tanks with six fish from each of the five treatment groups 
were placed into replicated tank systems. The experimental groups are described in Table 8-1 
and illustrated in Figure 8.2. 
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Table 8-1 Summary of the experimental design indicating description of prophylactic 
measures, IM challenge, number of fish in each group and number of fish sampled at 




Figure 8-2: Graphic illustration of experimental tank design 
Ten duplicate systems consisting of 2 x 300 litre tanks for housing fish, were equipped with 1 x 300 litre tank 
containing ~100 litres of bio-wheels with constant water flow 1200L hr-1 and constant aeration. Each tank 
contained 6 fish from each of 5 treatments. Fish were individually tagged with T bar anchor tags to indicate 
experimental treatments.  
 
8.2.4 Monitoring of fish health and euthanasia 
Fish were monitored twice daily for signs of adverse health. For the first six days post IM 
challenge, prior to the onset of clinic signs of VER, one fish from each treatment type was 
removed from each tank system and euthanased by Aqui-S overdose (Table 8.1). When fish 
At morbidity Scheduled*
PBS 60 0 10
RGNNV Extract 60 41 4
PBS 60 0 10
RGNNV Extract 60 32 9
PBS 60 0 10
RGNNV Extract 60 26 8
PBS 60 0 10
RGNNV Extract 60 54 4
PBS 60 0 10
RGNNV Extract 60 54 4
Sampling schedule






 IM injection of 100µL adjuvant/PBS 1:1
 IM injection of 100µL adjuvant/PBS:dsRNA 
(RGNNV)
 IM injection of 100µL adjuvant/RGNNV capsid 
protein
 IM injection of 100µL PBS:ds RNA (RGNNV)
 IM injection of 100µL PBS:ds RNA
Experimental Group 
Challenged 50 uL 
i.m. injection
Placebo vaccine




displayed more than one sign of VER they were euthanased. Euthanasia was conducted by 
Aqui-S overdose as described in 2.2.1. Euthanased fish were weighed, frozen whole in 
individually labelled plastic bags and stored at -20°C along with their identification tags. After 
20 days post challenge, when morbidity had reached plateau phase, all surviving fish were 
collected from the RGNNV challenged tanks, weighed and consolidated into two of the 
experimental tank systems. Fish that displayed a clinical sign of VER, mostly darkened colour or 
inflated swim bladders, yet continued to feed were placed in the “clinical sign” system and fish 
that did not display signs of VER were placed in the “no clinical sign” system. The “clinical sign” 
fish were removed from the “no clinical sign” fish to avoid injury and stress. When held in the 
same tanks, the “clinical sign” fish were actively attacked and outcompeted for feed by the “no 
clinical sign” fish. The condition of fish in the consolidated systems was monitored for a further 
80 days post IM challenge. During the 80-day period the streamer tags became damaged and 
were actively removed by the fish so accurate tracking of the individual treatments was, in 
many cases not possible. After 80 days all fish in the “clinical signs” tank were euthanased and 
half of the fish in the “no clinical signs” tank were euthanased. Euthanased fish were weighed 
and stored as previously described. Thirty-five fish with “no clinical signs”, which had retained 
their tags were retained for longer term monitoring of growth. All of the retained fish were 
from one of the two vaccinated treatment groups. Tags were removed in an effort to reduce 
injury from fish trying to eat each other’s tags. Grouping of the “no clinical signs” fish was 
required because the growth and subsequent aggression and territorial behaviour of the larger 
fish prevented retaining all of the survivors under conditions that would comply with Animal 
Ethics Permits. Throughout the remainder of the project, fish with “no clinical signs” were 
euthanased when fish growth caused overcrowding and the fish could not be maintained in 
conditions that complied with the ethical treatment of animals for scientific purposes. Ten fish 
from each of the experimental groups that were challenged with PBS were euthanased at 
scheduled intervals. One fish from each group was euthanased at days 0,2,3,4, and a further 6 
fish from each group were euthanased at day 20 (Refer to Table 8-1). 
8.2.5 Nucleic acid extraction 
Total nucleic acid was extracted from eye as described in 2.1.2. 
8.2.6 Analysis by RT-qPCR using qR1T and qR2T 






8.3.1 Expression of VER following experimental challenge of juvenile grouper with 
RGNNV extract and efficacy of protection of each preventative treatment. 
There was 100% survival and no adverse reaction evident in any of the five groups of fish 
challenged with PBS injection for the duration of the trial period. Within the RGNNV 
challenged groups, fish fed and behaved normally for five days post challenge. Six days post 
challenge, a small number of fish displayed some typical signs of VER. Clinical signs included 
inflation of swim bladder, lethargy, erratic swimming behavior, darkened body color and flared 
opercula. The number of fish with multiple clinical signs increased markedly between days 8 to 
10 post challenge after which morbidity plateaued (Table 8.2). Exposure to dsRNA (specific and 
non-specific design) was not effective in reducing morbidity in juvenile E.lanceolatus following 
IM challenge with viral extract. The groups that received the capsid protein within either 
vaccine formulation (vaccine alone, or vaccine + dsRNA) had reduced total numbers of fish 
displaying VER compared to the placebo vaccinated groups and the groups which received 
dsRNA in either form (Figure 8.3). By day 20 post viral challenge, the group that received 
vaccine and vaccine with anti-RGNNV dsRNA displayed 43% and 53% cumulative morbidity 
compared to the placebo vaccinated (68%) and either form of dsRNA injected (88% and 88%) 
(Figure 8.1). Observation of body mass of moribund and surviving fish from the RGNNV 
challenge indicates a trend whereby larger vaccinated fish tended to survive the RGNNV 
challenge. However, as there were small numbers of larger fish and body weight was not 















Table 8-2: Number of fish sampled or euthanased during the experimental challenge 
including experimental group and day of sampling/euthanasia post challenge. 
Fish which were sampled within the project sampling plan with an absence of clinical signs of disease are indicated 
by S. Fish that were euthanased due to multiple clinical signs of VER are indicated by D.  
 
 
Figure 8-3: Cumulative morbidity of fish displaying signs of VER from each experimental 
group following IM challenge with RGNNV extract. 
Total cumulative mortality (%) at day 20 post IM injection is indicated by data labels adjacent to each 
preventative treatment group. No fish from any of the experimental groups that were challenged with PBS 
injection displayed morbidity during the term of the trial (data not shown). Fish that were sampled prior to the 




































Days post viral challenge
Placebo vac Vaccine & dsRNA Vaccine dsRNA VNN dsRNA
 
Experimental Group 
Number of fish sampled and days post challenge 
sampled 
0 2 3 4 6 7 8 9 10 11 12 13 14 15 16 19 20 
Placebo vaccine 1 1 1 1 1 3 14 11 3 3 1 2 2 0 1 0 0 
Vaccine & Anti-VNN dsRNA 1 1 1 1 2 3 9 8 3 0 1 4 0 1 1 0 0 
Vaccine 1 1 1 1 1 3 14 3 2 0 1 1 1 0 0 0 0 
Anti-VNN ds RNA 1 1 1 1 1 1 9 14 11 7 3 4 0 1 0 1 0 
Non-specific ds-RNA 1 1 1 1 1 1 13 17 12 5 0 0 2 1 0 1 1 
Day Total 5 5 5 5 4 10 59 53 31 15 6 11 5 3 2 2 1 
Sub-clinical (S) or diseased (D) S S S S D D D D D D D D D D D D D 
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8.3.2 Body weight of fish 
The body weight of fish that were euthanased with clinical signs of VER were recorded (Figure 
8.4).  
 
Figure 8-4: Scatter plot of mass of individual fish from each treatment group v days when 
euthanased due to morbidity for each day post challenge by IM injection of RGNNV. 
Notably only 3 fish that received vaccine that were over 50 g in body weight were euthanased. 
 
8.3.3 Detection and quantification of RGNNV by RT-qPCR assay 
There was no detection of RGNNV genome by either assay from any fish challenged with PBS 
injection. RGNNV genome was detected with both assays from eye of viral challenged fish 
from day two post challenge, four days prior to the onset of signs of disease, until and beyond 
day 19 post challenge (Table 8-3). Assay qR1T, which targets the RNA-1 segment had higher Ct 




Table 8-3: Average Cycle threshold value of qR1T and qR2T from analysis on Eye tissue from 
viral challenged fish. 
 
 
The calculated copy number of RGNNV genome detected per mg of eye tissue by each assay 
ranged from 0.02 which was detected at day 2 post challenge, to 8.3 x105 which was detected 
at day 11 post challenge. (Figure 8-5). Mass of eye tissue ranged from 125 mg to 347 mg 
(average 180.4 sd. 49.9 mg). Prior to onset of clinical signs, the calculated copy number was 
less than 103 mg-1. From the onset of clinical signs at day 6, the calculated copy number of 
RGNNV mg-1 of eye tissue markedly increased in both assays. Detection by qR2T was 
consistently ten-fold higher than that of qR1T (Figure 8-5). Prior to the onset of clinical signs at 
day 6, the calculated copy number mg-1 was less in the two groups exposed to vaccine 
compared to the other three treatment groups. However, during the period of peak morbidity 















Target 0 2 3 4 6* 7 8 9 11 13 15 19
RNA 1 qR1T nd nd 37.7 26.7 19.7 16.1 16.2 17.2 15.5 16.7
RNA 2 qR2T nd 45.0 30.0 29.5 15.3 19.0 11.6 12.9 11.3 11.9
RNA 1 qR1T nd 31.8 nd 31.7 21.1 18.8 17.3 16.5 18.0 15.5 19.3
RNA 2 qR2T nd 29.9 28.8 29.6 16.8 15.7 12.4 11.9 13.4 10.8 14.4
RNA 1 qR1T nd 36.8 34.9 34.5 nd nd 16.0 15.8 15.5 16.4
RNA 2 qR2T nd 30.8 30.4 31.4 30.7 30.9 11.5 11.4 10.8 11.8
RNA 1 qR1T nd nd 35.7 25.4 17.6 19.5 15.7 15.8 16.3 16.0 14.7 16.8
RNA 2 qR2T nd 45.0 29.7 22.6 14.8 15.2 11.1 11.4 11.7 11.4 10.8 11.8
RNA 1 qR1T nd nd 31.1 28.9 19.2 12.9 16.1 15.5 16.1 16.0
RNA 2 qR2T nd 35.8 27.3 34.9 14.9 16.4 11.6 10.6 11.0 11.3














Figure 8-5: Calculated copy number of RNA 1 (Black columns) and RNA 2 (Red columns) 
segment per mg of tissue detected by qR1T and qR2T assay for each experimental treatment 
group (ds-RGNNV RNA; dsRNA, Vaccine, Vaccine +ds RGNNV RNA and Placebo) v days post 
challenge by IM injection.  
 
8.4 Discussion 
The application of RT-qPCR to quantify the detection of RGNNV genome segments RNA 1 and 
RNA 2 in response to IM challenge with RGNNV extract following exposure to experimental 
prophylactic measures was discussed within this chapter.  
The two RT-qPCR assays, qR1t and qR2T displayed similar sensitivity to detect RGNNV genome. 
Both assays detected RGNNV genome segments from day 2 post-challenge albeit with a high 
cycle threshold value (Ct) and very low calculated copy number per mg tissue. The frequency 
of detection and calculated copy number per mg of eye tissue from both assays dramatically 
increased in all experimental groups from day 6 post challenge, where clinical signs became 
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evident. Detection of RGNNV before the clinical disease was reported previously from 
experimental challenges of juvenile sea bass after day one post-infection (Dalle Valle et al., 
2005). Souto et al. (2018) reported calculated copy number of RNA 1 and RNA 2 segments by 
RT-qPCR in vitro of log 105.5-8.5 copies mL-1 within 24 hours post-inoculation yet an absence of 
cellular pathological effect (CPE) until after 48hours. 
Although RT-qPCR has significantly improved the ability to quantitatively determine viral 
replication and better understand the expression of VER, few publications have applied RT-
qPCR for a purpose other than detection in disease outbreaks. Comparison of the levels of 
RGNNV detection associated with disease previous reports is difficult. Many reports that have 
applied RT-qPCR to experimental infection with NNV have presented results in different 
formats including cycle threshold (Ct) value (Hodneland et al., 2011 and Panzarin et al., 2010, 
Agnihotri et al., 2015), copies mL-1 (Kim et al., 2018), copies per 200ng total RNA (Dalle Valle et 
al., 2005), copies per 4 µg total RNA (Lopez-Jimena et al., 2011), log10 viral copies ( Hick & 
Whittington, 2010) or log10 viral copies g-1 brain tissue (Souto et al., 2018). Only one of the 
prementioned studies were conducted on groupers (Kim et al., 2018).  
In this experiment, average Ct values from eyes collected from the onset of clinical signs, days 
6 to day 19 post challenge were 16.8 (s.d 1.67) (RNA 1) and 12.8 (s.d 2.14) (RNA 2) 
respectively. Brain samples from clinically diseased grouper had a Ct value of ca 10 (RNA 2) 
(Agnihotri et al., 2015), sea bass had a median Ct value of ca 15.0 (RNA 2) (Hodneland et al., 
2011) and a range of Ct value from 9.91 to 18.6 (RNA 2) (Parnzarin et al., 2010). Other authors 
report calculated copy numbers of 109 mL-1 (RNA 1) to 106 mL-1 (RNA 2) (Kim et al., 2016) or 105 
(RNA 1) and 107 (RNA 2) per 200ng total RNA (Dalla Valle et al., 2005).  
In this investigation, although both assays detected the RGNNV genome, the calculated copy 
number of qR1T was slightly less than qR2T. An increased calculated copy number of RNA 2 
compared to RNA 1 has been noted previously where the number of copies of RNA 1 was 100 
times less than those of RNA 2 from the brain of sea bass from days 3 to 14 post experimental 
challenge (Dalle Valle et al., 2005). It is possible the differences in levels of detection are 
related to variable transcription of the RNA 1 and RNA 2 gene segments as infection 
progresses. As RNA 1 encodes the mRNA for the RNA-dependant RNA polymerase, the 
replication and translation of RNA 1 is required for transcription of RNA 2. The time course of 
sample collection in this investigation may not be sufficient to resolve shorter-term variation in 
transcription of RNA 1 and RNA 2 during the early stage of progression towards disease. The 
reduced efficiency in assays that detect RNA 1 may also relate to secondary structure 
interaction between RNA 1 and its translated form, Protein A, that contribute to the formation 
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of the viral replication complex, termed spherules, which are essential for nodavirus 
replication (Kopek, Settles, Friesen & Ahlquist 2010). The formation of the replication complex 
in the mitochondria, serves to protect the naked RNA 1 genome and facilitate viral replication. 
In contrast, RNA 1 was detected at much higher quantities (102-104) than RNA 2 in a variety of 
tissues from H.septemfasticatus following experimental challenge (Kim et al., 2016).  
A range of criteria are applied to process of validation of an assay, one of which, the operating 
range of the assay, can be difficult to demonstrate beyond application of disease diagnosis. 
Specifically, determining the suitability of an assay to accurately and precisely detect NNV in 
sub-clinical carriers can be difficult because it requires access to experimental challenged 
animals where the infection status of the samples is pre-determined. In this study, NNV was 
detected by both RT-qPCR assays after IM challenge, prior to, and following the expression of 
disease symptoms. Similar results were reported by Dalle Valle et al. (2005) whereby RGNNV 
was detected within 1-day post challenge and clinical signs became evident 7 days post 
challenge. In this study NNV was detected at 2 days post challenge and clinical signs of VER 
were evident 6 days post challenge. NNV continued to be detected by RT-qPCR up to 80 days 
post IM challenge (data not shown). Groupers that were assigned to the non-clinical signs tank 
did not succumb to VER during an 18-month holding period (data not shown).  
The rapid progression of disease observed in this report agrees with numerous experimental 
challenges in other fish species that indicate mortality from day ~5-10 post infection 
(Hodneland et al., 2011; Lopez-Jimena et al., 2011). Hodneland et al. (2011) reported 84% 
mortality of IM injected sea bass within 10 days post infection. Dalle Valle et al. (2005) 
reported initial lethargy in sea bass 7 days post infection, followed by death of fish at 9, 10- 
and 11-days post infection and an absence of disease in survivors at 13- and 14-days post-
infection. Mortality in juvenile E. septemfasciatus (reclassified as Hyporthodus 
septemfasciatus) between days 6 to 9 were observed following challenge with a RGNNV titre 
approximately 105-6 TCID50 (Cho et al., 2017; Kim et al., 2018). 
 
The prophylactic measures had varying effect on the cumulative morbidity of RGNNV 
challenged fish. Experimental groups that received vaccines containing recombinantly 
expressed RGNNV capsid protein displayed reduced levels of morbidity compared to fish that 
received placebo vaccine or dsRNA constructs. Modest reductions in the cumulative morbidity 
were observed in the vaccinated fish (43-53% morbidity) compared to the other experimental 
therapies (placebo 68% morbidity and dsRNA 88% morbidity). Although the presentation of 
dsRNA constructs provided no protection against the development of VER following exposure 
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to RGNNV extract in this experiment, the technology should not be discounted as a tool to 
better understand and manage VNN. The application of dsRNA as a therapeutic has been 
reported for the prevention of viral diseases of crustaceans (Owens et al., 2014). Although the 
technology faces a number of hurdles there is at least one US patent claiming successful 
application of dsRNA to prevent disease in an aquaculture species namely for the prevention 
of Infectious Myonecrosis Virus in shrimp and other invertebrates (Loy et al.US patent No. 
US8822427B2). This project attempted delivery of naked dsRNA, which was not protected 
from degradation. The delivery of unprotected dsRNA has been reported previously (Owens et 
al., 2014; ). One of the main problems in the development of siRNA for therapeutic use is the 
need for a delivery method that prevents the degradation of siRNAs by cellular nucleases 
(Chernikov et al., 2019). Adjustments to the delivery, concentration, target sequence and 
duration of priming may lead to improvements in the efficacy of dsRNA prevent VER. 
Considering the range of variables that require refinement in dsRNA, a more ethical approach 
investigating dsRNA as a therapy would be to refine the target design in cell culture systems 
before further trials are commenced in fish. Approaches using dsRNA to knockdown fish 
viruses have been successfully applied to prevent the expression of the major capsid protein of 
the tiger frog Iridovirus in fathead minnow cells (Xie et al., 2005). However, further work with 
cell culture systems are beyond the resource and short time frame of this study. 
The modest reduction in morbidity in vaccinated fish compared to unvaccinated fish was a 
promising result. The results suggest that some level protection is provided by the vaccine. 
However, the protection wasn’t consistent across the vaccinated cohort.  
Body mass was also noted to be variable within the experimental groups. Very few vaccinated 
fish with a body mass over 50g displayed morbidity following challenge with viral extract. 
There has been no reported effect of fish size on the efficacy of vaccination in grouper. There 
is a large range in body mass across the studies that have investigated vaccination against NNV 
in grouper (Table 8-4) but so far, no statistically analysed effect of body weight on vaccination. 





Table 8-4 Details of species, age and body weight from previous studies involving vaccination 
of grouper against NNV or bacteria. 
 
 
Within the literature there is very little information about the development of a competent 
humoral immune system in grouper in relation to age or body mass. Mao et al. (2012) 
reported with detectable antibodies to VNN and the oval shaped thymus of 4-month old (~112 
dph) fish was clearly visible and there were amounts of T lymphocytes present. However, no 
protective functionality of the antibodies or T-lymphocytes was demonstrated. The differential 
morbidity of vaccinated fish may be related to factors other than body weight. However, few 
of those factors can be investigated with the available data.  
 
8.5 Conclusion 




Species Age (dph) body mass (g)
E.coioides  from 1 to 18 dnp Lin et al. 2007
E.coioides dnp 0.36 Lai et al., 2014
E.lanceolatus dnp 20 Liu et al., 2006
E.malabaricus dnp 20 Liu et al., 2006
E.septemfasciatus 28 Tanaka et al. 2001
E.coioides dnp 33 Mo et al., 2019
E.coioides dnp 32 Huang et al., 2014b
E.coioides dnp 35 Atujona et al., 2019
E.septemfasciatus dnp 75 Yamashita et al. 2009 
E.septemfasciatus dnp 80 Oh et al. 2012
Details of Groupers in the Studies
Reference
dnp = detail not provided
 The efficacy of vaccine and dsRNA preparations to prevent infection and disease in 
juvenile E. lanceolatus following IM challenge with RGNNV viral extract were 
assessed. 
 The performance of the qR1T and qR2T assays to detect RGNNV from grouper 
derived brain and eye tissue following experimental challenge by IM injection with 
RGNNV. 
 RT-qPCR analysis detected RNA 1 and RNA 2 NNV segments from grouper tissues 
prior to the onset of disease, during the period of peak morbidity and for a period 





CHAPTER 9. ROLE OF PARENTAGE IN SURVIVAL FROM VIRAL 




 Initial attempts with vaccination led to a modest improvement in survival of E. 
lanceolatus following RGNNV challenge.  
 Grouper are aggregative spawners. The juveniles used in the experimental 
challenge were produced in a mass spawning event with 7 potential parent 
contributions.  
 Evidence of genetic resistance to NNV is reported in some fish species. 
 There is very limited evidence of genetic resistance to NNV in grouper. 
 Modest efficacy of the vaccine to protect against VER could be related to 
parentage rather than a protective effect of vaccination. 
 
Aims of this Chapter 
 Investigate if vaccinated fish that survived RGNNV (resistant) have a different 
parental assignment than fish that succumbed to VER disease (susceptible) 













The juvenile E.lanceolatus used in the trial described in Chapter 8 were derived from a mass 
spawning containing eight parent fish. It is possible the differential survival of vaccinated fish 
compared to the other experimental groupers was influenced an unknown parentage-linked 
genetic element. 
Genetic selection for resistance to disease is often pursued as a management strategy to 
reduce the impact of disease outbreaks in aquaculture. Successful breeding of families with 
resistance to infectious pancreatic necrosis virus (IPNV), salmon alphavirus and infectious 
salmon anaemia virus (ISAV) have been reported in salmon aquaculture (Yanez et al., 2014). 
Previous studies with grouper species identified a relationship between major 
histocompatibility complex (MHC11) polymorphism and resistance to Singapore grouper 
Iridovirus (SGIV) in 40-60g E. coioides whereby allele (EPOC-DBB*1001) (NCBI JN980423) was 
significantly associated with resistance (Min et al., 2016).  
There is limited evidence of genetic resistance to NNV in grouper species. Although there are 
rumoured reports of cross-species hybrid groupers being less susceptible to VNN, there are no 
published reports identifying genetic markers for resistance to VNN in hybrids or within a 
single grouper species. In L.calcarifer, a single study with larval fish identified five significant 
quantitative trait loci (QTL) for resistance to VNN which accounted for 2.2 to 4.1% reduced 
calculated copy number and 2.2-3.3 % survival time as phenotypic traits that indicated 
resistance (Liu et al., 2016). The authors proposed genetic resistance to NNV in L.calcarifer to 
be complex and controlled by the accumulation of small effects of many loci (Lui et al., 2016). 
A significant improvement in VNN resistance was noted in a cohort of 3-month-old L.calcarifer 
that possessed a variant (410_417) in the 3’ untranslated region (UTR) of Receptor-
transporting protein 3 (Rtp3) (Liu et al., 2017). Approximately 22% of fish that survived water 
bath challenge to RGNNV displayed the variant 410_417 compared to approximately 13% of 
the fish that succumbed to VER (Liu et al., 2017). Unfortunately, the samples were collected 5 
days post challenge when mortality across the cohort reached 50%. In numerous studies, 
including that indicated in Chapter 8, mortality in susceptible cohorts typically exceeds 50% 
and consequently, a number of the fish included in the “survival group” may have succumbed 
to infection within a further 1- or 2-days post sampling. An analysis of survivors after the 80% 
mortality phase, or when the mortality curve reached a plateau stage, would have provided 
greater confidence in the significance of this allele.  
Selective breeding programs for highly pathogenic diseases typically rely on binary assessment 
of susceptibility and resistance via disease-challenge testing (Houston 2017). The earliest 
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studies phenotypically determined “susceptible” as those individuals that succumbed to 
disease and “resistant” as those that survived challenge. More recently, determination of 
“resistance” has been refined to indicate a blocking of reproduction of the pathogen, namely 
survival and an absence of detection of the pathogen (Yanez et al., 2014). Survivors, where the 
pathogen can be detected are termed “tolerant” (Yanez et al., 2014). 
Although it was not the intent of the challenge trial discussed in Chapter 8, the production of 
the juveniles used in this project from a mass spawning event may have inadvertently 
introduced a variable genetic element to the vaccine efficacy experiment. As a precautionary 
measure, prior to further assessment or attempted optimisation of the vaccination process, 
some assessment of the parentage of the experimental challenge fish is warranted. 
Fortunately, Bright et al. (2016) published multi locus sequencing analysis (MLSA) using 
microsatellite markers to determine parentage based on E.lanceolatus from The Company One 
broodstock. The aim of this investigation is to apply the markers of Bright et al. (2016) to 
determine the parentage of a selection of the vaccinated fish that were susceptible to RGNNV 
and those that survived RGNNV challenge. 
9.2 Materials and Methods 
9.2.1 Source of E.lanceolatus for family assignment 
All the experimental challenge fish used in the family assignment were from the vaccinated 
group. Nine of the experimental challenge fish that were euthanased with signs of VER were 
included in the analysis as the susceptible group. Six of the experimental challenge fish, which 
did not display signs of VER, were euthanased at day 20 post challenge after the mortality 
curve had plateaued from the peak morbidity period between days 7 to 10 post challenge 
(Figure 7.2). As one of the aims of the efficacy investigation was to determine long term 
survival, only a small number of fish were euthanased for this investigation. Although 
parentage assignment could be conducted on fin clips, samples of brain or eye were required 










9.2.2 Nucleic acid extraction 
Total nucleic acid was extracted from eye tissue of the experimental challenge fish as 
previously described in 2.1.2. Total nucleic acid was extracted from fin clips from the adult 
grouper that contributed to the experimental challenge cohort. Fin clips were extracted as 
previously described in 2.1.2.  
 
9.2.3 Quantitative RT-PCR to detect RGNNV 
Quantitative RT-PCR applying the qR2T assay to detect RGNNV was conducted as previously 
described in 8.2.6. 
 
9.2.4 Confirmation of suitability of family assignment primers.  
Eight primer pairs were selected for parentage assignment by polymorphic microsatellite 
analysis (Bright et al., 2016). Prior to submission to AGRF a preliminary assessment of primer 
suitability was conducted against the six nucleic acid extracts from fish that did not display 
signs of VER by applying touchdown PCR described by Bright et. al (2016). Briefly, PCR was 
conducted on a Maxygene thermal cycler (Axygen) in a 20 µL reaction with 2.5 µL of TNA 
extract and 0.5 µM each primer in a MyFi™ DNA polymerase Mix according to the 
manufacturer’s instructions (BIO-21117 Bioline, NSW). The thermal cycle profile consisted of a 
3 min incubation at 95⁰C followed by 20 cycles of 30 s denaturation at 95⁰C, 30 s of annealing 
temperature 62⁰C (decreasing by 0.5 ⁰C per cycle) and 45 s extension at 72⁰C followed by 15 
cycles of 30 s denaturation at 95⁰C, 30 s of annealing temperature 50⁰C and 45 s extension at 







Table 9-0-1: Details of primer sequences applied to MLST analysis to determine family 
assignment 
 
9.2.5 Gel electrophoresis 
PCR amplification was confirmed by agarose gel electrophoresis as previously described in 
2.5.3. The gels were loaded with 20 μL of PCR product and subjected to 60 min at 100 volts 
with a Hyper Ladder™ 50bp DNA ladder (BIO-33054, Bioline, NSW) (1 % gel). The gels were 
visualised and photographed on a UV trans illuminator.  
 
9.2.6 Family assignment by microsatellite markers 
Following confirmation of suitability of primers, total nucleic acid extracts from 7 parent and 
15 experimental challenge fish, were submitted to the Australian Genome Research Facility 
(AGRF) for fine mapping and custom genotyping services applying the primers of Bright et al. 





Set Id. Locus Orientation Sequence (5'-3') Size Tm 
F TGT AAA ACG ACG GCC AGT TTT GCC TTT CCT AGA CTT AT
R CAT CAC ATG ATT CCT TTC TAT
F TTC CAC AGC AAT TAG CAG CA
R TTT CCT CCC ACA GTT CCA AAG
F TCA GCA AGC ACT TTT TGG AC 
R TGC TTC CTT CAG TGC ATC AG
F TGC CCC TCC GAC AAC TAA TA
R AAC GGG ACT TGT GGT TTT TG
F TGT AAA ACG ACG GCC AGT GCT CGA AGA TGA GCT GGA AG
R AAG GTG CTG CTC CTG CTT T
F TGT AAA ACG ACG GCC AGT ACC ATG CAT AAA TGC CCA CT
R GCT CTC TGT CTC GCA AGG AT
F TGT AAA ACG ACG GCC AGT TCT GTG CTG ATG CCG ACT AC
R CCG TGT TTG CAC ACT CTC TG
F TGT AAA ACG ACG GCC AGT TCA ATG TGT GCA AAC GCT GTA




Source of Al l  primer  sequences  Bright et. a l . (2016)

































9.3.1 Gel electrophoresis to confirm primer suitability 
The primers of Bright et al. (2016) amplified products in the six extracts used in the pilot 
assessment. Refer to Figure 9.1 for image of gel electrophoresis. 
 
Figure 9-1: Gel electrophoresis image of amplicons 
Produced by application of the eight primers A to H) of Bright et al. (2016) on extracts from the six fish (Fish 1 to 
6) that did not display signs of VER to determine family assignment in E.lanceolatus. Refer to Table 8.1 for primer 
sequences. 
 
9.3.2 Quantitative RT-PCR for the detection of RGNNV genome. 
All samples collected from juvenile fish were positive for the detection of the RGNNV genome. 
Cycle threshold values ranged from 23 to 30 (Table 9.2). The RT-qPCR for detection of RGNNV 
RNA 2 was positive for all samples indicating, that the fish which did not succumb to VER 




Table 9-2: Family assignment and qR2T Cycle threshold value (Ct) of vaccinated fish that 
displayed clinical signs or succumbed to VER following IM challenge to RGNNV extract. 
 
9.3.3 Family assignment by microsatellite markers 
Allele counts from each sample for each marker were provided by the Australian Genome 
Research Facility (Appendix 2). Five reactions out of 175 failed to amplify. Family assignment 
was performed based on allele sizes generated. The data provided by Markers An31 (primer 
set G) and Elms19 (primer set F) had very little resolution power and were not considered in 
the family assignment (Appendix 2). Family assignment analysis indicated 4 out of 6 fish that 
did not display clinical signs of VER were from Male #2 and Female #2. The remaining 2 fish 
that did not display clinical signs of VER were from Male #2 and Female #3 and Male #2 and 
Female #4. Within the susceptible fish 7 out of 9 fish had the same parentage assignment as 
those of the tolerant group.  
9.4 Discussion 
Although the experimental challenge study was not intended as an investigation into genetic 
selection for disease, due to the aggregate spawning behaviour of grouper, the modest 
survivals evident in the vaccinated groups of RGNNV challenged animals may have related to a 
different parentage rather than an efficacy of the vaccine i.e. a genetic trait. Although some 
correlative studies investigating genetic traits and survival to NNV have been reported in other 
species, no genetic resistance to NNV has been demonstrated in groupers. Studies linking 
genetic resistance to VER in other species have indicated the mechanisms of resistance are 
likely complex (Liu et al., 2016). This also applies generally to research reporting on genetic 
Sample Id. Clinical disease/No clinical signs Female Male
Fish-1 No clinical signs 27 F3 M2
Fish-2 No clinical signs 27 F2 M2
Fish-3 No clinical signs 27 F2 M2
Fish-4 No clinical signs 30 F2 M2
Fish-5 No clinical signs 27 F2 M2
Fish-6 No clinical signs 30 F4 M2
Fish 7 Clinical disease 24 F3 M2
Fish 8 Clinical disease 25 F2 M2
Fish 9 Clinical disease 23 F3 M2
Fish 10 Clinical disease 23 F2 M2
Fish 11 Clinical disease 23 F3 M3
Fish 12 Clinical disease 25 F3 M1
Fish 13 Clinical disease 22 F4 M2
Fish 14 Clinical disease 25 F2 M2






resistance to viral disease in salmon (Yanez et al., 2014). Genetic resistance to disease typically 
involves detection of combinations of traits that are complicated to measure (Yanez et al., 
2014). The interaction between multiple immune mechanisms, viral variants and 
environmental fluctuation make identification of traits that link to disease resistance very 
difficult (Yanez et al., 2014). Investigation of such traits was both beyond the scope of this 
project and restricted by a void in the understanding of mechanisms of the grouper immune 
system and its differential development with growth. Nonetheless, working within the 
limitations of knowledge and resources available at the time of this study, investigation 
comparing parentage of the vaccinated fish that were susceptible to RGNNV (euthanased due 
to clinical disease signs) against those animals that were tolerant of RGNNV (survivors) was 
conducted. Quantitative RT-PCR to detect RGNNV indicated the survivor were positive for the 
detection of NNV genome and were hence considered a tolerant phenotype for parentage 
analysis. Working with the MLST markers Bright et al. (2016) applied to successfully assign 
parentage to 574 offspring from a broodstock cohort from The Company One stock, this study 
investigated parentage of tolerant v susceptible individuals. The parentage assignment was 
comparable between both cohorts whereby two individuals from Male #2 and Female #2 
dominated both the tolerant and susceptible groups. Within the restriction of the small 
number of samples analysed, the results of the parentage assignment were in agreement with 
those observed by Bright et al. (2016) whereby, a dominant male sired the majority of 
offspring and although polygamous mating was observed, the same dominant male 
predominantly spawned with a particular female. Whilst Bright et al. (2016) reported all of the 
markers except ELMS7 were useful for parentage assignment, this study noted that ELMS19 
also had poor power in determining parentage assignment. This study demonstrates the 
modest improvements in survival following challenge with RGNNV in the vaccinated groups 
that were described in Chapter 8 were not simply caused by differential parentage within the 
experimental cohort. Further investigation into the optimisation of the vaccine and vaccination 











The following outcomes and conclusions were described in this chapter: 
 
  
 RT-qPCR detected RGNNV in the eye of fish that survived RGNNV and those that 
succumbed to VER following IM challenge. 
 Surviving fish are therefore considered tolerant rather than resistant to infection by 
RGNNV. 
 Results of Multilocus sequence analysis indicate the fish that were tolerant to RGNNV 
following IM challenge were of the same parentage as fish that were susceptible to 
RGNNV following IM challenge. 
 The modest improvements in survival observed in vaccinated fish were not due to 
variable parentage within the cohort produced to due to the grouped spawning 
production of the experimental cohort. 
 Further investigation into the efficacy of vaccination to prevent VER following exposure 




CHAPTER 10.  TESTING EFFICACY OF EXPERIMENTAL VACCINE TO 
PREVENT VER FOLLOWING CHALLENGE WITH NERVOUS 
NECROSIS VIRUS IN LARGER FISH 
Background  
 Initial attempts with vaccination led to a modest improvement in survival of 
E.lanceolatus following RGNNV challenge.  
 Some fish species display age related resistance to VER. 
 Successful vaccination relies on the fish having attained a competent adaptive 
immune system. 
 Many of the vaccinated fish that were tolerant of RGNNV challenge were a larger 
body weight than the fish that succumbed to disease. 
 Delaying vaccination and challenge until fish are slightly larger (and therefore 
older) may improve the efficacy of vaccination as a strategy to prevent VER. 
 The time frame for approval of a recombinant expressed capsid protein vaccine is 
likely to take a number of years. 
 An emergency/research permit vaccine could be obtained in a shorter time frame 
based on heat-killed cell culture produced antigen. 
 
Aims of this chapter  
 Investigate if a refined vaccination strategy, on larger fish >50g, improves efficacy 
of vaccination to prevent VER. 
 Investigate if heat-killed cell culture derived vaccine on larger fish is an effective 






The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates the 
registration of veterinary vaccines in Australia (https://apvma.gov.au/node/1108). The 
registration process is lengthy, and in some cases, requires demonstration of compliance 
across multiple authorities. Vaccines containing cell-culture derived antigen must be prepared 
in compliance with Australian Government Department of Agriculture and APVMA (pers. 
comms from APVMA). Vaccines containing expressed recombinant antigen must address the 
standards regulated by Office of the Gene Technology Regulator (OGTR) and APVMA (pers. 
comms from APVMA). Although the path to registration for commercial production is long, 
there is provision for the registration of an experimental vaccine to provide interim or 
emergency protection (https://apvma.gov.au/node/1108). 
Experimental vaccines are typically autogenous vaccines prepared from a pathogen isolated 
from a specific location and administered to other stock at risk within the same location 
(https://apvma.gov.au/node/1108). The several years that may be required to register a 
vaccine within the APVMA is not compatible with the immediate need for the current grouper 
aquaculture industry to prevent the economic losses caused by VER outbreaks in pond grow-
out systems. For reasons of upscale and difficulty with biosecurity compliance requirements, a 
cell culture-derived vaccine is not the preferred vaccine format for future commercial 
preparations; however, if effective, the format provides an interim measure to prevent losses 
due to VER for the period required to meet compliance for commercial registration of 
expressed recombinant capsid protein vaccine. Therefore, this study investigated an 
autogenous cell culture-derived vaccine for effectiveness to prevent VER. 
The observation of increased survival in larger vaccinated fish described in Chapter 8 may be 
due to several factors, one of which is the larger fish were in better condition and hence 
responded to vaccination more efficiently. The absence of improved survival in the non-
vaccinated fish of similar body weight in the experimental trial (Chapter 8) indicates that 
survival following challenge was not a bodyweight-viral dose relationship. Although 
understanding the mechanism between bodyweight and vaccination efficacy is not within the 
scope or resource budget of this study, further investigation into a relationship is possible.  
Researchers that apply experimental procedures to animals are obligated to ensure the 
ethical, humane and responsible use of animals in their care. One aspect of that obligation is 
to minimise the number of animals used (NHMRC, 2013). To minimise the number of fish used 
within experimental processes, testing the efficacy of the autogenous vaccine on juvenile 
E.lanceolatus was combined with testing the efficacy of the recombinant vaccine on larger 
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body weight fish. This chapter investigates the efficacy of vaccination, using a heat-killed viral- 
cell culture antigen or expressed recombinant capsid protein as antigen to prevent VER in 
juvenile grouper with a minimal body weight of 50g. 
10.2 Materials and Methods 
10.2.1 Experimental E.lanceolatus 
Juvenile E.lanceolatus, (116 days post hatch), were provided by a commercial supplier, Fin Fish 
Enterprises (Australia). Two hundred fish, produced from a single mass spawn were used in the 
investigation. Fish were housed under the same conditions as described in section 2.3, 
including at a water temperature range of 24-28°C, until all fish had a body weight exceeding 
50g.  
10.2.2 Expressed recombinant viral capsid Vaccine production 
The vaccine produced from expressed recombinant protein was prepared as described in 
section 6.2.7. For this trial the purified protein was retrieved after approximately 9 months 
storage at -80°C. 
10.2.3 Heat-killed cell culture derived vaccine production 
 Heat-killed cell culture derived vaccine (HK-vaccine) was prepared from 2 x 15 ml E 11 striped 
Snakehead whole fry tissue (SSN) cell cultures (Nakai, European Collection of Authenticated 
cell cultures Sigma 01110916) inoculated with RGNNV extract (Iwamoto et al., 1999 and 2000). 
Briefly, one ml of the RGNNV extract was inoculated onto two confluent monolayers of SSN-
E11cells that were prepared in 15cm2 cell culture flasks (Corning), supplemented with Leibovitz 
L-15 media containing glutamine (Sigma L1518) and 10% Foetal Bovine Serum (Sigma F6178). 
The flasks were incubated at 28°C for 3-4 days, until CPE extended across the entire 
monolayers. The cultures were then frozen and thawed 3 times and filtered through 0.45µM 
and 0.22µM filters. The culture supernatant was stored in a sterile 50ml tube at -20°C. RT-
qPCR analysis to detect NNV was conducted on a total nucleic acid extract prepared from a 
400µl aliquot of supernatant as described in section 2.2.9. NNV was detected by the qR1T PCR 
with a Ct value of 10.38 which equates to a calculated copy number of 2.29 x 108 copies mL-1. 
The viral culture supernatant was subjected to 40-minute incubation at 60°C (Labnet) to 
deactivate the virus (Frerichs et al., 2000). Vaccine was prepared by mixing 15ml of the 
deactivated viral culture with 15ml of Fruends’ incomplete adjuvant and homogenising the 
mixture as previously described for the other vaccine formulations (Section 6.2.7). Prior to 
commencement of the experiment a pilot study was conducted to confirm no adverse impact 
of the heat-killed cell culture vaccine. Fourteen days after delivery of the grouper, ten 
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groupers were anaesthetised, injected with 100µl of HK-vaccine (as described in section 2.3.3 
and observed for 14 days to monitor any adverse effect of vaccine. After 14 days of no notable 
adverse reaction, the experiment was commenced as described below. The ten fish were 
maintained throughout the duration of the experiment, however, no longer term effects of 
vaccine were observed. 
10.2.4 Vaccination of Fish 
One hundred and eighty fish were divided into 3 experimental treatment groups namely: (1) 
Placebo vaccinated with Adjuvant + PBS, (2) vaccinated rCP vaccine), (3) vaccinated with HK-
vaccine. Fish were anaesthetised and injected with vaccines as described previously (section 
2.3.2 and 2.3.3). A timeline of procedures and description of the experimental procedures is 
outlined in Tables 10.1 and 10.2. Briefly, fish were vaccinated four weeks after receipt, with 
100µL vaccine by IM injection by the same protocol described in section 2.3.3, followed by a 
booster four weeks after vaccination (Table 10-1). A further ten fish were included as negative 
controls. The negative control fish were injected (IM) with placebo vaccine following the same 
protocol and schedule as the experimental vaccine group fishes. 
 
Table 10-1: Timeline of age of fish days post hatch at acclimation, vaccination, booster and 
challenge with viral extract. 
 
  Acclimation Vaccination Booster Challenge 
Days of this experiment 0 28 56 70 
Age of fish (days post hatch) 116 144 172 186 
 
 
10.2.5 Experimental Challenge with RGNNV extract 
Two weeks after the booster (186 dph) vaccine or equivalent placebo vaccine, fish were 
anaesthetised, weighed and challenged with either intramuscular injection with 50 µL RGNNV 
extract (calculated copy number 6.36 x 104 mL-1 of viral extract, prepared in 2.2.6) or 50 µL 
sterile PBS. One hundred and eighty fish were challenged with the viral extract described in 
section 2.3.3. The ten negative control fish, that were vaccinated with placebo vaccine 
(adjuvant: PBS 1:1 ration), were challenged with IM injection of PBS following the same 
protocol as the NNV challenged fishes. Ten fish from each vaccine type that were challenged 
with viral extract were then distributed into tanks (n=30 fish per tank) (Table 10-2 & Figure 10-
2). The negative control, PBS challenged fish were held in a separate recirculation system 
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within the same experimental room. The tank system of the negative control fish was a 
duplicate system of the fish challenged with viral extract (Refer to section 2.3.1). 
 
Table 10-2: Summary of experimental design indicating experimental groups, description, 
number of fish in the trial and number of fish sampled at morbidity or at scheduled time 
points during the experimental trial 
 
 
Figure 10-1: Diagram depicting experimental tank system. Three replicate systems each consisting of 
dual 200 litre tanks on a co-circulation system each containing 10 fish from each experimental group (placebo 
vaccine= blue fish; recombinant capsid protein vaccine= yellow fish; Heat-killed cell-culture vaccine= pink fish) 
making a total of 30 fish in each tank. The tanks on the top row were sampled at morbidity or at the end of the 
trial period and the tanks on the bottom row were sampled on schedule weekly, at morbidity or at the end of the 
trial period.  
 
10.2.6 Monitoring of fish health and euthanasia 
Fish were monitored twice daily for signs of adverse health. Fish were euthanased when more 
than one sign of VER was observed. In the absence of signs of disease, a fish from each of the 
experimental groups was euthanased every seven days for the first three weeks of the study. 
Euthanasia was conducted by Aqui-S overdose as described in 2.2.3. Euthanased fish were 
weighed, frozen whole in individually labelled plastic bags and stored at -20°C along with their 
identification tags. After 40 days post challenge all fish were euthanased with an overdose of 
At morbidity Scheduled*
Placebo vaccine  IM injection of 100µL adjuvant/PBS 1:1 RGNNV Extract 60 57 3
Recombinant Capsid protein 
vaccine (rCP)
 IM injection of 100µL adjuvant/ rCP-RGNNV 1:1
RGNNV Extract
60 6 54
Heat-killed cell culture vaccine 
(HK)
 IM injection of 100µL adjuvant/heat-killed cell 
culture 1:1 RGNNV Extract
60 5 55
Placebo vaccine (Negative 
control)
 IM injection of 100µL adjuvant/PBS 1:1
PBS
10 0 10
* indicates at scheduled days in the absence of clinical signs of VER
Experimental Group Description







Aqui-S (as described section 2.2.3). The clinical state of all fish was recorded at the time of 
euthanasia.  
 
10.2.7 Nucleic acid extraction 
Total nucleic acid was extracted from a whole eye from each euthanased fish as described in 
sections 2.2.1 t0 2.2.3. Fish that were euthanased on schedule and at morbidity were 
subjected to nucleic acid extraction and quantitative RT-PCR. 
 
10.2.8 Quantitative RT-PCR to detect RGNNV 
Quantitative RT-PCR applying the qR1T and qR2T assay to detect RGNNV was conducted as 
previously described in section 8.2.6. 
 
10.3 Results 
10.3.1 Expression of VER following experimental challenge of juvenile grouper with 
RGNNV extract and efficacy of protection of each prophylactic measure. 
The average body weight (abw) of groupers on the day of challenge was 103.5 g (𝜎 20.39 g) 
(data not shown). There was 100% survival and no adverse reaction evident in any of the 
groupers challenged with PBS injection. Within the NNV challenged groups, fish fed and 
behaved normally for six days post challenge. Seven days post challenge, a small number of 
fish displayed some typical signs of VER. Clinical signs included inflation of swim bladder, 
lethargy, erratic swimming behavior, darkened body color and flared opercula. The number of 
fish with multiple clinical signs increased markedly between days 8 to 10 post-challenge after 
which morbidity plateaued (Figure 10-2). The groups that received either vaccine formulation 
had reduced total numbers of fish displaying VER compared to the placebo vaccinated groups 
(Figure 10.2). By day 20 post viral challenge, 17% (HK-vaccine) and 20% (rCP-vaccine) of the 
vaccinated fish succumbed to VER compared to 93% of the placebo vaccinated (Figure 10.2). 
To remove any impact of scheduled euthanasia on measurements of survival or morbidity, the 
morbidity curves were only calculated from the tanks that were sampled in response to 





Figure 10-2: Cumulative morbidity (%) of fish with different vaccine formulations (placebo: 
blue line; heat-killed: pink line and recombinant capsid protein: yellow line) versus days 
post-challenge with NNV extract by IM injection. 
 
 
10.3.2 Detection of RGNNV by RT-qPCR assay 
There was no detection of NNV genome using qR1T or qR2T from any fish challenged with PBS 
injection. Within the groups that were challenged with RGNNV there were a variable number 
of positive detections of NNV by the RT-qPCRs (Table 10-3). There was 100% concordance 
between qR1T and qR2T assay results (Table 10-4). The number of detections of NNV by RT-
qPCR was different to the number of groupers that displayed signs of VER (Table 10-3).  
Within the group that was vaccinated with placebo vaccine and challenged with RGNNV, fifty-
seven (97%) fish were positive for the detection of NNV by both assays. Only three fish from 
the placebo vaccinated group survived challenge, did not display signs of VER and were also 
negative by both assays for the detection of RGNNV when euthanased at day 40 (Table 10-3; 
Figure 10-3). 
Within the rCP-vaccinated group that was and challenged with RGNNV, twenty-three (38%) 
were positive for the detection of RGNNV by both assays (Table 10-3). Only six of the fish from 
the rCP-vaccine that were positive for the detection of RGNNV also displayed clinical signs of 
VER. A further 17 groupers were positive for the detection of RGNNV by RT-qPCR with an 
absence of clinical signs of disease (Table 10-3) (Figure 10-3). Thirty-seven fish that were rCP-
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vaccinated and challenged with RGNNV were negative for the detection of RGNNV by RT-qPCR 
(Table 10-3; Figure 10-3). 
Eleven of the groupers that received HK-vaccine, were positive for the detection of NNV by 
both RT-qPCR assays (n=60 fish each group; Table 10-3; Figure 10-3). Only five of the groupers 
from the HK-vaccine group had clinical signs of VER (Table 10-3; Figure 10-3). Forty-nine of the 
fish that received with HK-vaccine were negative for the detection of RGNNV by both RT-qPCR 





Table 10-3: Number and percentage (%) of groupers positive and negative for the detection 
of RGNNV genome by RT-qPCR from each experimental group and number of groupers 
displaying clinical signs of VER or no clinical signs of VER at the time of euthanasia. 
Experimental Group 

















Placebo vaccine 57 95% 3 5% 57 95% 3 5% 
Heat-killed vaccine 11 18% 49 82% 5 8% 55 92% 
Recombinant capsid protein vaccine 23 38% 37 62% 6 10% 56 93% 





Figure 10-3: Number of groupers positive and negative for the detection of RGNNV by RT-
qPCR from each experimental group with observation of presence (VER clinical signs) or 




10.3.3 Quantification of RGNNV by RT-qPCR assay 
RGNNV genome was detected with both RT-qPCR assays (qR1T and qR2T) from eye of virus-
challenged fish from day 7 until day 40 when the trial was terminated (Table 10-4). Assay 
qR1T, which targets the RNA-1 segment had slightly higher Ct values than qR2T, which targets 
the RNA-2 segment (Table 10-4). RGNNV was detected by qR2T with lower Ct value in the fish 




Table 10-4: Cycle threshold values of each RT-qPCR assay from eye of groupers from 








Figure 10-4: Average Cycle threshold (Ct) values of positive detections by qR2T from eyes 
collected from grouper from each experimental group according to the presence or absence 








Target 0 7* 8 10 11 13 14 18 20 21 28 40
RNA 1 qR1T nd 20.4 19.4 27.8 ns ns 18.1 20.9 20.9 ns ns 28.7
RNA 2 qR2T nd 19.8 18.2 25.3 ns ns 16.5 19.0 ns ns ns 28.5
RNA 1 qR1T nd 37.5 ns 30.0 34.0 ns 34.0 ns 19.2 34.9 33.6 36.7
RNA 2 qR2T nd 37.2 ns 29.8 33.3 ns 33.7 ns 19.0 34.6 33.3 36.3
RNA 1 qR1T nd 38.9 ns 33.7 ns 26.8 nd ns 33.6 nd 33.6 29.8
RNA 2 qR2T nd 38.6 ns 33.4 ns 26.5 nd ns 28.3 nd 36.0 29.4
RNA 1 qR1T nd nd ns ns ns ns nd ns ns nd nd nd
RNA 2 qR2T nd nd ns ns ns ns nd ns ns nd nd nd
ns= no samples           nd= not detected    * indicates onset of clinical signs      Bold indicates scheduled sample
Placebo vaccine ( Negative 
Control: PBS challenge)











10.4  Discussion 
In this study, vaccination of juvenile groupers with average body weight (abw) greater than 
50g was associated with 17-20% morbidity (80-83% survival) following IM challenge with 
RGNNV (average body weight at challenge 103.5 g, (𝜎 20.39 g)). In contrast, 93% of the 
unvaccinated fish succumbed to VER following challenge with viral extract (7% survival). The 
survival of vaccinated fish in this trial was improved compared to the initial experimental trial 
discussed in Chapter 8. The mechanism that conferred improved efficacy of vaccination on the 
larger fish is unknown.  
The acquisition of competence of the adaptive immune system is a prerequisite for successful 
vaccination. Excluding groupers, in many fish species, only the larval stages are highly 
susceptible to NNV (OIE, 2018). Despite the general acceptance of age-related susceptibility to 
NNV in juvenile barramundi, there is only a single report investigating the NNV susceptibility 
transition period (Jaramillo et al., 2017). In barramundi, juveniles older than 5 weeks of age 
develop a subclinical infection, whereas younger cohorts suffer clinical disease and mass 
mortality (Jaramillo et al., 2017). There is no characterisation of the mechanism that ensures 
resistance (Jaramillo et al., 2017) and a recent review of vaccination as a preventative strategy 
against VER did not refer to the development of the fish immune system (Hazreen et al., 2019).  
Due to their typically low economic value, juvenile fish are often the subject of disease 
challenge and vaccine efficacy experiments. Although less expensive, and logistically more 
easily managed, challenges with juvenile fish may fail to consider conditions that affect the 
development and expression of adaptive antiviral immunity. Many studies are driven by a 
need for commercial outcomes and focussed on the production of a vaccine, rather than the 
basic science of grouper immunity. The FAO generally recognise that the lack of understanding 
of immune function in host species is one of the factors that reduce the ability to manage 
disease in aquaculture species (FAO 2018). 
Foundational studies into vaccination of salmon identified the significant influence of water 
temperature on immune function in fish and discusses the term degree days (DD) as a unit to 
represent the interaction between number of days post-vaccination and water temperature 
(DD = water temperature (C⁰) x number of days) (Holm et al., 2014 in Gudding et al., 2014). DD 
has also become an increasingly popular method for explaining variation in fish growth and 
development (Chezik et al., 2014). Recently, the body weight and water temperature have 
been demonstrated to be important in fish immunization (Soto et al., 2014).  
The Biological Theory of Relativity (BTR) provides a more sophisticated framework for the 
study of a range of biological processes in marine ectotherms (Neuheimer 2019). The theory is 
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proposed to characterise biological phenomena, as a function of the variable interaction 
between water temperature and time with the biological variability of an organism (size of 
organism, age of organism, maturity of organism and environmental conditions of organisms’ 
habitat amongst others). For example, in the context of vaccination: the biological process of 
expression of effective adaptive antiviral immune response following vaccination in grouper 
would be studied in relation to grouper age, species, size, nutritional status, (biological 
variations) stocking density, salinity, water quality (environmental variations) and water 
temperature and time (biological time). The recognition and study of the multitude of 
interactions between biological time and biological variability allow the identification of the 
critical factors for a prescribed biological function (Neuheimer 2019). Adoption of the BTR 
approach increases the ability of researchers to make predictions about biological functions 
and ultimately allow researchers to manipulate the interaction to achieve a desired biological 
outcome (Neuheimer 2019). Although using different terms, the BTR approach is similar to the 
concept proposed by Stentiford et al. (2017) that disease outbreaks in aquaculture are likely 
the result of a complex interaction between host genetics-environment-pathogen and likely 
requires a multidisciplinary approach. The Biological Theory of Relativity and the 
multidisciplinary approach (Stentiford et al., 2017) are recent concepts and there has been no 
concerted approach to record the range of factors that constitute “biological time” or 
“biological variation” or multitude of factors that may influence the development of immune 
competence or initiate VER disease outbreaks in juvenile groupers.  
Although age and water temperature are considered important factors influencing the 
development of adaptive immunity in fish, few of the studies that investigate vaccination 
against NNV in grouper describe the age of fish or water temperature used in experimental 
studies (Table 10-5), although fish bodyweight is provided in the description of experimental 
groupers (Table 10-5). Review of the grouper vaccination studies indicates this project, 
amongst others, may have serendipitously been conducted across a transitional period of 
“biological time” required for the attainment of adaptive immune competence in juvenile 
cultured grouper (Table 10-5). Studies that report greater than 60% survival in groupers 
following vaccination and challenge, (Table 10-5) (Atujona et al., 2019; Yamashita et al., 2009; 
Oh et al., 2012 and this study: Chapter 10), involved larger bodyweight juveniles than the fish 
in less successful studies that report lower survival following vaccination and challenge (Mo et 




Table 10-5: Summary of the age, weight, water temperature (⁰C) and reported survival of 




However, within the concept of BTR or host-environment-pathogen model, it is unlikely that 
bodyweight is the sole factor influencing the effectiveness of vaccination to prevent VER. 
Water temperature has been demonstrated to affect in vitro and in vivo replication of RGNNV 
(Nishizawa et al., 2012). The bodyweight of groupers in the vaccination studies is influenced by 
other factors such as age, stocking density, nutritional status or other factors that could 
similarly impact on the ability of the grouper to respond to the vaccination. The slow release of 
any commercially produced vaccine against VER, despite the significant commercial value and 
reported successful application in experimental conditions since 2001 (Tanaka et al., 2001), 
suggests the prevention of VER disease in grouper grow out culture is more complicated than 
anticipated, and prevention of VER may rely on knowledge beyond vaccination.  
 
In this study, although vaccination led to improved survival in E.lanceolatus following challenge 
with NNV extract, analysis by RT-qPCR assay detected NNV in the surviving and moribund fish. 
Although survival between the two vaccinated experimental groups was similar (87% and 
80%), the detection of RGNNV varied between the two experimental groups. Namely, less fish 
in the HK-vaccinated group were positive for NNV (20%) compared to the rCP-RGNNV 
vaccinated group (41%) (Figure 10-5). Further interpretation of the effectiveness of each 
vaccine to prevent infection or the status of fish concerning RGNNV is not possible based on 
the results of RT-qPCR analysis. Detection of viral genome by RT-qPCR may be due to the 








E.coioides  from 1 to 18 dnp dnp *80-90% Lin et al. 2007
E.coioides dnp dnp 0.36 no challenge Lai et al., 2014
E.lanceolatus dnp 25-30 20 no challenge Liu et al., 2006
E.malabaricus dnp 25-30 20 no challenge Liu et al., 2006
E.lanceolatus 98 24-28 18 47-57% this study (Chapter 8)
E.septemfasciatus dnp 28 28 35% Tanaka et al. 2001
E.coioides dnp 28 33 17% Mo et al., 2019
E.coioides dnp dnp 32 no challenge Huang et al., 2014b
E.coioides dnp dnp 35 90% Atujona et al., 2019
E.septemfasciatus dnp 20 75 60+% Yamashita et al. 2009 
E.septemfasciatus dnp 20-24 80 100% Oh et al. 2012
E.lanceolatus 144 24-28 103.5 80-83% this study (Chapter 10)
Details of Groupers in the Studies
Reference
dnp = detail not provided
*this study reported survival of 44-69% in no-vaccine challenged fish. Virulence of the viral extract is questionable.
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viral genome or non-infectious particles (Gu et al., 2014). Although RT-qPCR is useful for 
tracking the increase in the detection of viral genome from infection to disease expression, its 
ability to determine the carrier or recovery status of grouper following exposure to NNV is 
restricted. Viral isolation in a compatible cell culture system is the definitive proof of the 
presence or absence of viable viral isolation may have improved (Schnurr 2006). Analysis of 
tissue samples by virus isolation may have improved interpretation of the RT-qPCR results in 
this project. Inclusion of tissue analysis by viral isolation has been incorporated into 
subsequent research that extends beyond this project.  
Regardless of the interpretation of the RT-qPCR results, this study demonstrated that 
increased survival of juvenile groupers, E.lanceolatus following experimental challenge with 
RGNNV viral extract, was markedly improved, with either HK-vaccine (83% survival) or rCP-
vaccine (80% survival) antigens compared to placebo vaccinated groupers (7% survival). 
Survival in vaccinated grouper following NNV challenge was improved in this study compared 
to the modest survival of 43-53% of vaccinated grouper in the trial described in Chapter 8 that 
studied smaller bodyweight groupers. This study indicates the significant losses imposed on 
the grouper aquaculture by the endemic strains of RGNNV present in Northern Queensland 
may be preventable with vaccination. However, the efficacy of vaccination to protect against 
VER requires further optimisation, as within the conditions of this study, the efficacy of 
vaccination was influenced by grouper bodyweight. Although further research is required 
before commercialisation of the vaccine, the results of this study are very promising and 
provide confidence to support further investment in vaccine development.  
 
10.5 Conclusion 
The following outcomes were described in this chapter: 
 
 
 Vaccination against RGNNV on larger fish >50g abw displayed improved protection 
against VER. 
 Vaccination of E.lanceolatus with a vaccine derived from either recombinant 
expressed capsid protein or heat-killed cell culture antigen led to increased survival 
(80-83%)/ reduced morbidity (20-17%) compared to placebo vaccinated control fish 
(7% survival/ 93% morbidity) after 40 days post challenge. 
 Bodyweight, or some factor that is reflected as bodyweight, appears to affect the 




CHAPTER 11. SUMMARY OF FINDINGS AND DIRECTION FOR 
FUTURE WORK 
11.1 Summary of Findings 
This work improved understanding of the management of Betanodavirus infections in the 
culture of grouper in Australia. The project aimed to answer three broad research questions. 
The following summary presents the discoveries relating to the research questions: 
 
To improve knowledge in the strains of Betanodavirus associated with VER outbreaks the 
following was investigated 
 The species of NNV that were associated with three natural outbreaks of VER in 
marine aquaculture systems in Northern Queensland were determined 
 The level of variation/conservation between strains that have been associated 
with VER in Northern Queensland and Australia was determined 
The complete sequences of mRNA of RNA 1 and RNA 2 were obtained from three disease 
outbreaks of marine finfish aquaculture ventures in Northern Queensland (collectively referred 
to as NQAus NNV). The NQAus NNV strains obtained from outbreaks of VER in tropical marine 
fish species in Northern Queensland were all RGNNV species. Phylogenetic analysis of both the 
RNA 1 and RNA 2 segments did not detect any chimeric recombination with any other NNV 
species such as SJNNV or BFNNV. RGNNV continues to be the only species of Betanodavirus 
detected from Australian fish. Comparison with other Australian-collected RGNNV strains 
indicated highest homology to the strains collected from tropical marine species rather than 
temperate or freshwater species.  
Comparative analysis with other strains in the NCBI database demonstrated the remarkable 
conservation of the RGNNV genome, both temporally and geographically. The RNA 1 and RNA 
2 segments of the three NQAus NNV strains retained 97-98% homology to the original RGNNV 
strain isolated from Japan (SgWAk97) in 1997. The high level of conservation of the genome 
with other RGNNV strains had implications for vaccine design. 
Research Question 1: What strains of Betanodavirus are associated with VER 




To assess the usefulness of qPCR as a management tool the following topics were investigated:  
 The qR2T assay described by Hick & Whittington, which is also the current ANZSDP to 
detect NNV from grouper was applied to grouper derived tissue. 
 The qR1T assay that targets RNA 1, designed by Hick & Whittington to detect NNV, 
was applied to grouper derived tissue. 
Positive amplicons produced from RNA 1 and RNA 2 were cloned to produce standard control 
plasmids for the qR1T and qR2T RT-qPCR assays described by Hick & Whittington (2010). The 
RT-qPCRs were applied to trace the viral copy number of RGNNV during the progression of 
disease in the experimental challenge. Both RT-qPCR assays detected viral genome before the 
onset of clinical signs at a cycle threshold values ranging from 45 to 22.6. During the period of 
peak morbidity, viral genome was detected by both RT-qPCR assays with a cycle threshold 
range of 10.6 to 21.1. Both assays detected NNV genome prior to the onset of VER disease, 
during peak period of morbidity and also up to 80 days post IM challenge. There were no false 
negative results obtained from either assay in this investigation when samples were sourced 
from grouper displaying clinical signs of VER. Both assays detected NNV in every tissue sample 
derived from fish that displayed several signs of VER. Based on known challenge status, there 
were no false positives. Neither assay detected NNV in E.lanceolatus tissues from any of the 
PBS- challenged groups that were not exposed to NNV. 
RT-qPCR was fit for purpose for application on brain and eye tissues of E.lanceolatus in 
situations that required rapid turnaround, high throughput, and quantitative detection of 
RGNNV genome such as during a during disease outbreaks or to demonstrate freedom from 
NNV infection. Both the qR1T and qR2T assays developed by Hick & Whittington (2010) are fit 
for purpose for the detection of RGNNV genome in eye and brain tissue collected from 
E.lanceolatus. 
 However, the interpretation of the results of RT-qPCR analysis must consider that detection of 
genomic material does not indicate viability of virus. As such, the RT-qPCR assay was not useful 
to assist in determining the nature of protection provided by the vaccines. In this study, 
vaccinated fish survived and did not display signs of VER. However, viral genome was detected 
from eye and brain tissues from the vaccinated fish that did not show signs of disease 
following IM challenge. It is not possible to determine if the viral genome that was detected by 
Research Question 2: Is qPCR a useful tool to assist in the management of VER in giant 
Queensland grouper, Epinephelus lanceolatus in Australia? 
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the RT-qPCR assays was viable virus. Consequently, it is not possible to determine if 
vaccination lead to the production of fish that were immune and not-susceptible to the virus 
or were sub-clinical carriers with increased tolerance. RT-qPCR is a useful tool to assist in the 
management of VER in giant grouper. However, it is not the only analysis platform required to 
understand and improve management of the disease.  
 
Vaccine and dsRNA were prepared that targeted the Ec2NQAus strain of NNV. The efficacy of 
the therapies to prevent VER were assessed by IM challenge of juvenile E.lanceolatus with viral 
extract. 
 
In an initial trial, the IM delivery of naked dsRNA designed against Ec2NQAus strain of NNV did 
not reduce severity of morbidity following IM viral challenge and no further investigation into 
dsRNA was conducted. Although this trial was unsuccessful, a range of variables could be 
adjusted to improve the potential of dsRNA as a treatment or preventative. A more recent 
accessing of the IDT dsRNA design tool indicates the anti-NNV dsRNA will cross react with six 
transcripts from the human genome (Refer to Appendix 3). Notably four of the transcripts are 
members of the C-type lectin domain family 4 member A (CLEC4A) gene which is involved in 
the regulation of immune reactivity (uniport.org/uniprot/Q9UMR7) and speculatively, may 
also be an important component of the grouper immune system. Until the knowledge of the 
grouper immune system is improved, research seeking to apply dsRNA to prevent VER will be 
very difficult. 
This study demonstrated vaccination is effective in preventing VER following IM challenge with 
viral extract. The effectiveness of vaccine appears to be affected by fish body weight. In an 
initial trial, involving fish with average body weight (~18g), the vaccinated groups of 
E.lanceolatus displayed between 43-53% cumulative morbidity after challenge with NNV 
compared to 88% morbidity in dsRNA exposed groupers. The modest reduction of morbidity 
by 35-45% indicated the vaccine formulation presented some potential as a preventative 
measure. There was a trend for vaccinated fish over 50g to have reduced morbidity. 
In a subsequent study, E.lanceolatus with average body weight over 50g were vaccinated and 
challenged. The outcome was increased protection against VER in the slightly larger fish with 
the vaccinated groups experiencing 20-23% morbidity compared to the 93% morbidity in 
placebo vaccinated groupers.  
Research Question 3: How effective is vaccination or dsRNA designed against the 




During the term of the project additional research questions were posed as important 
considerations to achieve the project aims. The additional discoveries are summarised here: 
 
Ideally, the efficacy of therapies to prevent VER is determined via a challenge model that is 
most representative of the natural infection route. Although waterborne transmission of 
RGNNV is the most likely path of transmission leading to natural VER outbreaks there is limited 
success applying waterborne transmission to experimental challenges. In a novel approach, 
waterborne challenge via co-circulation with diseased fish along with co-infection with the 
marine leech, Zeylanicobdella arugamensis was tested as an infection model. During a 40-day 
trial, despite habitation within a shared recirculation system containing 10 fish that displayed 
clinical signs of VER following exposure to RGNNV via IM challenge, none of juvenile 
groupers E.lanceolatus exposed/non-exposed to the marine leech Z.arugamensis succumbed 
to a VER disease outbreak. Furthermore, RGNNV was not detected by RT-qPCR from leeches 
collected from any of the tanks. The inability to induce VER via waterborne challenge despite 
the addition of leech infestation, lead to the adoption of intramuscular injection of RGNNV 
extract as a challenge model for all subsequent studies. 
 
Recognising that the cohort of fish used in the experimental challenge were produced from a 
mass spawning event with eight potential parents, the influence of parentage on 
survival/mortality was investigated by applying Multi-loci sequencing analysis. Parentage did 
not coincide with improved survival or increased mortality within the studies 
conducted. Although other genetic factors may be involved, the variance in survival between 





Inclusion of leeches to improve waterborne transmission of RGNNV 





Understanding the replication characteristics of Betanodavirus may allow targeted approaches 
to prevent VER. This study completed a review of the functional motifs of the Betanodaviruses, 
mapped them to a schematic diagram of the mRNA segments and sought to confirm the 
presence or absence of the motifs in the NQAus NNV strains. Review and confirmation of the 
multiple motifs across an entire genome have not been reported previously from any strain of 
Betanodavirus.  
The three strains of NQAus NNV obtained in this study retain the functional motifs of the 
Betanodavirus genome that are critical for viral replication and associated with most virulence. 
The confirmation of the presence of the essential motifs indicated that outcomes of this 
research based on the NNV strains obtained would likely be valid for translation to industry 
applications. 
11.2 Future work beyond this study 
Improved delivery of viral antigen 
Along with previous reports, this project succeeded in demonstrating protective immunity 
against NNV using either expressed recombinant RGNNV capsid protein or heat-killed RGNNV 
grown in cell culture as a vaccine antigen. Whilst the results are encouraging, further 
refinement of the vaccination process is possible. Although vaccination is an effective measure 
to prevent disease in cultured fish species, the requirement of handling to complete injection, 
imposes a level of stress on the fish and increased costs to production. A vaccine that could be 
delivered as an oral antigen would avoid the risk of handling stress. A factor reducing the 
effectiveness of oral vaccination is the inability to deliver antigen of sufficient quantity and 
integrity to effectively stimulate immune memory. As the minimal epitope for immune 
stimulation has been identified to be quite small, the delivery of antigen via recombinant 
bacteria, virus or algae may provide an optimal vaccination strategy. Some experimental 
vaccination applying the improved delivery have been reported this year. Gonzalez-Silvera et 
al. (2019) reported oral vaccination of sea bass using direct delivery of E.coli expressing the 





Identification and conservation of the functional motifs of Betanodavirus 
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Improved understanding of the development of grouper immunity 
Perhaps the most pressing issue to improve the management of VER in grouper is to identify 
the mechanisms of the immune system development in grouper that are involved in response 
to RGNNV and viruses generally. This would allow a more multidisciplinary and systematic 
approach to understanding VER expression and likely, other viral diseases. The need to better 
understand the immune function of aquaculture species is a factor limiting disease 
management across the multitude of tropical species (FAO 2018). There is an urgent need for 
research investment into understanding the mechanisms of immune function. Whilst such 
studies will not lead to production of commercialised products, they will provide the 
foundational knowledge that can be applied to adopt a more logical approach to improve 
health and reduce factors that impede fish immunity in aquaculture. For example, improved 
understanding of immune development may identify changes to husbandry practises or 
improve diet formulation that increase grouper health. 
 
Investigate impact of environmental parameters on grouper immunity 
Although the efficacy of vaccines can be accurately demonstrated in experimental challenge 
facilities, there are a multitude of other factors in grow out systems that may adversely affect 
fish immune function and ultimately contribute to VER outbreaks. Considering the 
metrological and agricultural conditions that dominate the locations prioritised for 
aquaculture development in Northern Australia, increased understanding of the following 
should be considered: 
 Effect of temperature and salinity on grouper immune function. 
 Effect of contamination of marine water ways with agricultural pesticides/herbicides 
on grouper immune function. 
 Refinement of grouper grow out diet formulation to support optimal grouper immune 
function. 
 
Investigate the roles of microRNA in the replication and management of NNV. 
Whilst the presentation of dsRNA constructs provided no protective effect against the 
development of VER following exposure to RGNNV extract in this experiment, the technology 
should not be discounted as a tool to better understand NNV. The paradox of NNV is that one 
of the smallest viral genomes is capable of causing disease in such a range of fish species, with 
worldwide distribution, across temperate and tropical and marine and freshwater culture 
systems. Reverting to basic principles for how the Betanodavirus genome achieves such 
infectivity highlights further paradox in the nature of this virus. Namely why, considering the 
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requirement for the virus to be very efficient within the constraints of its genome size, would 
the 403 nt of UTR of RNA 2 (~28% of the RNA 2 strand) that is not translated to produce the 
viral capsid protein, be retained in the genome if it served no purpose? In the absence of 
protein translation, a potential role of non-translated genomic sequence is viral and/or host 
gene regulation. Whilst, I have not been able to investigate this particular topic, I believe it is 
an important question to raise and the knowledge gained by understanding any potential roles 
of v-miRNA in Betanodavirus may provide a useful model to improve knowledge in other RNA 
viruses such as Influenza. The improved efficiency and affordability of next generation 
sequences techniques provides an unprecedented potential for researchers to investigate the 
complexities of viral-host interactions.  
11.3 Implications of findings from this study 
Although the viral aetiology of VER in Australian fish species was described by JCU researchers, 
Dr John Glazebrook and Steve de Beer (1990), research into the disease did not continue at 
JCU until this present study.  
This study has provided a strong basis for future work in the management of VER in grouper 
and has been applied towards the fast tracking of an NNV vaccine under FRDC project 2018-
098: “Vaccination for emergency and long-term control of nodavirus in Australian marine 
aquaculture”. The project aims to apply the demonstrated application of recombinantly 
expressed capsid protein-vaccine within a commercial field study and acquire data to support 
both the commercialisation of a vaccine and registration for approval by the Australian 
Pesticides and Veterinary Medicines Authority.  
The protocols to implement RT-qPCRs into a laboratory setting within this research project 
were audited against the international standard for testing and measurement (ISO 17025) 
within the field of animal health by the National Association of Testing Authorities (NATA). The 
laboratory, JCU AquaPATH, attained NATA accreditation in June 2018 at the James Cook 
University Townsville Campus. The specific scope of accreditation is the “detection of viruses 
by nucleic acid detection” specifically, the detection of Nervous Necrosis Virus. The facility is 
one of only three laboratories present in Northern Australia and one of only two universities 
nationally, that hold this scope of accreditation. The establishment of JCU AquaPATH on the 
James Cook University Campus provides core capability that will support future research in 
tropical aquatic animal health at James Cook University.  
 





























APPENDIX 1 MEDIA AND BUFFERS 
Lysogeny broth (LB) 
Component Mass (grams litre-1) 
Yeast 5 
Tryptone 10 
Sodium chloride 5 
 
LB agar 
Component Mass (grams litre-1) 
Yeast 5 
Tryptone 10 
Sodium chloride 5 
Bacteriological agar 15 
 
Blood agar 
Component Mass (grams litre-1) 
Enzymatic digest of Casein 7.5 
Enzymatic Digest of animal tissue 7.5 
Liver digest 2.5 
Yeast extract 5 
Sodium chloride 5 
Bacteriological agar 12g 
Sheep’s blood 100 mL 
 
Preparation of stock solutions for cloning media 
Component Volume to prepare  Mass Stock concentration  
Isopropyl β-D-1-
thiogalactopyranoside (IPTG) 
5 mL 0.12 g 500 mM 
5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-Gal) 
2 mL (in dimethylformamide) 0.1 g 50 mg mL-1 
 
 
Additions of for LB media and Agar 
Component Stock concentration Final required Dilution of stock required 
 (IPTG) 500 mM 0.5 mM 1000 
 (X-Gal) 50 mg mL-1 80 ug mL-1 625 
Ampicillin a 100000 ug mL-1 100 ug mL-1 1000 
Ampicillin b 100000 ug mL-1 50 ug mL-1 2000 






TAE Buffer (50x) (1 Litre) 
242 g Tris base  
57.1 ml glacial acetic acid  
37.2 g Na2EDTA·2H2O (2 mM) H2O to 1 litre. 
For working solution add 200ml to 9800ml H2O. 
 
SDS PAGE 10× Tris glycine buffer  
10 g SDS  
30.3 g Tris  
144.1g Glycine  
Dissolve ingredient in 800 ml distilled water and adjust volume to 1 litre  
Dilute 100ml in adjusted volume to 1 litre with distilled water. 
 
SDS PAGE Silver Fixative 
500ml Methanol 
50ml Acetic Acid 
400ml Distilled water 
Mix solutions and adjust volume to 1 litre  
 
SDS PAGE Development Solution  
20 g Na2CO3 
400µl Formalin 
800ml+ Distilled water 




APPENDIX 2: FAMILY ASSIGNMENT RAW DATA 
Counts of Alleles of microsatellite amplicons from primers of Bright et al. (2016) used in MLS 
analysis to determine parentage of vaccinated fish that displayed (clinical) or did not display 














Group Ct value M F Sample Name Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2
An2 An2 An2 An2 An25 An25 An25 An25 An31 An31 An31 An31 An4 An4 An4 An4
Parent not tested F1 KCJCU-001 244 246 243.68 245.85 170 192 169.48 192.32 190 190 189.65 189.65 Failed Failed Failed Failed
Parent not tested M1 KCJCU-002 232 246 231.34 245.78 174 192 173.68 192.44 192 202 191.81 202.17 195 201 195.12 200.78
Parent not tested F2 KCJCU-003 232 232 231.28 231.28 170 192 169.47 192.36 196 202 195.87 202.04 185 201 184.99 200.47
Parent not tested F3 KCJCU-004 226 232 225.07 231.22 168 168 167.35 167.35 190 192 189.64 191.72 195 201 194.75 200.63
Parent not tested M2 KCJCU-005 232 246 231.27 245.75 172 184 171.71 184.1 190 200 189.69 200 193 195 192.87 194.78
Parent not tested  F4 KCJCU-006 232 232 231.31 231.31 170 170 169.47 169.47 192 200 191.72 200 193 193 192.84 192.84
Parent not tested M3 F5 KCJCU-007 232 244 231.23 243.64 186 194 186.03 194.3 190 196 189.54 195.73 195 201 194.78 200.63
Sub-clinical 27 M2 F3 KCJCU-008 232 246 231.31 245.79 168 172 167.36 171.59 190 192 189.64 191.72 193 201 192.84 200.63
Sub-clinical 27 M2 F2 KCJCU-009 232 246 231.33 245.76 184 192 184.18 192.44 Failed Failed Failed Failed 193 201 192.91 200.47
Sub-clinical 27 M2 F2 KCJCU-010 232 232 231.29 231.29 170 172 169.61 171.56 196 200 195.89 200 185 193 184.91 192.88
Sub-clinical 30 M2 F2 KCJCU-011 232 246 231.44 245.87 170 172 169.72 171.78 200 202 200.15 202.15 185 193 185.13 193.06
Sub-clinical 27 M2 F2 KCJCU-012 232 232 231.39 231.39 170 184 169.72 184.2 196 200 196 200.15 193 201 193.06 200.61
Sub-clinical 30 M2 F4 KCJCU-013 232 232 231.31 231.31 170 184 169.61 184.11 Failed Failed Failed Failed 185 193 184.91 192.88
Clinical 24 M2 F3 KCJCU-014 232 246 231.26 245.87 168 172 167.32 171.53 190 192 189.59 191.68 193 195 192.8 194.88
Clinical 25 M2 F2 KCJCU-015 232 232 231.28 231.28 172 192 171.62 192.32 200 202 200 202.05 193 201 192.8 200.47
Clinical 23 M2 F3 KCJCU-016 232 232 231.22 231.22 168 184 167.37 183.94 190 192 189.58 191.67 193 195 192.8 194.72
Clinical 23 M2 F2 KCJCU-017 232 232 231.25 231.25 172 192 171.64 192.32 196 200 195.78 199.84 195 201 194.83 200.47
Clinical 23 M3 F3 KCJCU-018 232 232 231.21 231.21 170 184 169.37 183.97 190 196 189.54 195.73 195 201 194.78 200.47
Clinical 25 M1 F3 KCJCU-019 226 246 225.17 245.79 168 192 167.36 192.2 192 192 191.72 191.72 195 201 194.75 200.63
Clinical 22 M2 F4 KCJCU-020 232 232 231.13 231.13 170 184 169.47 183.86 190 200 189.48 199.84 193 195 192.68 194.75
Clinical 25 M2 F2 KCJCU-021 232 232 231.39 231.39 184 192 184.19 192.44 196 200 195.91 200 185 195 184.98 194.97
Clinical 24 M2 F3 KCJCU-022 232 246 231.25 245.8 168 172 167.48 171.52 190 200 189.59 200 193 195 192.91 194.81
Group Ct value M F Sample Name
Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2 Allele 1 Allele 2 Size 1 Size 2
Parent not tested F1 KCJCU-001 An8 An8 An8 An8 ELMS7 ELMS7 ELMS7 ELMS7 ELMS9 ELMS9 ELMS9 ELMS9 ELMS19 ELMS19 ELMS19 ELMS19
Parent not tested M1 KCJCU-002 150 172 150.34 171.56 346 346 346.95 346.95 260 264 260.07 263.87 386 386 385.54 385.54
Parent not tested F2 KCJCU-003 144 150 143.81 150.34 345 345 345.38 345.38 254 264 254.63 263.94 382 384 381.8 383.64
Parent not tested F3 KCJCU-004 144 144 143.7 143.7 346 346 346.92 346.92 254 260 254.42 260.09 382 386 381.84 385.58
Parent not tested M2 KCJCU-005 144 166 143.89 165.89 346 346 346.92 346.92 260 264 260.12 263.92 382 386 381.77 385.52
Parent not tested  F4 KCJCU-006 142 144 141.64 143.89 345 346 345.48 346.93 260 262 260.08 261.97 386 386 385.57 385.57
Parent not tested M3 F5 KCJCU-007 144 144 143.7 143.7 345 345 345.48 345.48 260 260 260.12 260.12 382 386 381.77 385.53
Sub-clinical 27 M2 F3 KCJCU-008 162 166 161.96 165.87 345 346 345.48 346.93 264 264 263.92 263.92 384 386 383.7 385.57
Sub-clinical 27 M2 F2 KCJCU-009 142 166 141.59 165.89 346 346 346.93 346.93 260 262 260.12 262.01 386 386 385.53 385.53
Sub-clinical 27 M2 F2 KCJCU-010 144 144 143.8 143.8 Failed Failed Failed Failed 260 262 260.2 262.09 386 386 385.62 385.62
Sub-clinical 30 M2 F2 KCJCU-011 144 144 143.8 143.8 Failed Failed Failed Failed 254 262 254.47 262 382 386 381.89 385.62
Sub-clinical 27 M2 F2 KCJCU-012 144 144 143.9 143.9 346 346 346.85 346.85 260 260 260.31 260.31 382 386 381.8 385.46
Sub-clinical 30 M2 F4 KCJCU-013 142 144 141.73 143.9 345 346 345.44 346.85 260 262 260.22 262.06 386 386 385.5 385.5
Clinical 24 M2 F3 KCJCU-014 144 144 143.8 143.8 346 346 346.94 346.94 260 262 260.14 262.02 382 386 381.88 385.62
Clinical 25 M2 F2 KCJCU-015 142 144 141.65 143.9 345 346 345.32 346.77 262 264 262.07 263.96 382 386 381.83 385.57
Clinical 23 M2 F3 KCJCU-016 142 144 141.64 143.89 346 346 346.91 346.91 260 262 260.07 261.97 382 386 381.88 385.65
Clinical 23 M2 F2 KCJCU-017 142 144 141.64 143.71 346 346 346.91 346.91 260 262 260.1 262 386 386 385.6 385.6
Clinical 23 M3 F3 KCJCU-018 142 144 141.59 143.62 346 346 346.8 346.8 254 260 254.4 260.19 382 386 381.78 385.51
Clinical 25 M1 F3 KCJCU-019 144 144 143.81 143.81 346 346 346.95 346.95 254 260 254.32 260.1 386 386 385.67 385.67
Clinical 22 M2 F4 KCJCU-020 144 150 143.8 150.17 345 346 345.48 346.77 264 264 263.9 263.9 382 382 381.77 381.77
Clinical 25 M2 F2 KCJCU-021 144 144 143.71 143.71 345 345 345.48 345.48 260 260 260.08 260.08 386 386 385.47 385.47
Clinical 24 M2 F3 KCJCU-022 142 144 141.59 143.62 346 346 346.94 346.94 254 260 254.54 260.17 386 386 385.62 385.62
142 166 141.59 165.86 345 346 345.5 346.95 260 262 260.2 262.08 382 386 381.87 385.61
ELMS 19 poor resolution
An2 An 25 An 31 An 4
An 8 ELMS 7 poor resolution
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APPENDIX 3: UPDATED ANALYSIS OF DSRNA DESIGN BY IDT 
DESIGN ANALYSIS TOOL. 
Updated output from IDT dsRNA design analysis tool. Accessed 29.9.19. Tool indicates dsRNA 
would target a number of genes of human (A image) and mouse (B image) origin. A lack of 
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